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Summary 
 
Exosomes are biological nanoparticles which play a role in long distance cell-
to-cell communication. These 40-100 nm sized vesicles are released by virtually 
all cells and derive from the multivesicular bodies within their parent cells. They 
modulate their target cell fate by induction of cell signaling as well as RNA and 
protein cargo transfer. Exosomes have also moved into the spotlight of clinical 
research, with potential use as biomarkers or next generation therapeutic delivery 
agents.  
Exosomes are thought to be highly efficient intercellular messengers but 
quantitative characterization is lacking. Also, their routes of cell uptake and 
subcellular fate within recipient cells remain elusive. This work introduces an in 
depth and quantitative characterization of exosome cargo, physicochemical 
properties, labeling, isolation and their recipient cell interaction at the single cell 
– single vesicle level.  
 
Basic protocols for exosome purification were revisited in order to allow for 
isolation of exosomes with sufficient yields and in as native state as possible to 
enable functional studies. Since exosome integrity and recovery yields after 
differential ultracentrifugation (UC), the most commonly used protocol for 
exosome isolation, turned out to be poor and unreproducible, we describe an 
alternative protocol based on ultrafiltration (UF) with subsequent gel filtration 
(GF) for recovering exosomes relatively selectively, with intact biophysical and 
functional properties and significantly higher yields.  
 
Next we establish methods for specific exosome labeling using fluorescent marker 
proteins transiently expressed in parent cells, which led to a focus on FP tagged 
CD63 constructs. CD63-emGFP labeled exosomes were extensively characterized 
and showed identical properties compared to unlabeled exosomes based on 
sucrose density gradient, CryoTEM microscopy and proteomics analysis. 
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Furthermore, we successfully adapted fluctuation correlation spectroscopy for 
characterization of fluorescently labeled exosomes. 
 
In another part of this work we describe a high content screen for exosome uptake 
which we use to provide a first systematic and quantitative profiling of exosome 
uptake across a panel of exosome parent recipient cells, including HEK293, Huh7, 
B16F10 as parental cells and additional primary fibroblasts, primary keratinocytes, 
iPS derived motor neurons and HUVEC primary human endothelial cells as 
recipient cell lines. These quantitative profiling data reveals preferences in 
exosome internalization by different cell types and suggests that specific receptor 
ligand interactions may determine tissue specificity. 
 
Finally, we address one of the fundamental questions in the field of cellular 
communication: how exosomes released by one cell enter and interact with their 
recipient cell. Our data quantifies for the first time the cell uptake dynamics of 
exosomes at the single vesicle and single cell level and reveals a quantitative 
efficiency paralleling that of infective pathogens rather than artificial delivery 
vehicles. We demonstrate that exosome uptake is largely mediated by active 
recruitment and surfing on filopodia to reach endocytic hotspots for their 
internalization at the filopodia base.  This provides a cell biological explanation for 
the remarkably high efficiency of exosomes in targeting recipient cells and 
discovers a new parallel to some viruses and other pathogens. We propose that 
the process of filopodia surfing may have evolved as a highway for exosomes into 
the cell, being hijacked by certain pathogens for host cell interaction. This data 
does not support the previously reported exosome uptake by vesicle fusion with 
the plasma membrane or cargo release by endosomal escape. Instead we observe 
intact exosome uptake to enter endocytic vesicles, which then scan along the 
endoplasmic reticulum (ER) and end up in lysosomes. Our data suggest a model 
of controlled cargo delivery to defined subcellular localizations like the ER, rather 
than vesicle fusion and free release into the cytoplasm. 
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1 Introduction 
 
1.1 Exosomes 
1.1.1 Background 
 
Exosomes were initially discovered in the early 1980s  1,2, when they were 
primarily assigned a role in cellular waste disposal. This appeared plausible due to 
their intracellular origin from the endo/lysosomal system where they arise by 
inward budding of the endosomal membrane, giving rise to so called into the 
Multivesicular bodies (MVB). Upon fusion of the MVB with the plasma membrane, 
exosomes are released into the extracellular space. Their secretion thus 
inherently results in depletion of intracellular components. Waste removal by 
exosomes in response to changing environmental conditions has been repeatedly 
demonstrated over three decades, such as in studies on the elimination of 
transferrin receptors during reticulocyte maturation 1, excretion of materials into 
urine during nephric clearance 3 or the balancing of cholesterol levels 4. 
The view that trash disposal is the primary function of exosomes changed 
dramatically when a study by Raposo and co-workers showed that exosomes from 
B-cells stimulate T-cell proliferation via recognition of MHCII receptors on the 
exosome surface 5, which suggested a specific function in cell-to-cell signalling. 
This discovery was followed by an avalanche of studies demonstrating further 
examples of exosomal signalling in various physiological processes including the 
inflammatory response 6–8,  immune tolerance 9–11, anti-tumor immune response 
12,13, chemotaxis 14,15, intercellular signaling within the tumor microenvironment 
16, non-synaptic communication in the nervous system 16,17, and in retroviral as 
well as prion pathology 18,19. 
The complex composition of cell recognition molecules presented on the exosome 
surface, including tetraspanins, MHC Class I and/or Class II antigens, integrins and 
other cell-adhesion molecules, already indicates a propensity for delivery to and 
uptake into recipient cells in a very specific manner. In addition the 
physiochemical properties of exosomes like their small size and fluidity allow 
them to reach virtually all types of tissue and even (be engineered to) penetrate 
tight barriers such as the blood brain barrier 20,21.  
Today it is widely recognized that exosomes play an important role in cell-to-cell 
and tissue-to-tissue signaling. This has recently called for new terminology, 
introducing ‘microvesicular signaling’ for this specific form of intercellular 
communication, alongside with the well-established forms of autocrine, 
paracrine, endocrine, and juxtacrine signaling 22–24.  
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Since the initial findings of Raposo and co-workers, it has been demonstrated that 
microvesicle- and exosome-signaling goes beyond the initially revealed 
interaction between cell- and vesicle-surface antigens: exosomes can also transfer 
their cargo to recipient cells to exert a function within the host cell – almost in 
analogy to viruses. A breakthrough discovery was published in 2006 25 when 
exosomes from embryonic stem cells were demonstrated to shuttle messenger 
RNA into haematopoietic progenitor cells and undergo translation to produce the 
encoded proteins. Shortly after, Valadi and coworkers demonstrated functional 
exosome-based transfer of mRNA between mouse and human mast cells 26. It has 
become a widespread notion that exosomes do indeed shuttle functional cargo of 
virtually every class of biological macromolecules:  cholesterol 4, protein 27–29, 
retrotransposon DNA elements 30, messenger RNA 26,27, microRNA 26,31–41 as well 
as exogenously introduced siRNA 21,42–44. Also, there are increasing data 
suggesting that the repertoire of exosome cargo is under dynamic control and 
thereby directly depends on parent cell type and state. 
 
Apart from their increasingly apparent role in the homeostasis of a living organism 
and physiological cell-cell communication, exosomes have also been implicated in 
pathological cell communication. As a potential collateral damage of their cell-to-
cell communication capabilities, exosomes were found to contribute to spreading 
of toxic proteins in neurodegenerative proteinopathies (reviewed in 45), including 
alpha synuclein in Parkinson’s disease 21,46,47 or tau in Alzheimer’s disease 48. 
Furthermore, a growing body of work has suggested a central role of exosomes 
secreted by solid tumors in cancer progression, such as by priming pre-metastatic 
niches 49–53. Even various parasite exosome interactions have been reported 
(reviewed in 54). Studies reveal cell-autonomous defense programs to monitor 
subcellular compartments for infection and to evoke counter-responses which are 
connected to extracellular vesicle release through lysosome exocytosis to clear 
recalcitrant pathogens. 55.  
  
1.1.2 Exosome Isolation and Differentiation/ Biogenesis 
 
Basically all body fluids as well as in vitro cell culture supernatants contain a 
variety of Extracellular Vesicles (EV), which are classified into three types based 
on their biogenesis. Ectosomes are shedded from the plasma membrane; 
Exosomes arise from intracellular MVBs. Apoptotic bodies are vesicles 
heterogeneous in size and content which are released during the process of 
programmed cell death. All classes of EV are double lipid membrane enclosed 
vesicles and have similar or at least partially overlapping physicochemical 
properties. The isolation of exosomes on the complex background of other 
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extracellular particles is thus still a major challenge in the field. For many years, 
the gold standard protocol for isolation of exosomes was based on their 
sedimentation properties during differential ultracentrifugation 56 which however 
is increasingly recognized to co-purify a number of other extracellular particles 57. 
To address this, typical protocols in the literature later started to include either 
additional ultracentrifugation steps or a sucrose gradient fractionation which 
retrieves exosomes relatively selectively at a typical sedimentation density of 
1.14-1.17 g/ml sucrose56. A different approach is based on polymer mediated 
precipitation which is now commercialized by different manufacturers. Finally, 
also affinity based purification using antibody capture through extravesicular 
marker proteins are now being increasingly implemented 58. All methods have 
their limitations either in the purity, the yield, the integrity or the irreversible 
binding to beads which may enable analytical characterization, but is 
incompatible with the requirements for functional studies. There is still a lack of 
data on the potential bias that different isolation procedures may introduce, in 
particular since we haven’t been able to study exosomes in their native state upon 
release from their parent cells without any enrichment or purification steps. The 
first part of this work aims to address the issue of isolating exosomes in high 
purity, sufficient quantities for functional studies and retained integrity. This 
resulted in a new exosome isolation protocol which we thoroughly characterized 
and benchmarked against standard methods, as published in a joint effort with 
the labs of Dr. Wood (Oxford University) and Dr. El Andaloussi (Karolinska 
Institute) and included in the results of this thesis (Paper I, Nordin J et al, 
Nanomedicine 2015). 
 
1.1.3 Exosome Characterization and Quantification 
 
A large variety of cell lines and tissues release microvesicles, and associated with 
these is an equally large diversity in reported and anticipated functions, behavior, 
markers and content of exosomes. This complicates the transition of this young 
and dynamic field into one of uniform definitions. In 2011 the international 
Society for Extracellular Vesicles (ISEV) was founded as a communication 
platform. Databases like ExoCarta 59, EVpedia 60 or Vesiclepedia 61 were installed 
to facilitate the exponentially growing interest and research in this exciting field, 
and align the relevant conventions. ExoCarta provides a resource for the most 
commonly used markers for exosome identification. These comprise chaperone 
proteins such as HSPA8 or HSP90, proteins of the ESCRT complex such as Alix and 
TSG101, proteins involved in transport and fusion like Annexins (ANXA2) or Rabs 
(Rab11, Rab7, Rab2), and tetrapanins like CD63, CD9 and CD81.  
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Gene 
Symbol 
Number of 
times 
identified 
 
Gene 
Symbol 
Number of 
times 
identified 
CD9  98 
 
LDHA  72 
ALIX 96 
 
EEF1A1 71 
HSPA8 96 
 
YWHAZ  69 
GAPDH 95 
 
PGK1 69 
ACTB 93 
 
EEF2 69 
ANXA2 83 
 
ALDOA 69 
CD63 82 
 
HSP90AB1 67 
SDCBP  78 
 
ANXA5 67 
ENO1 78 
 
FASN 66 
HSP90AA1 77 
 
YWHAE  65 
TSG101 76 
 
CLTC 64 
PKM 72 
 
CD81 64 
Table 1) List of top 24 proteins that are often identified in exosomes 
(ExoCarta status March 2015) 
 
 
Beside such relatively ubiquitous and generally highly abundant exosome 
markers, more than 170`000 molecules were identified in exosome samples as a 
result from ca 260 high throughput data sets and 6800 publications including 
exosome profiling data to date (EVpedia- status March 2015).  
 
 
High-
throughput 
studies 
High-throughput 
datasets 
Molecule
s 
Publicatio
ns 
Principal 
investigators 
168 263 172,080 6,879 3,336 
Table 2)  Publication statistics for exosome content related high-throughput 
studies 
 
 
Due to the heterogeneity and low concentrations on one side but also the 
overlapping characteristics of different EV populations on the other side there is 
a need to fill the gap between the molecular and micrometer scale 
characterization, which is driving the development of more sophisticated 
technologies. Tunable resistive pulse sensing (TRPS) based on a tunable 
elastomeric pore sensor, size adapted flow cytometry and nanoparticle tracking 
analyses (NTA) based on single particle light scattering are more recent 
developments to address the needs of exosome research. However, the most 
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commonly used methods for exosome characterization still largely encompass 
transmission electron microscopy for size and shape determination, the detection 
of exosome marker proteins by western blotting, as well as density 
characterization by sucrose gradient fractionation. In consequence there is still a 
general lack of quantitative characterization in exosome biology.  A quantification 
of exosomes based on total protein content is entirely non-representative and 
reproducible due to the highly variable co-purification of proteins and other 
vesicles, and gives no information about numbers of vesicles. 
In this work, we have addressed this issue and provide the first quantitative 
characterization of exosomes and their interaction with recipient cells at the 
single vesicle level, which is part of the publication I (Ultrafiltration with size-
exclusion liquid chromatography for high yield isolation of extracellular vesicles 
preserving intact biophysical and functional properties) and the manuscripts I 
(Quantitative profiling of exosome parent-recipient cell pairing by high content 
screening using CD63-emGFP vesicle labeling.) and manuscript II (Exosomes surf 
on filopodia to enter cells at endocytic hot spots, and shuttle with endosomes to 
scan the endoplasmic reticulum – a highway to the cell.) included in the results 
part of this thesis. 
 
Finally, the field has suffered from a lack of reagents to modulate exosome 
production or release from parent cells which might provide more stringent and 
functional controls. Recently emerging strategies such as sphingomyelinase 
expression modulation or pharmacological inhibition through GW4869 33, or 
Rab27a expression modulation 62 will thus become of increasing relevance for 
future studies.  On this background we need to be aware of a critical perspective 
with respect to current understanding of heterogeneity of microvesicle 
preparations, analytics, controls and the validity of an assignment of activities to 
exosomes versus potential other extracellular microvesicles or particles. 
 
 
1.2 Horizontal transfer and functional delivery of RNA into recipient 
cells by exosomes 
 
Following the initial discovery that mRNA can get shuttled by exosomes and is 
translated within recipient cells 25,26, Valadi and coworkers also revealed the 
presence of miRNAs within exosomes - a discovery which led to an eventual 
explosion of the field. However, a function of exosomal miRNA within recipient 
cells still remained elusive for a few years. A subsequent report that certain 
miRNAs are enriched in exosomes 27 and that the miRNA profile differs between 
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cell types suggested an active sorting mechanism. This finding still supported the 
two theories, a means to dispose of “unwanted” miRNAs or a functional relevance 
of the small RNA cargo within recipient cells. In 2010, three groups independently 
reported that intercellular transfer of miRNAs contained in exosomes results in 
silencing of target gene expression in the recipient cells 31,33,37. Zhang et al 37 
presented that THP-1-derived microvesicles delivered miR-150 into human 
HMEC-1 endothelial cells, resulting in elevated exogenous miR-150 levels in 
recipient cells concomitant with knockdown of c-Myb expression and enhanced 
cell migration – established downstream effects of miR-150. Pegtel and colleagues 
demonstrated that Epstein-Barr-Virus (EBV) encoded mature miRNAs were 
secreted via exosomes by infected B-cells; In co-cultures with infected B-cells the 
authors demonstrated silenced expression of EBV host cell target genes as well as 
viral miRNA luciferase reporters in non-infected MoDC recipient cells 31. As this 
study monitored miRNA function in recipient cells upon exposure to full 
conditioned medium using a co-cultivation of parent and recipient cells, the 
assignment of the miRNA delivery to exosomes, albeit plausible, was however still 
indirect. More direct evidence was finally presented in an independent study by 
Kosaka and coworkers in which miR-146b was loaded into exosomes by transient 
overexpression of a pri-miR146b expression construct in COS7 parent cells. 
Exosomes purified by ultracentrifugation from conditioned medium then resulted 
in silencing of a miR-146b luciferase reporter but not a seed mutated control 
reporter in HEK293T recipient cells. The same study revealed that exosome 
release is dependent on nSMNase activity, and used nSMNase knockdown as 
control for assigning the functional reporter gene silencing to exosomes 33 63.  
An intriguing advantage of exosomes is the ability to transfer packages of 
macromolecular cargo in a targeted manner across physical distances. However 
there are also reports for an involvement of exosomes in trans-synaptic transfer 
of cargo, including miRNAs, in the immune system 36,64, and potentially also the 
central nervous system (CNS) 65,66. In immune synapse formation, transfer of 
miRNAs from the T cell to the antigen presenting cell by CD63 positive exosomes 
has been reported to occur in an antigen dependent and unidirectional manner, 
resulting in silencing of a miRNA luciferase reporter gene in the recipient cells 36. 
Although there has still been no direct evidence for exosomal transfer of miRNAs 
and other functional cargo across synapses in the CNS, it is intriguing to speculate 
that this is happening since exosomes, released by neurons depending on synaptic 
activity, were found to be recaptured by other neurons 17. These vesicles might 
be an excellent means for anterograde and retrograde information transfer 
between synaptically coupled neurons. 
A new facet of high relevance for any functional studies of exosomal miRNA came 
from a study by Arroyo et al, which revealed that circulating miRNAs are not 
restricted to vesicles 67. Instead, more than 80 % of miRNA detected in plasma and 
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serum was found to be associated with non-vesicular, protease sensitive Ago2 
containing complexes. Interestingly, profiling data showed that certain miRNAs 
were exclusively associated with either the vesicles or the non-vesicular 
complexes, whereas some miRNAs were found in both. The authors speculate 
that vesicle-associated versus Ago2-complex-associated miRNAs in the circulation 
might originate from different cell types specialized for distinct release 
mechanisms.  
 
 
1.3 Engineered exosomes as nucleic acid delivery bio-vehicles 
 
The parent cell fingerprint of exosome cargoes and receptors and their tissue 
homing capability has not only opened an entirely new avenue in the diagnostics 
and biomarker field 27 but has also leveraged great interest in miRNA and RNA 
therapeutics research 44. Due to their natural function in transferring 
macromolecular cargo across cells there is increasing interest in translating 
exosome biology towards next generation drug delivery vehicles 68 69 . The current 
gold standard for therapeutic siRNA delivery is largely based on liposomal 
vehicles. These synthetic nanovesicles share a number of physicochemical 
features in common with exosomes, such as encapsulation of the RNA cargo by a 
lipid bilayer, similarity in size, shape and content of certain lipids such as 
cholesterol and neutral lipids. Despite the extensive and growing knowledge base 
on the structure-activity-relationship (SAR) of liposomal siRNA formulations, the 
elucidation of mechanisms and routes for the most efficient functional cell uptake 
and subcellular distribution of liposome delivered cargo is still a holy grail in 
nucleic acid therapeutics development. Exosomes therefore appear as a highly 
attractive role model to guide the development of next generation, biomimetic 
delivery vehicles. 
Intrigued by the idea of using exosomes themselves as biological delivery vehicles 
for siRNA and other nucleic acid therapeutics whilst avoiding immunogenicity 69. 
Wood and coworkers have pioneered a strategy for loading exosomes from 
mouse DCs with siRNA in vitro and allografting them to animals from the same 
species. In addition, tissue directed delivery was achieved by introducing targeting 
peptides on the surface of these exosomes as fusions with surface markers 
transiently expressed in the parent cells. This successfully allowed to obtain 
systemic delivery of siRNA into specific tissue or even across the BBB and 
knockdown of targets in the brain 70 .  
 
The therapeutic potential of exosomes has been further underlined by reports of 
successful delivery of exosome encapsulated anti-inflammatory drugs to the brain 
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by intranasal administration in mouse models of LPS-induced inflammation 20, or 
tumor targeted delivery of chemotherapeutics loaded into exosomes in breast 
cancer models 71. It has been proposed that in mesenchymal stem cells, 
transfected synthetic miR-143 gets repackaged into exosomes which then 
mediate functional transfer of the synthetic miRNA into osteosarcoma cells in in 
vitro models 72. This suggests that potential secondary spreading through 
exosomes might be exploited to deliver therapeutic siRNA indirectly to tissues and 
organs that are hard to target directly by current synthetic formulations, making 
use of repackaging into exosomes with preferred homing propensities from one 
to another tissue. However it has also been described that microvesicles 
originating from mesenchymal stem cells induce apoptosis and necrosis of certain 
immortalized cell lines in vitro and in vivo 73, suggesting that the observed 
outcomes of repackaged miR-143 within exosomes may be a consequence of 
cellular toxicity. Furthermore, it is not established yet whether transfection 
reagents have an impact on exosome biogenesis, which may influence their 
contents and cellular interaction, or even contaminate exosome samples isolated 
from the transfected cells. Therefore, to corroborate this idea, further studies on 
repackaging and secondary spreading of artificially delivered siRNA or miRNA 
through exosomes remain to be done, in particular also with careful controls for 
the impact of lipid transfection reagents on recovered exosomes.  
 
 
Prior to the translation of these revolutionizing basic discoveries into a 
therapeutic application however, there are still a number of hurdles to be taken, 
including a thorough assessment of safety profiles as well as viable strategies for 
exosome manufacturing. Also the loading process of therapeutic cargo into 
exosomes without compromising their integrity and function requires further 
research 74,75. The availability of exosome based drugs on the market therefore 
appears as an exciting but rather long term vision. However, in the short term an 
in depth understanding on their mechanism in tissue targeting and cell uptake 
may be of high impact for the tailoring of improved synthetic liposomal delivery 
vehicles 69, potentially allowing for reverse engineering of vesicular cell entry 
strategies employed by nature.  
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1.4 Strategies for monitoring exosome uptake 
 
While the body of literature on functional delivery of exosomes and their cargo 
has become extensive, we are still only at the very beginning of unravelling 
structural features or surface markers of exosomes that determine their tissue 
targeting, the underlying cell uptake pathways as well as the subcellular fate of 
the vesicles and their cargo within the recipient cell. Certain questions such as the 
study of exosome uptake receptors and pathways may already be answered by 
quantitative endpoint measurements of exosome uptake in fixed cells. This bears 
the advantage to non-invasively stain exosomes within the target cells post-
fixation, provided that a differential marker or cargo is available that is not 
expressed within the recipient cell. This strategy was used in exosome uptake 
studies using methods of varying levels of resolution, ranging from  FACS 76,77, 
fluorescence microscopy and high resolution microscopy, to electron microscopy 
78,79. 
The method of choice to monitor exosome uptake dynamics is by fluorescence 
microscopy in live cells. A prerequisite for this approach is to trace the vesicles 
already prior to its interaction with recipient cells with fluorescent lipid stains, 
surface markers or cargo. While fluorescent labelling of microvesicles via 
fluorescent polymer beads has been well established for quantitative analysis of 
exosomes by flow cytometry 76,80 the labelling of exosomes for functional studies 
does demand for less invasive approaches. A relatively straightforward approach 
is to stain exosomes post isolation with lipophilic carbocyanine dyes such as DiI, 
DiO or DiD. These compounds are lipid-like molecules with fluorescent head 
groups and long aliphatic tails capable of inserting into the vesicle membranes. 
Alternative lipid stains that might be used are FM4-64, R18, CFSE, PKH-26 81, PKH-
67 78, Top Fluor Sphingomyelin or Top Fluor Cholesterol (data not shown). 
Employing lipophilic carbocyanine dyes is relatively straightforward and allows for 
the use of synthetic fluorophores with optimal photophysical properties as well 
as flexibility over the entire spectral range. This strategy has meanwhile been used 
in several fluorescence microscopy based studies of exosomes 51,78,82–84. 
Furthermore, one could potentially also apply this strategy to integrate other 
synthetic ligands into exosomes such as PET tracers or even small molecule ligands 
targeting a receptor of choice. The major drawback of lipophilic tracers however 
is that they are not exosome specific and indiscriminately stain all vesicles and 
lipid fragments contained within the sample. To complicate matters, additional 
washing and ultracentrifugation steps are needed to remove unincorporated 
tracers which potentially introduce further bias and yield issues. Also, the 
integration of non-natural lipids might alter the physicochemical properties of the 
exosome membrane and thereby affect their functionality. Thus, careful 
optimization of labelling ratios as well as monitoring changes of exosome size and 
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zeta potential may be required to allow for the least perturbing conditions. 
Another difficulty is that in salt-containing buffers or media most of these lipid 
stains rapidly form micelles or aggregates themselves. Since these particles can 
have similar physiochemical properties as exosomes they may not be easily 
removed by washing and may require more sophisticated purification steps. Even 
if such micelles generally appear to have a poor efficiency in cell staining at least 
for nonphagocytic cells 85, thorough control experiments need to be done to 
unambiguously assign the observed signals to exosomes.  
A second strategy is to label the exosomes at the protein receptors; this might 
either be done post-purification based on random protein conjugation at primary 
amines by using standard succinimide chemistry 86,87, or at cysteines using 
maleimide 88,89 – activated dyes. This approach also allows for flexibility in choice 
of synthetic fluorophores (or ligands) and might be slightly less invasive than 
inserting synthetic lipids into the lipid bilayer; however, it still has drawbacks in 
lack of exosome specificity and potential interference with protein receptor 
function. A more specific and less invasive approach to visualize exosomes 
therefore seems the expression of fluorescent protein (FP) fused exosome surface 
markers such as CD-63 36 or CD-9 90 in parent cells prior to exosome isolation. This 
may even allow for real time tracing of exosomes directly upon their release such 
as in trans-well experiments or in animal models.  To limit a potential interference 
with exosome uptake function, the fluorescent proteins may be integrated at the 
luminal side of a transmembrane marker which should not or only minimally 
affect extra-vesicular membrane-membrane interactions with the target cell. 
Apart from a limitation to fluorescent proteins, another potential issue may be 
the non-physiological overexpression of FP-tagged receptor in the parent cells 
which may influence exosome biogenesis, release as well as their composition due 
to cell stress or simply altered surface marker abundance. Therefore, a careful 
analytical characterization of labelled versus unlabeled exosomes is crucial. These 
issues were addressed in this work and are summarized in manuscript I 
(Quantitative profiling of exosome parent-recipient cell pairing by high content 
screening using CD63-emGFP vesicle labeling). 
A third option for visualizing exosomes is by introducing labelled cargo post-
isolation, such as by electroporation 42,43,50. In theory this should leave the outer 
surface unchanged. However, it remains to be shown whether this method results 
in exclusive encapsulation of the cargo within the vesicles and not additionally 
promote sticking to the outside or formation of self-aggregated nanoparticles of 
the cargo such as has been encountered during siRNA loading 74. Alternative 
techniques for post purification cargo loading, or loading of FP-conjugated protein 
cargo overexpressed within the parent cells still remain to be investigated. 
Finally, double labelling of exosomes by combining either of the strategies 
mentioned above may allow mitigating some of the issues in specificity, as for 
22  
example allowing for discrimination of cell derived micro vesicles from lipid-dye 
micelles. Also, double labelling may give additional mechanistic information such 
as on when cargo gets released within the recipient cell, or how long a single 
vesicle stays intact (i.e. 82 ).  
 
 
1.5 Initial contact of exosomes to the recipient cell surface 
 
The increasingly emerging model is that exosomes specifically bind to cell surface 
receptors prior to their internalization, and several such receptors have been 
identified to date. One of the first efforts to identify exosome uptake receptors 
was published in 2004 78 and was based on a study of bulk uptake of PKH67 lipid 
labelled exosomes from mouse bone marrow derived dendritic cells (BMDC) into 
BMDC by FACS. In this system and as repeatedly observed in later studies, the 
vesicle uptake efficiency was dependent on the presence of serum and Mg2+ and 
sensitive to reduced temperature, which suggests a specific and energy 
dependent process. Using monoclonal antibodies (mAbs) to specifically block a 
number of candidate receptors in the recipient cells resulted in partial (up to 40 
%) inhibition of uptake when simultaneously blocking either several a5 and b3 
integrins (CD51 and CD61), CD11a and its ligand CD54 or the tetraspanins CD9 and 
CD81. Complement receptors (CD11b/c, CD18) on the other hand did not seem to 
be involved. Significant uptake inhibition was also observed when adding a 
soluble analogue of phosphatidyl serine (PS), O-phospho-L-serine but not the 
control stereoisomer. This observation was particularly interesting since PS is 
known to play a central role in recognition and phagocytosis of apoptotic cells or 
expelled nuclei during erythroproeisis when exposed as an “eat me” signal at the 
outer membrane leaflet. Also, these results established a connection to a previous 
study that had postulated the soluble molecule MFG-E8 (milk fat globule protein 
E8) in serum to function as an opsonin that docks exosomes to target cells 91. A 
plausible scenario might be that MFG-E8 functions as a bifunctional ligand that 
recognizes PS on the exosomes by its two factor V/VIII domains and 
simultaneously binds a5b3/5 integrins on host cells via its RGD (Arg-Gly-Asp) 
domain. Supporting this hypothesis, an agonistic anti-mouse MFG-E8 antibody 
increased, whereas addition of an RGD containing hexapeptide reduced exosome 
uptake in BMDC cell 78. In a search for phosphatidylserine binding receptors, 
Miyanishi and coworkers screened a library of hamster mAbs against mouse 
peritoneal macrophages for blocking phagocytosis of apoptotic cells and 
identified Tim1 (T-cell immunoglobulin- and mucin-domain-containing molecule) 
and Tim4 as key receptors in binding of PS and engulfment of apoptotic cells. The 
same study showed that PS recognition by Tim1 and Tim4 also plays a role in 
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binding and potentially also uptake of exosomes into phagocytic cells. Using a 
bead-based binding assay, the authors showed that exosomes mediate indirect 
association of Tim1-Fc with Tim4-Fc suggesting that exosomes can be bound by 
both receptors simultaneously. Moreover, overexpression of these receptors in 
Ba/F3 cells also increased the binding of immunogold labelled exosomes to the 
cell surface, suggesting similar mechanisms are involved in target cell binding of 
exosomes, at least in phagocytic cells. Finally, evidence that PS may play a role in 
exosome uptake also in non-phagocytic cells was presented in a study addressing 
tissue factor exchange between breast cancer cells 29. Exosome mediated transfer 
of tissue factor from MDA-MB-231 to MCF-7 cells was blocked by over 70 % by 
pre-incubation of the vesicles with AnnexinV, which should shield 
phosphatidylserine exposed on the exosome membrane – suggesting that 
phosphatidylserine might play a more general role in the interaction of exosomes 
with target cells not only in phagocytic cells.  
A different angle was presented in a study characterizing the requirements for 
exosome transfer of MHCII/peptide complexes during cognate T-cell / DC 
interaction 92. While the recruitment of DC exosomes to T-cells was generally 
dependent on T-cell activation, surprisingly it was independent of the antigen 
specificity - suggesting that the T-cell receptor itself was not involved in mediating 
exosome transfer. Rather the authors provided evidence supporting a direct 
interaction with LFA-1 based on a substantial (> 80 %) blocking of DC exosome 
uptake by LFA-1 specific neutralizing mAbs. Addition of Mn2+ to resting T-cells 
dose dependently induced exosome uptake in absence of T-cell activation. The 
authors assigned this activity to a Mn2+ mediated induction of a high-affinity state 
of LFA-1 and concluded that LFA-1 activation was sufficient to provoke DC 
exosome binding and uptake in T-cells during immunological synapse formation. 
Since exosomes are particularly rich in tetraspanins that, promiscuously, associate 
with integrins, Rana and coworkers assessed the involvement of Tspan8 
complexes in receptor-mediated uptake of exosomes in endothelial cells 93 and 
rat pancreatic adenocarcinoma cells 94. By comparing in vitro and in vivo target 
cell and tissue selectivity of exosomes isolated from parent cells overexpressing 
different combinations of tetraspanins the authors suggest that the tetraspanin 
web contributes to the homing preferences of exosomes originating from 
different sources. This theory appears enticing since it directly suggests a future 
scenario where profiling the receptor portfolio might enable to predict target 
selectivity and ultimately tailor exosomes for drug delivery, however many more 
systematic studies will be required.  
Finally, recent work by Christiansson and colleagues has investigated exosome 
uptake from the perspective of conceptional analogies to the uptake of viral 
particles.  Since virus derived cell penetrating peptides such as HIV-TAT as well as 
Lipoproteins are known to enter cells through heparan sulphate proteoglycan 
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receptor (HSPG) dependent pathways, the authors specifically investigated a 
putative role of the HSPG receptor in uptake of exosomes 95. Using lipid labelled 
exosomes from U87 glioblastoma cells, the uptake into GBM and CHO cells was 
monitored by fluorescence microscopy under different conditions of HSPG 
modulation. Indeed, exosome uptake was partially inhibited by addition of 
heparin and heparan sulphate derivatives but not the close analogue chondroitin 
sulfate. In addition, genetic modification of the HSPGs of both, the syndecan and 
glypican type, enzymatic depletion of cell-surface HSPG by xyloside as well as 
pharmacological inhibition of endogenous proteoglycan biosynthesis all 
significantly attenuated exosome uptake. Interestingly, HSPG receptors were also 
identified to be present on the surface of the exosomes themselves opening for 
the possibility of bidirectional recognition. However, the authors convincingly 
conclude that the exosome HSPGs are not directly involved in contacting the 
recipient cell since enzymatic depletion of receptors from exosomes by xylosidase 
did not impact uptake. Of note, inhibition of exosome uptake by heparin has most 
recently also been observed in other systems by us (data not shown) and others 
81, again suggesting a more general relevance of HSPG receptors beyond the 
initially used glioblastoma cells. 
To summarize, a number of different receptor/ligand interactions are emerging 
to play a role in exosome uptake, including phosphatidylserine, tetraspanins, 
integrins as well as the HSPG receptor (see also overview in Table 1). As a unifying 
hypothesis it appears plausible that, in line with the diversity of exosome parent 
and recipient cells, there is not just one way for exosomes to bind to target cells, 
but that several types of receptors are selectively involved for different exosomes 
to target different recipient cell types under different conditions. Hence there is 
a clear demand for a better understanding of how these vesicles target and enter 
their recipient cells, and how they deliver their cargo to reach its subcellular site 
of action. 
 
 
1.6 Exosome internalization  
 
As outlined above a variety of receptors and ligands have been associated with 
the cellular uptake of exosomes. Accordingly, a variety of different uptake routes 
for exosomes have been described, some of which were noted to be cell specific. 
In agreement with the established receptor-based contact of exosomes to the cell 
surface, the current leading model suggests that exosome uptake occurs by 
energy-dependent, receptor-mediated endocytosis 78,79,82,87. A fairly extensive 
study performed by Svensson and colleagues demonstrated that PKH26-labelled 
exosomes generated by glioblastoma (GBM) cells were taken up by a variety of 
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cell lines (HeLa, CHO, MEF, HUVEC and U87 GBM cells). Uptake was found to be 
saturable and dose dependent as determined by competition with unlabeled 
exosomes 79. Based on a co-localization with the known lipid raft marker cholera 
toxin B, the authors addressed the possibility of lipid raft mediated endocytosis 
and confirmed that depletion of cholesterol-rich lipid rafts by simvastatin (an 
inhibitor of cholesterol synthesis) decreased uptake of GBM exosomes. 
Consistently, GBM exosome uptake was significantly inhibited by the addition of 
filipin III, an inhibitor of lipid raft-dependent and caveolar endocytosis. This study 
also demonstrated that exosome uptake is negatively regulated by caveolin-1, a 
lipid raft-associated protein. Caveolin-1 is described to regulate the signaling of 
membrane protein extracellular signal-regulated kinase 1/2 (ERK1/2) and heat 
shock protein 27 (Hsp27), both of which - as well as their downstream targets - 
were found to be phosphorylated and upregulated up to 4.5 fold during exosome 
uptake in the same study. Inhibition of ERK1/2 signaling using the small molecule 
ERK1/2 inhibitor U0126 decreased exosome uptake alongside with reducing p-
Hsp27 in a dose-dependent manner. While it remains unclear how exosomes, 
caveolin-1 and ERK1/2 interact, this study is the first to relate exosome uptake to 
specific intracellular signaling pathways in the host cells. This introduces another 
important question to the field: Is exosome uptake dependent on the cell 
signaling / activation status of the recipient cell? A question that likely will be 
subject to further research in the near future. 
 
In contrast to the findings of Svensson et al 2013, an earlier report by Parolini and 
co-workers had described that exosomal uptake is primarily mediated by fusion 
with the plasma membrane under acidic pH conditions such as typically 
encountered within the tumor microenvironment 96. The authors used Octadecyl 
rhodamine B (R18)-labelled exosomes and observed a fluorescence increase of 
the dye in the recipient cells. Such an effect would be consistent with a fusion of 
exosomes with the plasma membrane thereby leading to an unquenching of the 
dye highly concentrated and self-quenched within the exosomes. In addition, R18 
from the exosomes co-localized with PKH67 in pre-stained recipient cells. While 
the authors conclude that this reflects an exosome / parent cell mixing event, such 
an effect would be consistent not only with plasma membrane fusion but also 
with co-localization or fusion with intracellular vesicles or potentially even 
recycling of exosomal lipids downstream of an initial uptake by endocytosis or 
other routes. Curiously, this study also demonstrated elevated levels of caveolin-
1 within the exosomes generated under acidic conditions, which was incorporated 
into caveolin-1 naïve recipient cells. Caveolin-1 is postulated to promote tumor 
progression 97, however was also demonstrated to negatively regulate exosome 
uptake in the study mentioned above 79. Further elucidation of the relationship 
between exosomes and caveolin-1 is required, which may reveal a dynamic 
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feedback relationship between exosome uptake and exosome-delivered caveolin-
1. 
Of note, uptake by fusion had also been reported in an earlier study describing 
microvesicle uptake into platelets 98. In this paper, exosomes were generated 
carrying different donor-acceptor pairs of lipid dyes and the fluorescence within 
recipient cells was monitored over time by live cell confocal microscopy. Since 
unquenched donor fluorescence was observed as early as 3 minutes after uptake 
this would support a dilution of the lipids, consistent with membrane fusion taking 
place already during the initial phase of uptake.   
The question remains whether such a fusion might be a phenomenon limited to 
special systems such as platelets or exosomes released and/or taken up in the 
tumor microenvironment. In this light it is interesting to note that Parolini and 
coworkers indeed reported a number of specific differences in both, exosome 
properties as well as their uptake efficiency under acidic conditions. For example, 
melanoma-derived exosomes demonstrated enhanced delivery to metastatic 
tumor cells compared to primary tumor cells, while overall exosome uptake was 
more efficient under acidic conditions. Melanoma exosomes derived under acidic 
conditions were also shown to undergo enhanced cellular uptake compared to 
exosomes released by parent cells under physiologic conditions, regardless of the 
environmental pH of the recipient cells, suggesting a change in the constitution of 
exosomes themselves. Consistently, exosomes generated under an acidic 
environment displayed increased sphingomyelin/ganglioside GM3 content and 
were described as having significantly lowered membrane fluidity – a change in 
properties that might plausibly alter the preferred uptake mode.   
Yet an alternative route of exosome cell entry was reported by Feng and 
colleagues for cells of the monocyte lineage (Feng 2010). Leukaemia-derived 
(K562 and MT4 cell lines) PKH26 labelled exosomes were incubated with a series 
of phagocytic as well as non-phagocytic cells and, after washing with citric acid 
buffer and trypsinization to remove surface bound exosomes, uptake was 
quantified by flow cytometry. Exosomes were taken up by phagocytic cells (THP-
1 myelomonocytic cells, U937 lymphblasts, RAW 264.7- and J774.1-macrophages) 
by about 3 orders of magnitude more efficiently than by non-phagocytic cells (NIH 
3T3, Jurkat, T, 293T, COS-7 and HEL299). Fluorescence microscopy revealed that 
the phagocytic cells internalized labelled exosomes together with phagocytic latex 
beads and uptake was inhibited by dynamin2 knockdown, confirming that 
exosomes were indeed taken up through phagocytosis in these cells. 
Furthermore, this type of uptake was dependent on actin cytoskeleton and 
PI3kinase, as well as susceptible to antibodies blocking Tim4, but not when 
blocking Tim1 receptors. This work does not address however whether this form 
of exosome internalization is just a consequence of phagocytosis as a generic 
27  
function of macrophages, or whether exosomes employ more specific strategies 
to hitchhike phagocytic routes for functional cargo delivery to these cell types.  
The diversity in current exosome uptake data may also corroborate the 
assumption that exosome-recipient cell interaction is largely governed by parent 
cell derived receptors or physicochemical properties, which would further 
enhance the potential for the development of tissue targeted, exosome-based 
therapeutics.  
 
 
1.7 Intracellular fate of exosomes in recipient cells 
 
The fate of the vesicles and their cargo upon internalization and their intracellular 
trafficking within recipient cells has not been extensively documented to date, 
and much additional research will be required. Current studies agree that once 
internalized, exosomes are sorted and shuttled to various vesicular and 
endosome-associated organelles within the cell, ultimately with their markers 
targeted to the lysosome. Morelli and co-workers labelled bone-marrow dendritic 
cell (BMDC) -derived exosomes with KPH67 and monitored co-localisation with 
different organelle markers in dendritic cells using confocal microscopy. Within 
five minutes of adding the labelled exosomes, KPH67 could be detected within 
early endosomes and after two hours the dye was located within late 
endosome/lysosome structures. It was also demonstrated that BMDCs were able 
to process the contents of allogeneic exosomes, and subsequently display the 
processed peptides on the surface of the cell. This suggests that cells such as DCs 
are capable of processing exosomal content specifically for surface display and 
immune stimulation, implying a trafficking of cargo to the ER. A study by Tian and 
colleagues demonstrated exosome uptake and trafficking during live cell 
microscopy 82,87. Rat pheochromocytoma (PC12) derived exosomes were labelled 
with the fluorescent lipophilic marker, DiD, and vesicle surface proteins with 
TAMRA using succinimidyl ester chemistry. Similar to the findings of Morelli, this 
study demonstrated an initial localization of labelled exosomes in endocytic 
vesicles near the cell periphery at the early phases of uptake, after which 
components of the labelled exosomes were increasingly directed to the 
perinuclear region. Using single particle tracking (SPT) of double labelled 
exosomes, the authors also derive that exosomes undergo various stages of 
trafficking and sorting. Initially, labelled exosomes were observed to exhibit slow 
drifting at the plasma membrane surface, possibly through the action of 
retrograde actin flow. This phenomenon has been reported previously during 
virus attachment to receptors at the cell surface 99. After uptake, exosome 
movement was confined, followed by a rapid transport (possibly along actin). A 
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second phase of rapid movement ensued, directed to the perinuclear region of 
the cell (possibly along microtubules). The final stage of confinement resulted in 
the separation of the exosomal markers; the TAMRA marker directed to the 
lysosomes suggesting that the protein contents of the exosomes are degraded, 
while the lipid DiD label was recycled back to the cell periphery. This study 
reported no evidence for fusion using R18 labeling in parent cells which is known 
to recycle into mitochondria from the plasma membrane, which in this study was 
not observed; instead also the R18 dye was trapped within endocytic vesicles, 
further supporting endocytosis as the primary uptake route, at least in this 
system. 
 
The current literature of exosome uptake and intracellular transport contains 
several contradicting reports, possibly highlighting the disparity in the methods 
used to generate, isolate and analyze exosomes. In addition, this may relate to 
some of the key issues relevant to exosome biology which requires extensive 
elucidation. Are all exosomes equally proficient with respect to the uptake routes 
they can take, and is exosome uptake governed by the recipient cell type and 
state? Or, in turn do exosomes differ in preferred entry routes based on their 
origin and respective surface receptor repertoire? There is a growing body of 
evidence to suggest that exosomes do vary not only between cell types but that 
further subspecies even exist within the population of vesicles released from the 
same cell type 62,100,101. Along these lines, it is conceivable that even within the 
same recipient cell and for exosomes from the same parent cell, multiple entry 
routes co-exist at a given time. Mechanisms as to how exosomes deliver and 
release their cargo remain elusive. The diverse set of cargo is likely functional at 
different subcellular sites, which makes a model appear plausible where 
exosomes take a defined trafficking route within the recipient cell shuttling 
between various ‘bus stops’ to differentially release cargo targeted to different 
addresses. Alternatively, all cargo might be released in one compartment such as 
by vesicle fusion and then trafficked on to their respective final destination 
independently.   
 
The need for a better understanding of how exosomes target and deliver their 
cargo into recipient cells in order to translate their biology into medical 
application were the seed of this thesis. 
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contact type binding partner 
presented 
on 
parent cell (Exosome) target cell literature 
tetraspannin CD151 Exosome 
rat pancreatic 
adenocarcinoma cells   
endothelial cells Rana 2011 
 Tspan8 Exosome 
rat pancreatic 
adenocarcinoma cells   
endothelial cells Rana 2011 
 CD9 Exosome BMDC BMDC Morelli 2004  
 CD9 Exosome DC APC, Tcells Thery1999 
 CD81 Exosome BMDC BMDC Morelli 2004  
HPSG HPSG receptor 
plasma 
membrane 
U87 glioblastoma cells 
GBM and CHO 
cells 
Christianson 
2013 
phosphatidyl 
serine (PS) 
PS Exosome BMDC BMDC Morelli 2004  
 (MFG)–E8/ lactadherin Exosome BMDC BMDC Morelli 2004  
 MFG-E8 (opsonin) Exosome DC  Thery 1999 
 Tim1 and Tim4  
plasma 
membrane 
Ba/F3 (phagocytic cells) Ba/F3 cells  
Miyanishi 
2007 
 Tim4 
plasma 
membrane 
K562 or MT4 
RAW 264.7 
macrophages 
Feng 2010 
 PS Exosomes MDA-MB-231 MCF-7 Lima 2013 
 PS Exosomes 
U373/EGFRvIII-GFP cells 
glioma cells HUVECs 
U373 (human 
astrocytoma) 
Al-Nedawi 
2008 
selectin P-selectin (CAM) 
plasma 
membrane 
blood-derived 
monocytes, THP-1 cells , 
Plasma 
platlets 
Ian del 
Conde, 2005 
 PSGL-1 Exosomes 
blood-derived 
monocytes, THP-1 cells , 
Plasma 
Platlets 
Ian del 
Conde, 2005 
integrin LFA-1 n.d. DC T-cell 
Nolte-t Hoen 
2009 
 LFA-1 
plasma 
membrane 
bone marrow-derived 
dendritic cells 
CD8+ dendritic 
cell 
Segura 2007 
 CD51 a5 integrins 
plasma 
membrane 
BMDC BMDC Morelli 2004  
 CD61 b3 integrins 
plasma 
membrane 
BMDC BMDC Morelli 2004  
 CD11a (ITGAL) 
plasma 
membrane 
BMDC BMDC Morelli 2004  
 CD54 (ICAM-1) 
plasma 
membrane 
BMDC BMDC Morelli 2004  
 CD11B (Mac-1) Exosome DC  Thery1999 
 CD11a (ITGAL) Exosome BMDC BMDC Morelli 2004  
 CD54 (ICAM-1) Exosome BMDC BMDC Morelli 2004  
lipid raft not specified 
plasma 
membrane 
glioblastoma(GBM)cells, 
U87 MG 
HUVECs & 
U87MG cells 
Svensson 
2013 
 sphingomyelin/ganglioside 
GM3 
Exosome Mel1 Mel1 & PBMCs Parolini 2009 
 
Table 3) Receptors for interaction of exosomes with target cells: 
Different classes of receptors are listed which were reported to be involved in the 
binding and uptake of exosomes into recipient cells. Of note, an early study 91 
came already to propose several uptake receptors purely based on MS-proteomics 
profiling of exosomes, several of which were later confirmed to be involved in 
exosome uptake by other groups.   
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mode of uptake recipient cell parent cell 
Exosome 
label 
literature uptake inhibition 
Phagocytosis 
various monocyte & 
macrophage lines 
vs. Jurkat, , HEK, 
COS, 3T3 
K562 or MT4, T-
cell leukemia cells 
PKH26 Feng 2010 dynamin2 knockdown, tim4 mAbs 
Phagocytosis macrophages 
Human saliva, 
plasma and breast 
milk 
PKH67 Lässer 2011 no inhibition 
Hemifusion, 
phagocytosis 
melanoma DC R18 
Montecalvo 
2012 
4°C, cytochalasin D, bafilomycin A1 
Fusion melanoma cells  Mel1 cells R18 Parolini 2009 
pretreatment with proton pump 
inhibitors 
Fusion 
U373 cells (human 
astrocytoma) 
U373/EGFRvIII-
GFP cells, glioma 
cells, HUVECs 
EGFRvIII 
fused at C-
terminus to a 
GFP 
Al-Nedawi 
2008 
AnnexinV, Co-incubation of 
exosomes, blocking antibodies 
specific for various integrins, 
adhesion molecules or tetraspanins 
Fusion activated platelets 
blood-derived 
monocytes, THP-1 
cells , Plasma 
parent cell - 
NBD-PE,        
Rh-PE, DOTAP  
Ian del 
Conde 2005 
annexin V, antibody to PSGL-1 
Receptor 
mediated 
endocytosis 
BMDCs BMDCs PKH67 Morelli 2004 
simultaneous inhibition of CD51 & 
CD6, CD11a & CD54, CD9 and CD81 
mAbs, soluble analog of PS, O-
phospho-L-serine, 
Receptor 
mediated 
endocytosis 
PC12 PC12 
DiD & amine-
conjugation 
(TMR-NHS), 
R18 
Tian 2010 & 
2011 
4°C & CytoD 
Receptor 
mediated 
endocytosis 
HeLa, CHO, HUVEC; 
MEF, U87 GBM 
GBM PKH67 
Svensson 
2013 
MbCD, filipin III, simvastatin, CAV1 
knockout MEFs and kd 
Endocytosis SKOV3 
SKOV3, HEK293 , 
H4 cells 
CFSE 
Escrevente 
2011 
chlorpromazine, cytochalasin D, 
methyl-beta-cyclodextrin 
Table 4) Different routes of cell uptake reported for exosomes 
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2 Thesis and objectives 
 
This PhD project aimed to investigate exosomes as delivery vehicles and 
potentially identify learnings form the natural delivery routes which may 
eventually be transferred to synthetic formulations for systemic siRNA delivery. 
The starting point of this project was complicated by inconsistent literature on 
exosome isolation and characterization. Our first goal was therefore to generate 
a toolbox for thorough analytical characterization and thereby benchmarking 
different isolation methods Furthermore, we planned to establish methods for 
studying cell uptake and trafficking. In particular, we would like to characterize 
the major routes of cell uptake, fate within the target cell, directed cell-cell pairing 
(e.g. cancer cell- immune cell, mother milk – epithelial cells) and tissue specific 
exosome homing. The focus will be on quantitative and mechanistic 
characterization of exosome mediated cell uptake & intracellular trafficking. 
 
 
3 Extended methods 
 
3.1 Cell culture 
3.1.1 Parent cells 
HeLa (ATCC), Human hepatocellular carcinoma cells (Huh7, ATCC), human 
embryonic kidney cells (HEK293T, ATCC), rat pheochromocytoma PC12 cells, a 
mouse neuroblastoma cell line N2A (ATCC) and a mouse melanoma cell line 
(B16F10, ATCC) were cultured in complete media comprised of Dulbecco's 
Modified Eagle Medium (DMEM, Life Technologies), supplemented with 10 % 
fetal bovine serum (FBS, Cellgro) and penicillin/streptomycin (5 mg/ml, Cellgro). 
Human colon cancer cell line HCT-116 (ATCC) were grown in RPMI1640 
supplemented with10% FBS and penicillin/streptomycin (5 mg/ml, Cellgro). 
Human monocyt derived Dentritic cells (hum moDC) were isolated from buffy 
coats and differentiated with rhGM-CSF (100 ng/ml) and rhIL-4 (80 ng/ml) 
according to the protocol from Perrine Loesle (Amanda Littlewood-Evans’s Lab) 
and Sophie Muller from Karl Welzenbach’s laboratory. Briefly: First peripheral 
blood mononuclear cells (PBMCs) were isolated from a buffy coat by performing 
a Ficoll gradient. Buffy coat/ whole blood was diluted with PBS in a ratio 1:5 and 
transferred to 50ml Falcon tubes. 30 ml of diluted blood was underplayed with 
10ml Ficoll and centrifuged at 2200rpm at room temp for 20 min in a swinging 
rotor. Then lymphocytes/peripheral blood mononuclear cells were collected from 
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the interphase ring with a transfer pipette and transfer into a fresh 50 ml Falcon 
tube.  
Cells were washed cells twice with PBS-/- and then centrifuge at 1400 rpm for 5 
min. Pellets were pooled and cell number was determined with a Casty count. For 
cell adhesion 2x10^6 PBMCs/ml were resuspended in RPMI 1640-glutamax 
supplemented with 10 % FCS and 1 % penicillin/streptomycin and plated out with 
5ml/well in a 6 well plate (costar). After 2 hour incubation monocytes adhere to 
the plastic whereas lymphocytes remain non-adherent. Non adherent cells were 
removed and monocytes were washed twice with 5ml medium. Finally, 5 mL X-
Vivo 15/well supplemented with rhGM-CSF (100 ng/ml) and rhIL-4 (80 ng/ml) 
were added for differentiation and immature moDC were harvested 5 to 7 days 
after isolation.  
For bone marrow derived monocytic Dentritic Cells cultivation cells were isolated 
from Mouse tibias and femurs. The bones were removed from mice into ice cold 
PBS and tissue and muscle excess were removed.  The bone marrow was flushed 
out of the bone in fresh DMEM medium using a 1 ml 27-gauge syringe.  Then cells 
were filtered through a cell strainer (40um), using the back of the plunget to pass 
any large bone marrow pieces. After one washing step by centrifugation clear 
bone marrow cell pellet was resuspended and cultured in DMEM Glutamax 
(Gibco-BRL), 10% FCS and antibiotics, supplemented with 10ng/ml murine GM-
CSF for differentiation. For human and mouse moDC exosome isolation medium 
was exchanged after differentiation and subsequent collected at 48h.  
For fluorescent labeled exosome isolation, typically 5-8 x 10^6 HEK293, 4-5 x 10^6 
Huh7 or 4-5 x 10^6 B16 cells were seeded in a 15 cm culture dish with complete 
media and transfected with CD63 expression constructs the next day. Cell 
transfection was done in complete medium using Lipofectamine2000 (Life 
Technologies; 1 ug DNA/2.2 ul LF2000) following the manufacturer's instructions. 
After 4 hours, cells were washed and medium was replaced by OptiMEM (Gibco-
BRL). Conditioned media were collected at the time point as indicated in the 
experiments for exosome isolation. Typically, 100-200 ml of 48h conditioned 
medium (pooled from multiple dishes) was used in most experiments.  
All cells were cultured at 37°C with 5 % CO2 
3.1.2 Recipient cells 
Human primary fibroblasts from a healthy donor (Life Technologies, #C-013-5C) 
were grown in MEM (Life Technologies) supplemented with 15 % fetal bovine 
serum and penicillin/streptomycin (5000 g/ml, Cellgro) in 0.1% gelatine (Sigma 
Aldrich) coated T150 flasks. For exosome uptake experiments, cells were either 
plated in 8-well slides (ibidi) at a density of 40-60 % (confocal and DIC live cell 
imaging experiments) or 96-well plates (ibidi) at a density of 60 % (exosome 
uptake screening assay).  
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Transient expression of BacMam actin RFP in human fibroblast and other cells was 
obtained by adenoviral transduction as described in the manufacture protocol. 
Also transient expression of Adeno-Lifeact-mCherry in human fibroblast cells was 
obtained by adenoviral transduction, and cells were seeded onto line substrates 
or 2D substrates (Fibronectin coated coverslips) at least 6 hours prior to TIRF life 
cell imaging. Line substrate microfabrication was performed as described 
elsewhere 102. Human primary keratinocyte progenitors (CELLnTEC Advanced Cell 
Systems AG, Bern, Switzerland) were kindly provided by Gabi Schutzius (Novartis 
Basel) and cultured in Epithelial Culture Medium (CELLnTEC Advanced Cell 
Systems AG) under sub-confluent culture conditions to prevent differentiation. 
For the exosome uptake assay cells at passage 6 were detached with Accutase 
(CELLnTEC Advanced Cell Systems AG), and plated 48 hours prior to exosome 
addition at a density of 20’000 cells per 96-well. Human iPS cells from a healthy 
donor (Coriell) were kindly provided by Claudia Merk (Novartis Basel) and 
differentiated into motor neurons following a protocol adapted from 103,104, 
plated in Matrigel coated 96-well plates (ibidi) and cultivated for 3 weeks prior to 
exosome uptake studies. HUVEC primary human endothelial cells (Promocell) 
were kindly provided by Giorgia Jurisis (Novartis Basel) cultivated in Endothelial 
Cell Growth Medium (Promocell) and plated in 96-well plates (ibidi) coated with 
Collagen (50 ug/ml, PureCol™ Advanced BioMatrix). HEK293 cells (ATCC), B16-F10 
cells (ATCC), Huh7 cells (HSRRB) and HeLa cells (ATCC) were cultivated in DMEM 
(Life Technologies) supplemented with 10 % fetal bovine serum and  1x L-
Glutamine 200 mM (100X; Life Technologies) and penicillin/streptomycin (Life 
Technologies) and plated in 96-well plates (ibidi) at a cell density of 40-60 % 
confluency one day prior to exosome addition. 
 
3.2 Fluorescent labeling 
3.2.1 Exosome labeling 
For lipid labeling of exosomes, parent cell line MVBs were stained by TopFluor 
Sphingomyelin, TopFluor Cholesterol or Dioleoyl sn Glycero 3-Phosphoethanol 
Emine-N-Lissamine Rhodamine B-Sulfonyl (NRhPE/NFlPE) 105 106 107 treatment.  
TopFluor Sphingomyelin (Avanti Polar Lipids) and TopFluor Cholesterol (Avanti 
Polar Lipids) was dissolved in Dichlormethanol 1mg/100ul. For Parent cell labeling 
the TopFluor labeled lipid was further diluted 1:20 in PBS by extensive vortexing. 
The stain- PBS emulsions was dripped on the cell medium. A few drops per 10cm 
dish were enough for a strong staining. The TopFluor Sphingomyelin and the 
Cholesterol did form permanent drops in the medium.  After the incubation time 
of 8 to 24h cells were washed extensively and fresh medium was added.  
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Blocking Buffer (prepare 50 ml, 
store at 4 °C) 
Endconc. Reagent Amount 
1 % (w/v) BSA  0.5 g 
0.05 % (v/v) Tween 20  250 µl 
5 mM (v/v) EDTA  (stock: 0.5 M) 0.5 ml 
1 % (v/v) FCS 0.5 ml 
PBS def. up to 50 ml ~ 48 ml 
Total 50 ml 
 
3.2.2 Cell organelle labeling for life cell imaging 
For Antibody labeling eukaryotic cells were fixed, permeabilized and 
immunostained in 96 well plates with the following procedure: First cells were 
washed three times with OptiMem and once with PBS. Then cells were fixed with 
4% PFA (NBK) for 10-15min at 4°C. Fixation was stopped by PBS, BSA 0.15 % 
washing step. Permeabilisation was achieved by 100 ul/well 0.1 % Triton X-100 
(Sigma) incubation for 10-15 min at RT followed by a PBS, BSA 0.15 % washing 
step. Then non-specific binding sites were blocked at least for 60 min at RT 
(Albumin, Bovine serum, fraction V, low heavy metals (Calbiochem) before the 
primary antibody CD63 polyclonal-rabbit (1:200 dilution in PBS def / BSA 0.15 % ) 
incubation was started. After 30-60 min at RT cells were washed 4 x with PBS def 
/ BSA 0.15% to remove unbound primary antibody. Secondary antibody diluted in 
PBS def / BSA 0.15% was incubated also for 30-60 min at R.T. and cells were 
subsequently washed at least 4 x with 200 µl / well PBS def. / BSA 0.15 % to 
remove unbound secondary antibody, thereby reducing the background signal. 
Optionally a nuclear staining by Hoechst followed and then supernatant was 
removed and PBS or Vectashield added for imaging. 
 
Figure 1) Endogenous CD63 IF staining in HeLa cells 
 
3.3 Cloning 
3.3.1 Lysosomal-associated membrane protein - Lamp2 
Lamp2 is known as an exosomal marker 108 69 109. The goal is to label exosomes for 
their characterization, quantification and in vitro quantitative Imaging. Using 
molecular cloning techniques, the HuR region of the vector pSecTag 2A HuR GFP 
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Primer design for CD63 in TOPO-EmGFP-Vector (invotrogen): 
fwd1:  AAGCTTGCGGTGGAAGGAGGAATG 
rev1:   CTACATCACCTCGTAGCCACTTCTG    
Sequencing primers: 
fwd1 (in kit): AAAGCAGGCTCCGAATTCGC  1629-1648 
fwd2 (lst19):  ATCATGTTGGTGGAGGTGGC  1932-1951 
fwd3 (lst20):  AGGGCTGTGTGGAGAAGATTGG 2221-2242 
rev1 (lst21):  ACCCACGGCAATCAGTCCCAC 1751-1731 
and pSecTag 2A HuR mCherry (originally psecTag2 A of Invitrogen, Cat.-No. V900-
20) was replaced by a lamp2b domain.  
The lamp2b domain (expasy.ch P13473, NCBI Genebank ref sec 13992) was 
amplified from a cDNA library with PCR and gene specific primers (Microsynth).  
 
 
  L Tm 
Tm 
(overlap) %GC RE 
Lamp2b F1 
AATAATGCTAGCCACCATGGTGTGC 
TTCCGCCTCT 1096885 35 73.5 54.4 51.4 NheI 
Lamp2b F2 
AATAATGCTAGCCACCATGGTGTGC 
TTCCGCCT 1096886 33 72.4 50.8 51.5 NheI 
Lamp2b R1 
AATAATTTCGAACAGAGTCTGATATC 
CAGCATAACTTTTTCTTCTGCCAA 1096887 50 73.1 69.8 34 BstBI 
Lamp2b R2 
AGGAGGTTCGAACAGAGTCTGATAT 
CCAGCATAA CTTTTTCTTC 1096888 44 71.2 59.9 40.9 BstBI 
 
Table 5) Lamp2b primer design 
The cDNA library was generated by reverse transcription of mRNA which was 
isolated from HeLa cells by a Trizol RNA purification. Subsequently, the flanking 
sites were cleaved by restriction endonucleases and ligated into the linearized 
(and dephosphorilized) vector pSecTag2A. The DNA vectors were amplified in E. 
coli, column purified and controlled by site specific restriction digestion as well as 
DNA sequence analysis. The DNA constructs were stored at - 20° C. 
 
3.3.2 CD63-GFP, CD63-mCherry, CD63-GFP-mCherry 
For alternative fluorescent exosome labeling, the full length coding sequence of 
human tetraspannin CD63 isoform A (RefSeq NM_001257390.1) was TOPO cloned 
into the pcDNA 6.2 N-emGFP vector (Promega) to result in an N-terminal fusion 
of emGFP to CD63. Single-standed cDNA was synthesized from total RNA using 
the High Capacity cDNA Reverse Transcription kit.  
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Figure 2) CD63-emGFP vector map 
 
pcDNA 6.2 N-mCherry-CD63 and N-mCherry-emGFP-CD63 vectors were then 
subcloned by replacing the emGFP CDS by gene synthesized inserts (Solvias) 
comprising the CDS of either mCherry or an emGFP-mCherry fusion. 
For DNA amplification and sequence modification, PCR reactions were performed 
by using the PCR Phusion Master mix. 
 
CD63 2nd loop GFP 
The CD63 2nd loop eGFP was kindly provided by Yiqi Seow (Agency for Science, 
Technology and Research, Singapore). Murine CD63 was cloned into peGFP-C1 
vector. The sequence is shown below with yellow highlighting the 
transmembrane regions and cyan the extracellular loops. Bold marks the 
sequence which has been removed from CD63 to insert the construct. 
 
atggcggtggaaggaggaatgaagtgtgtcaagtttttgctctacgttctcctgctggccttctgcgcctgtgcagtgggat
tgatcgccattggtgtagcggttcaggttgtcttgaagcaggccattacccatgagactactgctggctcgctgttgcctgt
ggtcatcattgcagtgggtgccttcctcttcctggtggcctttgtgggctgctgtggggcctgcaaggagaactactgtctc
atgattacatttgccatcttcctgtctcttatcatgcttgtggaggtggctgtggccattgctggctatgtgtttagagacc
aggtgaagtcagagtttaataaaagcttccagcagcagatgcagaattaccttaaagacaacaaaacagccactattttgga
caaattgcagaaagaaaataactgctgtggagcttctaactacacagactgggaaaacatccccggcatggccaaggacaga
gtccccgattcttgctgcatcaacataactgtgggctgtgggaatgatttcaaggaatccactatccatacccagggctgcg
tggagactatagcaatatggctaaggaagaacatactgctggtggctgcagcggccctgggcattgcttttgtggaggtctt
gggaattatcttctcctgctgtctggtgaagagtattcgaagtggctatgaagtaatgtag 
 
MAVEGGMKCVKFLLYVLLLAFCACAVGLIAIGVAVQVVLKQAITHETTAGSLLPVVIIAVGAFLFLVAFVGCCGACKENYCL
MITFAIFLSLIMLVEVAVAIAGYVFRDQVKSEFNKSF QQQMQ NYLKDNKTATILDKLQKENNCCGASNYTDWENIPGMAK
DRVPDSCCINITVGCGNDFKESTIHTQGCVETIAIWLRKNILLVAAAALGIAFVEVLGIIFSCCLVKSIRSGYEVM 
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Figure 3) Tetraspanin a transmembrane protein 
Tetraspanins have four transmembrane domains, 
two extracellular loops and contain a series of highly 
conserved amino acid residues. The key features are 
four or more cysteine residues in the EC2 domain, 
with two in a highly conserved 'CCG' motif. (Source: 
Wikipedia) These are removed in the construct so it 
abrogates its normal functions. 
 
 
 
eGFP was cloned in between XhoI and and EcoRI. The sequence of the pmCD63-
eGFP is shown below with eGFP highlighted in green 
GCTAGCacaccatggcggtggaaggaggaatgaagtgtgtcaagtttttgctctacgttctcctgctggccttctgcgcctg
tgcagtgggattgatcgccattggtgtagcggttcaggttgtcttgaagcaggccattacccatgagactactgctggctcg
ctgttgcctgtggtcatcattgcagtgggtgccttcctcttcctggtggcctttgtgggctgctgtggggcctgcaaggaga
actactgtctcatgattacatttgccatcttcctgtctcttatcatgcttgtggaggtggctgtggccattgctggctatgt
gggaggCTCGAGGagcaagggcgaggagctgttcaccggggtggtgcccatcctggtcgagctggacggcgacgtaaacggc
cacaagttcagcgtgtccggcgagggcgagggcgatgccacctacggcaagctgaccctgaagttcatctgcaccaccggca
agctgcccgtgccctggcccaccctcgtgaccaccctgacctacggcgtgcagtgcttcagccgctaccccgaccacatgaa
gcagcacgacttcttcaagtccgccatgcccgaaggctacgtccaggagcgcaccatcttcttcaaggacgacggcaactac
aagacccgcgccgaggtgaagttcgagggcgacaccctggtgaaccgcatcgagctgaagggcatcgacttcaaggaggacg
gcaacatcctggggcacaagctggagtacaactacaacagccacaacgtctatatcatggccgacaagcagaagaacggcat
caaggtgaacttcaagatccgccacaacatcgaggacggcagcgtgcagctcgccgaccactaccagcagaacacccccatc
ggcgacggccccgtgctgctgcccgacaaccactacctgagcacccagtccgccctgagcaaagaccccaacgagaagcgcg
atcacatggtcctgctggagttcgtgaccgccgccgggatcactctcggcatggacgagctgtacaagGAATTCggtggcat
ccatacccagggctgcgtggagactatagcaatatggctaaggaagaacatactgctggtggctgcagcggccctgggcatt
gcttttgtggaggtcttgggaattatcttctcctgctgtctggtgaagagtattcgaagtggctatgaagtaatgGATCC  
MAVEGGMKCVKFLLYVLLLAFCACAVGLIAIGVAVQVVLKQAITHETTAGSLLPVVIIAVGAFLFLVAFVGCCGACKENYCL
MITFAIFLSLIMLVEVAVAIAGYVGGSRIHPSGVTGLVPSLGDREKRDSLCPQGKYVHSKNNSICCTKCHKGTYLVSDCPSP
GRDTVCRECEKGTFTASQNYLRQCLSCKTCRKEMSQVEISPCQADKDTVCGCKENQFQRYLSETHFQCVDCSPCFNGTVTIP
CKETQNTVCNCHAGFFLRESECVPCSHCKKNEECMKLCLPPPLANVTNPQDSGTEFGGIHTQGCVETIAIWLRKNILLVAAA
ALGIAFVEVLGIIFSCCLVKSIRSGYEVMD 
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3.4 Exosome isolation 
Different cell lines were plated in 15 cm dishes and transfected at ca 50 % 
confluency with CD63-EGFP using Lipofectamine 2000 in DMEM supplemented 
with 10 % FBS. After 4 hours, cells were washed and medium was replaced with 
OptiMem (GIBCO, 25 ml per dish) and cultivated for further 24 to 72 hours 
according to the experimental setup.  
 
3.4.1 Ultracentrifugation (UC) for isolation of EVs 
The EV isolation method by UC was adapted from Théry et al 56.  Supernatants 
were collected and subjected to two low speed spins, 300g for 5 min followed by 
3000g for 10 min to get rid of cell debris and larger particles. The supernatant was 
subsequently filtered through a 0.22 μm filter. Syringe filters (Merck Millipore), 
50ml Steriflip (Merck Millipore), or 250/500ml Stericups (Merck Millipore) were 
used. The final ultracentrifugation step was done at 120,000g for 70 min with a 
Beckman Coulter ultracentrifuge with Type 45 Ti fixed angel Rotor and 70ml 
Polycarbonate Bottle/Assembly. When indicated the EV pellet was resuspended 
in PBS and subjected to an additional PBS wash at 120,000g for 70 min. The final 
pellet was resuspended in 200-500ul PBS. 
 
3.4.2 Ultrafiltration (UF) for isolation of EVs 
The UF protocol involves the same initial low-speed spins and 0.22um filtration as 
that of the UC protocol. Instead of a high-speed ultracentrifugation at the final 
step, the cell culture supernatants were either spun at 3,500g for 15 min in 100-
kDa molecular weight cut-off (MWCO) Amicon spin filters (Merck Millipore) or for 
larger volumes enriched in Amicon ultrafiltration devices of the appropriate size. 
In the standard procedure a 50 ml Amicon device was used with a 100-kDa 
molecular weight cut-off (MWCO) millipore membrane and N2 or argon 5bar gas 
pressure with up to 4 refills (200ml total volume/membrane) to enrich the ECV. 
The flow through was discarded after NTA loss of particle control and ECV were 
recovered from the membrane by 500ul – 1000ul PBS wash. In some cases, 
membrane was washed with 2 x 50ml PBS prior ECV recovery to further protein 
clearance. 
 
3.4.3 Sucrose gradient (SG) for isolation of EVs 
For exosome isolation via sucrose gradient, ten 350ul sucrose fractions with 
increasing (8-80%) sucrose was overlaid via freezing in dry ice between each step 
and topped with 12ml conditioned medium in 17ml Polyallomer Beckman tubes. 
The gradient was centrifuged after defrosting at RT for 65 hours at 120’000 g at 4 
°C in a Beckman Optima Max ultracentrifuge and fractions were collected by quick 
freezing the gradient in dry ice, removing the tube and slicing 10- 20 frozen 
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“salami” fractions from the bottom with a razor blade. Each fraction was 
defrosted in an Eppendorf 1.5ml tube and sucrose content was determined by 
refractrometry. For subsequent FCS measurements 10ul sample were diluted 1:10 
in PBS or water since 0- 8% sucrose does not have significant impact on diffusion 
time or molecular brightness. Alexa488 measurements in a sucrose dilution row 
confirmed that under these conditions changes in measured translational 
diffusion times due to viscosity and refractive index changes were negligible. 
 
3.4.4 Gel Filtration with prior ultrafiltration (UF/GF) for isolation of 
EVs 
Exosome isolation via UF/GF was essentially performed as described in Paper I 
(Ultrafiltration with size-exclusion liquid chromatography for high yield isolation 
of extracellular vesicles preserving intact biophysical and functional properties). 
Typically, 100-200 ml of the pre-cleared conditioned medium was then 
concentrated to a volume of 0.5-1 ml on an AMICON ultrafiltration device as 
described above. Enriched medium was then loaded onto a Superdex200 column 
(GE Healthcare) connected to an ÄKTA prime FPLC instrument (GE healthcare) 
equipped with a UV flow cell. 0.5 to 1 ml ECV were loaded via loading loop in the 
circuit of the ÄKTA. Gel filtration was performed at 4°C using sterile filtered 50 
mM Tris-buffer (flow rate 0.5 ml/min). Ninety-six individual fractions of 200 l 
each were collected and NTA and/or FCS was performed in at least every second 
fraction. For Western blotting, fractions were pooled (4 fractions each, omitting 
one fraction in between pools) and further concentrated to a volume of 30 ul on 
an Amicon 10-kDa MWCO spin columns (Millipore). 
 
3.4.5 Exosomes isolation using ‘ExoQuick’ 
Conditioned cell culture medium was collected in sterile Falcon tubes and 
centrifuged at 3,000 g for 15 minutes at 4°C to remove dead cells and cell debris. 
The supernatant was transferred to a new sterile Falcon tube and was 
supplemented with ExoQuick exosome precipitation solution (SBI, #EXOQ20A-1). 
1 volume of ExoQuick to 2 volumes of Cell medium were incubated overnight (min 
12h) at 4°C. The solution was subsequently centrifuged at 1,500 g at 4°C for 30 
minutes. The supernatant was discarded and the remaining drops were collected 
at the bottom of the tube by centrifugation at 1,500 g at 4°C for 5 minutes. The 
remaining solution was discarded, without disturbing the pelleted material. The 
precipitated material was resuspended in 1/10 of the original volume in PBS or 
water (GIBCO, #20012019) supplemented with protease inhibitors (Roche, 
#11873580001). The resuspended material was then subjected to TEM, to an 
NP40s-dependent FCS analyses and further experiments. 
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3.5 Exosome characterization 
3.5.1 Western Blotting 
Aliquots of sucrose gradient fractions or pooled and spin column concentrated gel 
filtration fractions were heated in SDS sample buffer for 10 minutes at 70°C and 
electrophoresed on 4-12 % NuPage gels (Life Technologies). Proteins were 
transferred to Protran nitrocellulose membranes (Whatman) using a SD Transblot 
system (BioRad) and blocked for 1 hour in PBS with 5 % (w/v) milk powder 
(BioRad) at RT prior to primary antibody incubation either for 2 hours in blocking 
buffer at RT or overnight at 4°C. Immune complexes were visualized using HRP-
conjugated secondary antibodies (Santa Cruz) on a Biorad XRS system.  
Antibodies: CD63 (sc-15363, Santa Cruz, 1/500); PDC6I/Alix (ab117600, Abcam, 
1/500 dilution), Tsg101 (ab83, Abcam, 1/500 dilution); Lamp2 (ab25631, Abcam, 
1/500 dilution); Calnexin (ab22595, Abcam, 1/10’000 dilution); GFP (ab290, 
Abcam, 1/1000 dilution); Calreticulin (A301-130A, Bethyl laboratories, 1/10’000 
dilution); Ago2 (clone 11A9 Ascenion, 1/1000 dilution; 4G8, Wako Chemicals, 
1/1000 dilution); b4-GalT1 (HPA010807, Atlas, 1/500 dilution); SmB (S0698, 
Sigma, 1/1000 dilution). 
 
3.5.2 Nanoparticle Tracking Analysis (NTA) 
Label-free particle size and concentration determination was performed on a LM 
NTA instrument (NanoSight). For each sample a dilution row of 1:100 to 1:10’000 
was prepared with pre-filtered PBS in 2ml glass vials and analyzed.  Measurements 
of 1 - 4 x 10^8 particles/ml are most valid and represent the dynamic range of the 
instrument. With a camera gain of 500, full detection range and 90 second 
recordings all camera settings as well as analyses parameters (detection threshold 
of 2, minimum expected particle size of 50 nm, fixed minimal track length of 4) 
where kept constant throughout all measurements to make these comparable.  
 
3.5.3 MS-Proteomics 
UF-GF isolated exosomes were separated by SDS-PAGE on a NuPAGE 4-12 % (Life 
Technologies) gel and stained with a Colloidal Coomassie stain (Sigma). Sixteen 
equal sized slices were excised from each of the gel lanes. In-gel digestion and 
subsequent identification by liquid chromatography coupled with tandem mass 
spectrometry was performed as described 110, with the exception that a mix of 
Trypsin and Endopeptidase Lys-C (Promega) was used instead of trypsin alone. 
Database searches were done with Mascot (version 2.4, Matrix Science) against 
the UniProt database (release of April 2013) concatenated with a reversed version 
and supplemented with known contaminants (such as trypsin, BSA and commonly 
used tags). Protein identifications were validated and summarized in Scaffold 
(version 4.0.3, Proteome Software Inc.), setting the protein identification 
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threshold at a 1 % false discovery rate (FDR) in the reversed database. At these 
settings peptide FDR was 0.05 %. The resulting protein list is provided as 
Supplementary Table 1 of manuscript I (Quantitative profiling of exosome parent-
recipient cell pairing by high content screening using CD63-emGFP vesicle 
labelling). Keratin contaminants were removed and are listed separately. Trypsin 
and Lys-C were also removed from the list. Total spectral count is provided as a 
semi-quantitative measure, as well as the number of unique peptides for each 
protein. The spectral count is shown without correction for the total number of 
assigned spectra in each sample (24’626 for GFP-CD63 and 21’234 for the 
untransfected sample). 
 
3.5.4 Fluorescence Correlation Spectroscopy (FCS)  
FCS was performed on a Clarina II Reader (Evotec Technologies) with 488 nm 
argon ion laser excitation at 50 µW, a 40x water emersion 1.15 N.A. objective 
(UAPO Olympus), a 488/633 nm major dichroic mirror in the excitation path and 
a HQ535/50m filter in the emission path. In-focus light was collected through a 50 
m pinhole using a SPCM-AQR-13FC avalanche photodiode (Perkin-Elmer 
Optoelectronics). The confocal volume was calculated in approximation according 
to 111 using the measured diffusional correlation time diff of fluorescent Alexa488 
free dye standard, the known translational diffusion coefficient of Alexa488 
(Molecular probes; D = 280 μm2/s) and the axis ratio fitted from calibration 
measurements.  
FCS data analyses: Typically for each sample, several dilutions were made and 
measured in a 96-well glass bottom plate (Whatman, GE Healthcare) with 30 
repetitive measurements of 10 s each. NP-40S at 1% v/v (Cambridge Bioscience, 
Cambridge, UK) was used to induce vesicle disruption. Disruption of vesicles was 
confirmed by dynamic light scattering. Autocorrelation curves were fitted with a 
one- or two-component two-dimensional diffusion model 112 113 to extract 
translational diffusion times, particle numbers and molecular brightness’s. For a 
two-component two-dimensional diffusion model we made the assumption that 
the two major CD63-EGFP positive components in the isolations are intact 
EVs/large vesicles and a secondary subpopulation of smaller, potentially disrupted 
vesicles. We then analyzed all detergent treated samples with a one component 
fit to derive the translational diffusion time of disrupted vesicles. Alexa488 
measurements in an EV sample with and without NP40s confirmed that under 
these conditions changes in measured translational diffusion times due to 
viscosity and refractive index changes were negligible.  
The average value from these measurements was then defined as the 
translational diffusion time of the putative small, disrupted particles in a two-
component fit of the detergent free samples. This allowed to fit the data with 
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significantly improved Chi2 and delivered a reasonably homogeneous second 
population with translational diffusion times corresponding to a hydrodynamic 
radius in the range of ca. 70-100 nm.  
FCS measurements from gel filtration samples were typically analyzed with a one 
component fit since this method already separates the fluorescent 
subpopulations by size. In contrast ultrafiltration and ultracentrifugation exosome 
isolations are contaminated by free GFP and a two component fit does clearly 
improve the particle analyzes. To further improve the reliability of the 
measurements up to 3 outliers of the 30 10 second measurements were excluded 
from the final dataset.  An outlier was defined by a value which was typically 5 to 
10 fold larger or smaller than the average value. Background fluorescence was 
determined by corresponding non labeled samples and due to auto- fluorescence 
background in cell medium and fetal calf serum a minimal molecular brightness 
thresh hold was set in some experiments when indicated. 
 
 
3.5.5 Electron microscopy (EM) 
3.5.5.1 Transmission Electron Microscopy (TEM) 
A 10ul sample drop was topped with a glow discharger (custom made glow 
discharger) treated Formvar polymer coated grid (Plano Copper G2300C, mesh 
size 200- 400). ECV were bound on its surface during a 20 min incubation before 
the grid was then passed on onto 2 additional PBS drops (incubation 2min each) 
and 4 water droplets (incubation 1min each) for washing and salt reduction. 
Subsequent the sample was exposed to 2% uranylacetat in H2H for 5min before 
the UA was partially removed by a filter paper (Whatman #1). The UA rest was 
dried on the grid for minimum 10min before it was placed in a grid holder. All 
samples were prepared in duplicates or triplicates and all preparation steps are 
done at RT. The grids were then visualized in the transmission electron 
microscope (Philips CM10, equipped with Veleta camera SIS) at 80kV. 
 
3.5.5.2 Cryo-Transmission Electron Microscopy (Cryo-TEM)  
A 4 ul aliquot of sample was adsorbed onto glow-discharged holey carbon coated 
grid (Quantifoil, Germany), blotted with Whatman filter paper and vitrified into 
liquid ethane at −178°C using a Vitrobot (FEI, Endhoven, Netherlands). Frozen 
grids were transferred onto a Philips CM200-FEG electron microscope (FEI, 
Endhoven, Netherlands) using a Gatan 626 cryo-holder (GATAN Inc, Pleasanton, 
USA). Electron micrographs were recorded at an accelerating voltage of 200 kV 
and a nominal magnification of 50’000x, using a low-dose system (10 e−/Å2) and 
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keeping the sample at −175°C. Defocus values were ranging from −2 m to 3 m. 
Micrographs were recorded at 4K × 4K CMOS camera (TVIPS, Germany). 
 
3.5.5.3 Scanning Electron Microscopy (SEM)  
Cells were grown on Thermanox coverslips (Thermo Scientifc Inc, Nunc). After a 
quick wash (less than 10 seconds) in fresh culture medium without protein, cells 
were fixed with 2 % paraformaldehyde (Electron Microscopy Science, Hatfield, 
USA) and 2.5 % glutaraldehyde (Electron Microscopy Science, Hatfield, USA) in 0.1 
M cacodylate buffer (Sigma Aldrich), pH 7.4. Cells were rinsed in 0.1 M cacodylate 
buffer (3 x 5 minutes). Dehydration was performed in a graded ethanol series 
(30%, 50%, 70%, 90%, 95, 100% ethanol, 3 x 2 minutes each step). After 
dehydration, specimens were rinsed with hexamethyldisilizane (Sigma Aldrich) 
and dried in an oven (60°C for 2 hours). Samples were mounted on aluminum 
stubs by fixing the coverslip with carbon double-sided carbon tape, and sputter 
coated (Quorum SC7620) with gold/palladium (5-8 nm). Cells were examined with 
a scanning electron microscope (Versa 3D, FEI, Endhoven, Netherlands) using the 
ETD detector. 
 
3.5.5.4 Atomic force microscopy (AFM) & TIRF microscopy for 
exosome characterization 
Samples were prepared for AFM following a protocol adapted from Tian Tian,  
2010 82. A drop of sample in buffer was placed on a glass slide in a humidity 
chamber for 10- 20min, so that vesicles enrich by slow water evaporation and 
sediment on the glass. Buffer salt and water was carefully removed with N2 flow 
to reduce salt crust formation.  
AFM (bruker catalyst) and TIRF imaging (LeicaDMI6000, TIRF module) were 
performed in collaboration with Jane Hyötylä (Biozentrum Basel). In the 
subsequent analyses with gwyddion and Image j one image dataset from AFM and 
TIRF was manually overlaid (image J) since TIRF and AFM were not aligned for 
parallel imaging. 
 
 
3.6 Exosome recipient cell interaction 
3.6.1 Live cell imaging 
3.6.1.1 Confocal and DIC live cell microscopy  
For the combined confocal fluorescence and DIC live cell imaging cells were 
seeded into an 8-well m-slide (ibidi) and pre-stained prior to exosome addition as 
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indicated in each experiment. Cell membrane was labeled by CellMask Deep Red 
(dilution 1:1000 for at least 2 minutes, Life Technologies), MVB were labeled by 
N-rhodamine (Rh) or TopFluor-labelled (Fl) phosphatidylethanolamine (NRhPE & 
NFlPE). 5ul TopFuor Sphingomyelin or TopFluor Cholesterol (dissolved in 
Dichlormethan) was added in 1ml optiMem. After 10min incubation at 37°C cells 
were washed minimal 3 x with OptiMem and fresh medium was applied. NRhPE 
and NFlPE were dissolved in Ethanol and similar to the other lipids 5ul were added 
to OptiMem and then washed for imaging.  
Endoplasmic reticulum and Lysosomes were labeled with ER Tracker Red (500 nM, 
for at least 15 minutes, Life Technologies) and LysoTracker Green (dilution 1:1000, 
for at least 60 minutes, Life Technologies) according to the manufactures 
protocol. Actin was labeled by transfection with CellLight Actin-RFP (Life 
Technologies) 24 hours prior to imaging. Typically, images were acquired on a 
confocal LSM710 microscope with Big-detector (Zeiss) with a 100x or 63x oil 1.4 
NA PlanApochromat DIC objectives and temperature, gas and humidity control 
unit (Life Imaging Services). Differential interference contrast (DIC) was set up 
using the transmitting laser light of excitation as light source and the TPMT as 
detector. Auto fluorescence was detected by imaging unstained cells and 
fluorescence bleach through and cross talk was determined by imaging the 
samples with identical settings but reducing the appropriate laser power to zero.  
 
3.6.1.2 Single vesicle imaging  
Exosomes from CD63-emGFP/CD63-mCherry double transfected HEK293 cells 
were imaged either by confocal (63x Oil, NA 1.4 Plan-apochromat objective on a 
LSM710 microscope with Big-detector- Zeiss) or widefield (60x oil, NA 1.42 Plan 
Apo N objective on a DeltaVision Core microscope, Olympus IX71 stand and 
Photometrics CoolSNAP HQ2 CCD camera, – API) fluorescence microscopy after 
spotting onto coverslips. Vesicles were detected as light diffraction limited GFP or 
mCherry fluorescent spots of uniform size corresponding to the point spread 
function of the microscope (figure 5), confirming recovery of single vesicles. As a 
control and for evaluation of chromatic aberrations point spread functions with 
fluorescence 100 nm and 200nm tetraspec beads (Invitrogen) (figure 4) were 
imaged. Colocalization was quantified based on overlap of the point spread 
functions in the two fluorescent channels to derive the number of GFP (G), 
mCherry (R) and GFP/mCherry (RG) double positive vesicles  
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Figure 4) PSF measurement at the LSM710 (63x NA 1.4)  
Determination of chromatic aberration and alignment with 100 nm and 200 nm 
Tetraspeck beads. Left: excitation 488, Right: excitation 488 and 561, Top XY view, 
bottom XZ view 
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Figure 5) Imaging of fluorescent labeled exosomes on coverslip. 
Top: CD63emGFP labeled exosomes, below CD63 emGFP-mCherry labeled 
exosomes excitation 488nm, 651nm and overlay. All Exosomes appear as PSF 
similar to the 100 nm and 200 nm calibration beads. 
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3.6.1.3 TIRF live cell microscopy  
For live cell TIRF imaging, human fibroblasts were transiently transduced with 
Adeno-Lifeact-mCherry and seeded onto line substrates or 2D substrates 
prepared as described in 102 4 hours prior to acquisition. TIRF microscopy (Roper 
Scientific) was performed with a Nikon TI Eclipse inverted stand equipped with a 
PlanApo 60x TIRF Objective, a Photometrics Evolve EMCCD camera, 491 nm and 
561 solid-state laser diodes and was controlled using Metamorph imaging 
software. Typically fife cell positions per experiment were defined and 
subsequently imaged within 20-30 sec adding up to a 20 to 60 min time lapse. 
Fluorescent exosomes were quantified and characterized by FCS and typically 
added 5-10 minutes prior to image acquisition unless specified otherwise. 
 
3.6.2 Image analysis  
Confocal image stacks time series, confocal image plane time series and TIRF time 
lapse data were imaged with frame rates and time frames as indicated. Particles 
tracking and trajectory analysis was performed with the Imaris x64 (Bitplane) 
Particle Tracking Analysis module. For co-localization studies stacks were imaged 
with a Leica Sp5 HyD imaging setup using 60x 1.4 NA PlanApo Objective with 2 
color sequential line scanning, 130 nm z-sectioning and 40 nm xy oversampling. 
Stacks were deconvolved with Huygens remote manager (automatic threshold) 
and then analyzed with the JACoP plugin 114  for Fiji 115. 
 
3.6.3 Screening 
In preparation of exosome uptake screenings relevant parameters were 
determined in collaboration with Justin Hean and Dominic Trojer. Since several 
popular fixation methods, e.g. PFA, quench the activity of GFP, in a first step a 
panel of various fixatives was assessed for their capacity to preserve GFP 
fluorescence and adequately fix cells to the plate surface. Penfix (Thermo 
Scientific) turned out to preserved GFP fluorescence well (almost comparable to 
live cells) and in parallel keeps levels of background fluorescence low. In result 
penfix, with the best signal to noise ratio was used for all screening experiments 
as follows: recipient cells were washed with PBS 5x and fixed for 20 minutes at 
room temperature after incubation in 96 well plates (ibidi). The fixative volume in 
presence of 1 ug/ml Hoechst (Life Technologies) and 0.02 % (v/v) CellMask Deep 
Red (Life Technologies) was typically 50% of the media that the cells were 
cultured. After fixing, cells were washed 5x with PBS and then stored in PBS.  
Subsequent imaging was performed on the Operetta (Perkin Elmer), using the 40x 
or 20x wide objective. Harmony software was used to determine overall GFP 
intensity per well and Mean GFP spots per cell per well. The assay was additionally 
scaled down from the 96well to a 384 well format. Dose response of exosome 
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uptake as well as time response of exosome uptake was then characterized in 
both formats. The typical procedure was performed as followed: 1500 Huh7 cells 
were seeded per well into a Greiner 384 well plate. Cells were cultured in 30 ul 
per well in 10% FCS DMEM. After 4 to 6 h the Huh7 cells had settled and were co-
incubated with exosomes at pM concentrations as indicated for 20 hours (in 
triplicate). Where necessary, volumes were adjusted to maintain the 30 ul of 
media. Cells were fixed and stained as previously described using PenFix. Cells 
were stained with CellMask Deep Red plasma membrane stain and Hoeschst, in 
doing so the Operetta software could assign perimeters and nuclei to individual 
cells. Washing and fixing were done in an automated fashion at this point. It is 
documented in the literature that cellular confluency affects uptake of viruses, 
thus effects of cell confluency were investigated for exosome uptake. Huh7 cells 
were seeded in the 96 well plate at 0, 1000, 2000, 3000, 4000, 6000, 8000, 10 000, 
12 000, 15 000 cells per well and left to establish overnight. Similarly, in the 394 
well dish, cells were seeded at 0, 500, 1000, 1500, 2000 and 2500 cell per well. 
After 24 h exosomes were added to the cells at a final concentration of 10 pM per 
well. Cells were washed, stained, fixed and analyzed as previously described.  
 
 
3.7 Lipid nanoparticle formulations  
5’-Cy3 labeled siRNA 116 was mixed in a 1:5 ratio with unlabeled siRNA and 
formulated as described in detail in 117 . Briefly, the LNPs were formed by mixing 
equal volumes of lipid solution dissolved in ethanol with siRNA dissolved in a 
citrate buffer by an impinging jet process. The lipid solution contained a cationic 
lipid 117 , a helper lipid (cholesterol) and a PEG lipid in a ratio of 50:46:4 at a siRNA 
concentration of 1 mg/ml. The LNP solution was then diafiltered with a MWCO-
100 kDa membrane, sterile filtered and stored at 4°C. The vesicles typically had a 
diameter of ca 150 nm. 
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4 Manuscripts of this Thesis and Extended Results 
In this section I will summarize and discuss the results obtained during this thesis, 
largely structured by including three manuscripts (paper I, manuscript I and II). In 
addition, related data which are not shown in any of the manuscripts are also 
detailed in this section. 
 
4.1 Exosome reagents and methods: Toolbox generation 
4.1.1 Methods for analytical characterization 
In the field, the definition as well as qualitative and quantitative characterization 
of exosomes is based on their physicochemical properties and content. For our 
studies we therefore first established a variety of methods for exosome 
characterization, including measurements of density (i.e. by sucrose gradients), 
size (Dynamic Light Scattering and Nanoparticle Tracking Analysis), shape 
(Electron Microscopy) and single molecule fluorescence (Fluorescence 
Correlation Spectroscopy). In addition, RNA and protein cargo was characterized 
by RT-qPCR and Western blot analysis, respectively. Because of its potential 
informative value and straightforward sample preparation we also investigated 
the application of atomic force microscopy (AFM) (figure 6) coupled with TIRF 
(figure 7) for exosome characterization (Biocenter/University Basel, Janne Hyötylä 
group Roderick Lim). 
 
 
Figure 6) Exosome characterization by AFM  
Extracellular vesicles isolated from Top Fluor Sphingomyelin stained HeLa cells. 
Left and middle image shows topographic views of an exosome sample. Bright 
colors in the middle image represent exsosomes as high bulges. Right image 
visualizes the topographic profile of the line drawn in middle image. The peak 
length measured on the x-axis represents the size of the vesicle (70 and 100 nm). 
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Figure 7) Differentiation of single vesicles by combined AFM / TIRF imaging 
Proof of principle for differentiation of orthogonally labeled vesicles within the 
same sample. HeLa TFSM labeled exosomes were mixed with siRNA-Cy5 labeled 
Lipid Nanoparticles and imaged by AFM/TIRF. (A) AFM image, (B) TIRF image; (C) 
Overlay. Green: TFSM (exosomes). Red: Cy5 (LNP).  
 
AFM in combination with TIRF proved to be a powerful method to discriminate 
individual particles and assign fluorescence directly to morphological visualization 
to single vesicles – an unsolved issue in the exosome field. Additionally, it allowed 
determination of size and shape of the vesicle with a resolution of ca 5 nm. While 
we conclude that this method would be a method of choice for exosome 
characterization, unfortunately we did not have the chance to routinely access 
the instrument and thus were not able to characterize all exosome samples used 
in this study by this technology.  
 
An alternative technology for both, qualitative but in particular also quantitative 
exosome characterization is the application of single molecule techniques. Using 
Fluorescence Fluctuation Spectroscopy, we are able to perform absolute 
quantifications of particle numbers in the low nanomolar range and gather 
additional single particle information like hydrodynamic size and molecular 
brightness. In particular FCS data analysis with a two component fit strategy 
enables additionally an analytical separation of different subpopulations of 
fluorescent particles and thereby to dissect and quantify e.g. small (free 
fluorophores, free cargo) from large (intact) vesicles or loaded fluorescent cargo 
within the same sample (figure 8).  
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Figure 8) Exosome characterization by FCS analysis  
(A) Autocorrelation curve (blue line) overlaid with one component fitting curve (red 
line); (B) Autocorrelation curve (blue line) overlaid with two component fitting 
curve (red line); (C) Representation of a 1 and 2 component fit diffusion time (size) 
analysis with and without detergent treatment. Green bars represent the two 
component fit analyzes; orange bars represent the one component fit analyzes. 
The red frame marks samples treated with detergent.  
 
 
This is of particular note, as there is still a gap in the exosome field for quantitative 
information, and most data are based on bulk protein or RNA amounts rather than 
particle numbers and single particle cargo concentrations. In contrast to 
Lightscattering or Nanoparticle tracking analyses measurements these methods 
are limited to fluorescently labeled particles - which can in fact be an advantage 
when exosome specific labels are used. This now allows quantifying exosomes 
directly in medium and thereby calculating absolute yields for the different 
isolation methods, together with additional single molecule information such as 
diffusion times and molecular brightness – providing information about how 
many fluorescent molecules per particles are present.  
 
To determine the Influence of laser intensity on potential photobleaching of the 
relatively slow diffusing vesicles we measured Alexa 488 as free dye in two 
different concentrations as well as samples from different sucrose gradient 
fractions of a CD63-emGFP exosome isolation with laser intensities from 25 uW 
to 200 uW (figure 9a and 9b). 
  
C 
1 component fitting curve 
2 component fitting curve 
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FCS Difft. >50% Kfit [µs] Figure 9a) Influence of laser intensity 
variation on FCS measurements of 
exosomes  
Panels show the measured diffusion times 
at 25 uW to 200 uW laser power. Blue bars 
represent the average of 30 measurements 
of the sample as indicated. Red frame 
indicates a detergent treatment of the 
sample. While the photo stable 
fluorophore Alexa488 shows a constant 
diffusion time at all measurements, the 
diffusion time of GFP labeled sample does 
decrease with higher laser power due to 
photo bleaching 
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n Figure9b) Influence of laser 
intensity variation on FCS 
measurements of exosomes  
Panels show the measured 
particle number (n) at laser 
intensities of 25 uW to 200 uW.  
Blue bars represent the average 
of 30 measurements of the 
sample as indicated. Red frame 
indicates a detergent treatment 
of the sample. Laser intensity 
(bleaching) does not affect 
particle quantification. 
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As expected, both the molecular brightness and count rate increased with the 
excitation laser power, whereas at the same time the number of particles (n) did 
not significantly change. However, the measured diffusion time decreased with 
higher laser powers, which can be explained by GFP bleaching during the 
measurement in the confocal volume. Due to this measurement we chose 50 uW 
as the lowest stable laser power with decent molecular brightness of CD63-
emGFP particles for all following measurements. 
Additionally, we used a mild detergent mediated vesicle disruption to determine 
whether the analyzed particles are lipid based or possibly represent protein 
aggregates which typically do not dissociate under this treatment. 
 
Figure 10) Determination of number of CD63-GFP molecules per exosome by 
FCS 
The scheme on the left visualizes the effect of the detergent treatment of the 
vesicle. The vesicle carries multiple fluorophores but is recognized as one particle. 
By vesicle disruption CD63-emGFP molecules are separated and diffuse as single 
fluorophores. The middle bar graph shows the effect of vesicle disruption on the 
molecular brightness (CPP) in two different exosome samples. The intact particle 
(green bar) is much brighter than the single fluorophore (yellow bar). Red frames 
indicate detergent treatment. The right bar graph shows the effect of vesicle 
disruption on the particle number (n) in two different exosome samples. The 
particle number increases with detergent disruption. The ratio of the particle 
numbers before and after disruption represents the average number fluorophores 
per particle. 
 
Exosomes showed a ca 5 to 20 times higher average molecular brightness than 
the detergent treated species. In parallel with the detergent treatment the 
number of fluorescent particles inceased in a similar ratio. This effect can be 
explained by an dissosiation of vesicles carrying multiple fluorescent molecules. 
Additionally, the population of fluorescent particles within the sample became 
more homogenous upon detergent dissosiation and showed translational 
diffusion times perfectly in line with free CD63-emGFP as measured in 
55  
independent controls. The ratio of particle numbers of detergent treated and non 
treated sample represents an average of the number of fluorescent molecules per 
exosome. Due to possible bleaching and quenching effects the number of particle 
measurements appeared more reliable than the molecular brightness data. 
 
4.1.2 Tools for studying cell uptake & trafficking 
 
4.1.2.1 Labeling 
 
Specific fluorescent exosome labeling is the method of choice for studying inter- 
and intra-cellular particle trafficking.  The size of 20 to 150 nm particles is too small 
for standard diffraction limited bright field microscopy but is clearly in the scope 
of fluorescent microscopy methods like confocal and TIRF life cell imaging.  
 
Table 6 Exosome labeling strategies 
Labeling 
strategy 
Labeling of Exosomes by 
labeling parent cells 
labeling of Exosomes 
post isolation 
Labeling 
method 
MVB targeting lipid dyes lipophilic dyes 
transfection of fluorescent 
exosome marker constructs 
non selective labeling (NHS 
chemistry/PL chemistry) 
Advantages 
specific labeling, no additional 
cleaning after isolation 
No manipulation of parent cells, 
labeling of exosomes from body fluids 
possible, choice variety of dyes 
Disadvantages 
Parent cell manipulation, not all 
cell lines efficiently transfectable, 
not applicable to exosomes from 
body fluids 
Invariably stains all vesicles, potential 
self aggregation, additional 
purification step needed. 
 
There are two general different labeling strategies; either indirectly via labeling 
the parent cells or by labeling exosomes post isolation (table 6). In our hand the 
second strategy is not the strategy of choice since the exosome isolation protocols 
are not able to differentiate between different extracellular vesicle types and the 
issue of low yields gets worse by the necessary additional washing steps.  
To gain in specificity and not label all vesicles in the medium, we decided to label 
exosomes by labeling the structures in the parent cells from which exosomes 
derive using markers which are known to be enriched in exosomes. As exosomes 
are highly enriched in lipid raft markers like sphingomyelin and cholesterol 98 we 
first established a method to label exosomes indirectly by staining parent cells 
with these lipids as fluorescent derivatives prior to exosome isolation and 
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characterization. The stained parent cells showed a strong accumulation of 
TopFluor Cholesterol, TopFluor Sphingomyelin and NRhPE/NFlPE in late 
endosomal / MVB compartments (figure 11), and released fluorescent exosomes 
into the medium. Based on FCS measurements, this method yielded detergent 
sensitive fluorescent exosomes with expected translational diffusion times (Figure 
12). FCS measurements also uncovered a contamination with lipid dye micelles as 
well as free dye within the samples. Therefore, we decided to focus on a second 
strategy with labeling exosomes by fluorescent markers. For this approach we first 
cloned lamp2b-GFP and lamp2b-mCherry expression constructs. Since lamp2b is 
also a Lysosomal marker and expression levels as well as GFP brightness was 
relatively low, we focused on another exosome transmembrane protein, CD63 
and generated an emGFP tagged expression construct by TOPO cloning into a 
pCDNA vector (Figure 2).  This expression vector yielded high CD63-emGFP 
expression levels with a comparable localization to endogenous CD63 (Figure 1). 
As detailed in Paper I, manuscript I and II, CD63-emGFP positive particles with 
exosome characteristics (density, size, detergent sensitivity, protein content, 
shape) were then successfully isolated from medium of Hek293, Huh7 and B16F10 
cells transfected with this construct. The tetraspanin CD63 has meanwhile 
increasingly emerged as one of the most commonly used exosome markers in the 
field, and we have expanded the fluorescent label versions to mCherry as well as 
a double labeled mCherry-emGFP fusion construct for exosome double labeling 
experiments (manuscript I (Quantitative profiling of exosome parent-recipient cell 
pairing by high content screening using CD63-emGFP vesicle labelling)). 
 
 
Figure 11) Parent cell labeling with lipid dyes. 
HeLa cells labeled with TopFluor Sphingomyelin (green)  
and NRhPE (red). (Zeiss LSM710inv. 100x 1.4NA life cell imaging) 
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Figure 12) Lipid labeled extracellular vesicle characterization by FCS.  
TopFluor Cholesterol (grey bars) as well as TopFluor Sphingomyelin (orange bars) 
labeled extracellular vesicles were isolated and analyzed. Both vesicle types have 
similar translational diffusion times and are detergent sensitive. 
 
 
 
4.2 Exosome isolation (extended results to Paper I- 
Ultrafiltration with size-exclusion liquid 
chromatography for high yield isolation of extracellular 
vesicles preserving intact biophysical and functional 
properties) 
 
In order to study exosomes uptake characteristics, it is essential to have an 
isolation process which results in functional, highly purified and decently 
concentrated vesicles at sufficient quantities. Since cells release many different 
vesicles with similar and overlapping properties exosome isolation turned out to 
be a challenging task, although different methods had been published before. We 
therefore first set out to benchmark the most popular isolation processes used in 
the exosome field, such as differential ultracentrifugation, sucrose gradients, 
precipitation methods, as well as particle size separation methods in light of their 
satisfactory recovery of exosomes for functional rather than analytical studies. 
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Figure 13) Benchmarking of different exosome isolation techniques 
The conclusions from this extensive effort are summarized in figure 13. Each 
isolation method proved to have its advantages and limitations. The sucrose 
isolation method has the advantage to separate exosomes and subpopulations 
from the bulk medium by density and efficiently eliminate potential protein 
complexes and contaminations, however is laborious and of limited yield and 
reproducibility. An exosome isolation kit called ExoQuick generated the highest 
yield compared to other isolation methods but has the drawback to leave 
unknown components and a high salt content in the sample which likely interferes 
with testing exosome activity upon administration to cells. TEM imaging with 
negative stain confirmed that sucrose gradient isolated exosomes showed a “cup 
shape” as described in the literature. Also ExoQuick isolated exosomes were more 
homogeneous in size than SG isolated exosomes, which corresponds to 
lightscattering measurements (figure 14). 
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Figure 14) Exosome size characterization by TEM and DLS  
Left panels show TEM images of EV isolated by sucrose gradient (middle fraction) 
and ExoQuick. Right panels show DLS measurements from the same exosome 
isolation batches. 
 
Ultracentrifugation is one of the most common methods in the field, with 
evidence for recovering exosomes with functional activity as e.g. demonstrated 
by work from the laboratory of Matthew Wood (Oxford) 21. However, depending 
on the protocol/centrifugation steps it has a low yield of particles or purity. In 
particular, high forces of ultracentrifugation might damage the particles, promote 
vesicle aggregation (Paper I (Ultrafiltration with size-exclusion liquid 
chromatography for high yield isolation of extracellular vesicles preserving intact 
biophysical and functional properties) and manuscript I (Quantitative profiling of 
exosome parent-recipient cell pairing by high content screening using CD63-
emGFP vesicle labelling)) and potentially change their physiological properties. 
Most current protocols likely bring a bias in isolated vesicle subpopulations or 
even introduce additional species such as salts or polymers, which is a major 
drawback of commercial precipitation based exosome isolation kits. As a result of 
the heterogeneity of isolated exosome samples and their complex composition, 
an unambiguous quantification is still lacking in most studies. These issues may be 
less relevant in studies of exosome biogenesis and their release from parent cells, 
or their use as biomarkers which mostly relies on analytical characterization and 
does not normally require the vesicles to survive the isolation intact. For the 
purpose of the study in this work however, they pose a considerable issue for 
investigating the transfer and function of exosomes and their cargoes in recipient 
cells. To analyze this potential issue a first thoroughly comparison of UC and UF 
isolation was done. 
 
Therefor parent HEK 293T cells were transfected with our working horse 
expression construct for a CD63-emEGFP fusion protein. The isolation of CD63-
EGFP positive material was confirmed by Western blot and Nanoparticle Tracking 
(NTA-Nanosight) analysis. Briefly, 300 ml Medium (OptiMem) conditioned for 48 
hours post CD63-EGFP transfection was cleared from cell debris by successive 
centrifugation for 3 min at 300 x g and 15 min at 3,000 x g, pre filtered through a 
0.22 m filter and subjected to either Ultrafiltration or Ultracentrifugation for 
Exosome isolation. Samples were analyzed by FCS in several serial dilutions with 
and without detergent treatment (NP40s at 1 % v/v) for vesicle disruption. To 
minimize photo bleaching of slow diffusing large vesicles, low excitation intensity 
(50uW) was used.  Due to the high heterogeneity in the sample that became 
apparent in the FCS analysis, there was the need to use a multi component model 
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for fitting the data. For this analyzis it was assumed that the two major CD63-EGFP 
positive components in the isolations are intact exosomes / large vesicles and a 
secondary subpopulation of smaller, potentially disrupted vesicles. We then 
analyzed all detergent treated samples with a one component fit to derive the 
translational diffusion time of disrupted vesicles. Disruption of vesicles by NP40s 
was confirmed by dynamic light scattering. In addition, measurements of 
Alexa488 in an exosome sample with and without NP40s confirmed that under 
these conditions changes in measured translational diffusion times due to 
viscosity and refractive index changes were negligible.  As shown in figure 15A, 
vesicle disruption by NP40s indeed resulted in almost identical CD63-EGFP 
translational diffusion times in all samples, including conditioned medium. The 
average value from these measurements was then defined as the translational 
diffusion time of the putative small, disrupted particles in a two-component fit of 
the detergent free samples. This allowed to fit the data with significantly 
improved Chi2 and delivered a reasonably homogeneous second population with 
translational diffusion times corresponding to a hydrodynamic radius in the range 
of ca 80-100 nm (figure 15A).  In this experiment the vesicle concentration in the 
medium was high allowing to perform comparative measurements also directly in 
conditioned medium (post 0.22 um filtration). This side by side comparison 
allowed to determine absolute recoveries of exosome isolations. To a more robust 
determination of concentrations, uncoupled from potentially different ranges of 
recovered vesicle sizes and molecular brightness, we disrupted the vesicles with 
NP40s and compared the absolute concentrations of CD63-EGFP molecules in 
each fraction. Ultrafiltration recovered ca 25 % of the CD63-EGFP molecules from 
the conditioned medium, which was ca 2.5-fold higher than the recovery by 
ultracentrifugation (figure 15B). Similar fold differences were obtained in other 
side by side isolations. In addition, this analysis revealed that both methods 
typically delivered a high fraction of large vesicles with both methods. Given that 
the UC supernatant showed a reduced fraction of large vesicles (figure 15C) we 
hypothesized that this might indicate vesicle disruption or fusion during the 
centrifugation. In fact, the slight increase in translational diffusion time of large 
vesicles after ultracentrifugation as compared to their diff in medium would be 
consistent with aggregation or fusion enforced due to the centrifugation forces. 
We therefore performed additional experiments with two different labeled 
vesicles to get a clear answer on this question (confer manuscript I (Quantitative 
profiling of exosome parent-recipient cell pairing by high content screening using 
CD63-emGFP vesicle labeling.)). Altogether, these data argue that ultrafiltration 
not only provides higher yields of exosomes but also better preserves their 
physicochemical properties. 
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Figure 15) Quantification and characterization of Exosomes from ultrafiltration 
and ultracentrifugation isolations by Fluorescence Correlation Spectroscopy:  
CD63-EGFP positive vesicles were analyzed by FCS in extracellular vesicle samples 
isolated from transfected HEK293T cells by UC versus UF, as well as directly in 
conditioned medium (post 0.22 um filtration). UC pellet: Exosome pellet from UC, 
resuspended in PBS. UC SN: supernatant from ultracentrifugation, concentrated 
on a 10 MWCO filter. UF: Exosome sample from UF retentate. UF FT: Flowthrough 
from UF, concentrated on a 10kD MWCO filter. 
(A) Translational diffusion times for large vesicles are shown without (black bars) 
and with (shaded bars) NP40s treatment to disrupt vesicles. Translational diffusion 
times (left axis) were converted into hydrodynamic diameters (right axis) based on 
extrapolation of the measured diff for Alexa488 and the reported hydrodynamic 
radius of 5.8 Å (Nathanel et al). (B) Absolute concentrations of HEK293T CD63-GFP 
molecules upon vesicle disruption by NP40s quantified by FCS in 48 h cultured 
medium and yields from UC pellet, UC supernatant, UF isolate and UF flowthrough.  
All values were corrected for dilution factors. (C) Fraction of large CD63-EGFP 
positive vesicles. All samples show a high integrity of recovered Exosomes with the 
exception of the supernatant from UC. (D) Scheme of workflow for sample 
preparation (SN= supernatant, FF= flowthrough). 
 
Based on these results there was a need to establish a new isolation method and 
we decided to use a mild enrichment of particles in medium using ultrafiltration. 
Interestingly, it turned out that a similar protocol was being independently 
established in the lab of Samuel Al Andaloussi at the same time, with largely 
identical conclusions. We therefore characterized and advanced this method in a 
collaborative effort. The final protocol includes an additional gel filtration step to 
reduce the non-vesicular protein background to a minimum, and allows to handle 
large volumes of medium under mild and isotonic conditions. The combined 
ultrafiltration / size-exclusion liquid chromatography (UF-GF) exosome isolation 
protocol, and its side by side comparison to UC exosome isolation was reported 
in Paper I (Ultrafiltration with size-exclusion liquid chromatography for high yield 
isolation of extracellular vesicles preserving intact biophysical and functional 
properties). This isolation method is now our state of the art exosome isolation 
method. However it is still unclear whether the withdrawal of serum or using pre-
spun medium for generating conditioned medium, which is necessary to avoid 
contamination by exosomes contained in fetal bovine serum, might cause the cells 
to release exosomes of different composition than under fed conditions. This 
question has been subsequently addressed by Samir Andaloussi and Matthew 
Wood and coworkers 118. 
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Abstract 
 
Extracellular vesicles (EVs) are natural nanoparticles that mediate intercellular 
transfer of RNA and proteins and are of great medical interest; serving as novel 
biomarkers and potential therapeutic agents. However, there is little consensus on 
the most appropriate method to isolate high-yield and high-purity EVs from 
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various biological fluids. Here, we describe a systematic comparison between 
two protocols for EV purification: ultrafiltration with subsequent liquid 
chromatography (UF-LC) and differential ultracentrifugation (UC). A significantly 
higher EV yield resulted from UF-LC as compared to UC, without affecting vesicle 
protein composition. Importantly, we provide novel evidence that, in contrast to UC-
purified EVs, the biophysical properties of UF-LC-purified EVs are preserved, leading 
toa different in vivo biodistribution, with less accumulation in lungs. Finally, we show 
that UF-LC is scalable and adaptable for EV isolation from complex media types such 
as stem cell media, which is of huge significance for future clinical applications 
involving EVs. 
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Figure 1. Ultrafiltration allows efficient isolation of intact EVs. (A) Chart outlining UF and UC 
protocols. (B) NTA of UF and UC-purified EVs. (C) WB of UF and UC-purified EVs. (D) NTA 
(fluorescence mode) of UF and UC-purified eGFP-positive EVs. (E) TEM of UF and UC-purified 
EVs. Arrows 1a: 
fragmentation, 1b: fusion and 2: intact. (F) Absolute concentrations of CD63-eGFP molecules 
(left y-axis) and percentage of intact vesicles (right y-axis) according to FCS (SN=supernatant, 
FT=flow-through). (G) Molecular brightness for each particle (counts per particle) (CPP) (n=3). 
*Indicates pb0.05, results represent mean+s.d. (H) Fluorescence microscopy of CD63-eGFP-
positive EVs. 
 
 
Intercellular communication, via paracrine factors, is essential for survival of all 
multicellular organisms. Recent evidence suggests another route of cellular 
communication: extracellular vesicles (EVs), comprising of nano-sized 
exosomes, microve- sicles and apoptotic bodies.1 Due to their ability to convey 
information through RNA and proteins, EVs can influence both physiological2 and 
pathophysiology processes.3,4 Moreover, EVs from mesenchymal stem cells 
have been exploited for regeneration of injured tissues.5–7 Hence, EVs are 
emerging as disease biomarkers and nanotherapeutics.8 
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Despite progress in EV research, the challenge of purifying biologically intact 
EVs remains. Differential ultracentrifugation (UC)9 is the classical protocol for 
EV isolation. However, problems with UC include low and operator-dependent 
yields.10 Alternative strategies like immuno-affinity capture,11 polymer- based 
precipitation12 and microfluidics13 also present shortcom- ings, e.g. vesicle 
disruption and co-purification of non-vesicular proteins.10 Deriving an EV 
isolation method that enables high recovery of functional EVs in a scalable 
fashion is therefore essential for EV research. 
 
 
 
Figure 2. Size-exclusion chromatography separates EVs from contaminants. (A) TEM of UF-LC 
fraction 1 shows intact EVs, whereas fraction 2 contains protein aggregates. (B) Total protein 
staining of UF and UF-LC fractions. (C) WB of UF-LC and UC-purified EVs. (D) Venn diagram 
depicting protein overlap for UF-LC and UC-purified EVs. (E) Gene ontology (GO) enrichment 
terms for UF-LC and UC-purified EV proteomes. 
 
 
 
Table1 
Protein/vesicle ratio of UC and UF-LC-purified EVs. 
 
Protein/vesicle ratio (x10-15  
g/particle) 
N2a OptiMEM N2a Prespun iPSCs 
UC 0.25 0.25 0.70 
UF-LC 0.074 0.059 0.55 
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Here, we present a systematic comparison study between a robust EV purification 
method, ultrafiltration with size-exclusion liquid chromatography (UF-LC), 
adapted from previous studies,14–16 and UC. We show that UF-LC permits higher 
EV recovery with intact biophysical properties. 
 
Methods 
EVs were isolated by either UF or UC; UF samples were subsequently loaded 
on a Sephacryl column for size-exclusion fractionation. EV properties were 
evaluated using molecular (western blotting (WB), nanoparticle tracking analysis 
(NTA), LC/ MS/MS) and biophysical (transmission electron microscopy (TEM), 
fluorescence microscopy, fluorescence correlation spectroscopy (FCS), total 
internal reflection fluorescence microscopy (TIRF) and DiR-imaging) analyses (see 
supplementary data for details). 
 
Results 
UF-LC allows high-yield isolation of biophysically intact EVs 
 
OptiMEM conditioned medium was processed by UC or UF (Figure 1, A). 
According to NTA, more particles with similar size distribution were recovered 
after UF than after UC. Correspondingly, levels of vesicle markers (Alix and 
CD9) were higher in UF than UC samples. This finding was consistent across 
different cell lines and with CD63-eGFP labeled EVs (Figure 1, B-D and 
Supplementary figure S1A). 
TEM revealed EVs with rounded and cup-shaped morphol- ogy in both samples. 
Occasionally, UC-purified EVs appeared disrupted or fused (Figure 1, E), an 
observation not seen with UF-purified EVs. FCS was employed for more 
quantitative analysis of EV integrity. In FCS, EV hydrodynamic radius, 
concentration and changes in biophysical properties (e.g. fusion or 
fragmentation) were determined by measuring diffusion and intensity of CD63-
eGFP positive EVs. From these readings, 25% of the total CD63-eGFP molecules 
were recovered using UF, 2.5-fold more than using UC, with larger EV radius for 
UC.  
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Figure 3. Biodistribution of UF-LC-purified EVs. (A) Representative IVIS images of organs from 
Balb/c mice 24 h post injection of DiR-labeled EVs. (B) Biodistribution of UC and UF-LC DiR-
labeled EVs. ****Indicates pb0.0001% in comparison to the same organ in the corresponding 
group (n=5), results represent mean+s.d. 
 
 
 
 
Figure 4. UF-LC EV isolation from complex media types. Graph showing the concentration of 
particles (x108/ml) (left y-axis) and protein concentration (mg/ml) (right y-axis) across the 
eluted volume after UF-LC for (A) N2a pre-spun conditioned media and (C) iPSC conditioned 
media. WB of (B) N2a and (D) iPSC EVs. 
 
The brightness of individual particles (number of CD63-eGFP molecules per 
vesicle) was higher in UC than UF, suggesting vesicle fusion. Further, 
disintegration with NP-40 decreased the diameter of CD63-eGFP-positive 
material to 2 nm for both UC and UF-purified EVs, the putative size of free 
CD63-eGFP.17 After UC, only 10% of total vesicles were recovered in the pellet; 
while in the supernatant, only 38% of the vesicles were intact while the 
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remaining 62% of the eGFP-positive material was 2 nm. This is indicative of 
vesicle disruption, since disrupted vesicles release their CD63-eGFP into the 
supernatant as free CD63-eGFP (Figure 1, F-G and Supplementary figure 
S1C). Moreover, fluorescence microscopy of EVs in suspension revealed 
aggregates only in UC samples (Figure 1, H). Since protein complexes were co-
isolated using UF (Supple- mentary figure S2A-C), size-exclusion LC was used 
to fractionate OptiMEM conditioned media. Two distinct fractions were 
detected (Supplementary figure S2D-E), with vesicles and non-vesicular 
proteins found exclusively in fraction 1 and fraction 2, respectively (Figure 2, 
A-B). UF-LC presented with consistently high EV recovery rates (70% ± 19%), 
along with higher EV marker expression as compared to UC samples (Figure 2, 
C and Supplementary figure S2F-G). LC/MS/MS of EVs purified by both 
methods presented a good correlation in overall protein expression and gene 
ontology annotations (Figure 2, D-E, Supplementary figure S3A-E and 
Supplementary Table S1), although the protein/vesicle ratio was lower in UF-LC 
than for UC-purified EVs (Table 1). TIRF imaging further corroborated the 
presence of aggregates/fusion of EVs only in UC samples (Supplementary figure 
S4A-B). 
 
UF-LC-purified EVs demonstrate different in vivo biodistribution compared to UC-
purified EVs 
Based on the distinct differences observed in EV integrity, we speculated that this 
would influence EV biodistribution. DiR-labeled EVs were injected 
intravenously and mice were 
imaged 24 h later. UC-purified EVs showed a 4.6 times (p0.0001) 
stronger signal in lungs compared to UF-LC-purified EVs (Figure 3, A-B) while 
the reverse was seen in the liver. 
 
UF-LC can be extended to complex biological fluids 
After subjecting conditioned pre-spun and stem cell media to UF-LC, EV markers 
were again solely detected in fraction 1, which corresponds to the peak of particles 
(Figure 4, A-F and Supplementary figure S5A-D). Moreover, UF-LC samples consis- 
tently had a lower protein/vesicle ratio than UC samples (Table 1). 
 
Discussion 
 
Research in EVs has recently received increasing attention, however, one major 
roadblock is the lack of a scalable technique permitting efficient purification of EVs. 
Here we report the first systematic comparison study comparing both 
biochemical and biophysical aspects of UF-LC and UC-purified EVs. NTA, WB and 
state-of-the-art LC/MS/MS demonstrated that UF-LC generated EVs with the 
same proteome as UC. Furthermore, our protein/vesicle ratio was consistently 
lower in UF-LC than UC samples, suggesting higher EV purity.18  TEM, FCS, TIRF 
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and fluorescence microscopy data suggest that EVs fuse, disrupt and aggregate 
during the UC isolation process, an aspect that is circumvented with UF-LC. We 
postulate that these large EV aggregates account for the accumulation in the lungs 
in our in vivo experiments. Another finding from this study is that UF-LC can be 
adapted for EV isolation from stem cell media. We believe that using UF-LC for EV 
isolation will allow researchers to venture into new avenues aimed at unraveling EV 
biological functions. 
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Supplementary data 
 
Details of materials and methods  
 
Cell culture 
NSC-34, a fusion of motor neuron enriched embryonic mouse spinal cord with mouse 
neuroblastoma, Neuro2a (N2a), a mouse neuroblastoma, B16F10, a mouse melanoma 
and human embryonic kidney (HEK293T) cells were cultured at 37°C with 5% CO2 in 
complete media comprised of Dulbecco's Modified Eagle Medium (DMEM), 
supplemented with 10% fetal bovine serum (FBS), and penicillin/streptomycin (P/S, 5000 
µg/ml) (all from Life Technologies, Carlsbad, CA, USA). Mouse induced pluripotent stem 
cells (iPSCs) were cultured on 0.1% gelatin coated plates at 37°C with 5% CO2 in complete 
stem cell media comprised of DMEM (Lonza, Basel, Switzerland) supplemented with 15% 
knockout serum-replacement, 2mM L-glutamine, 1 mM sodium pyruvate, 0.1mM non-
essential amino acids (all from Life Technologies), 50 µg/ml P/S, 0.2mM 2-
mercaptoethanol (Sigma, St Louis, MO, USA ) and 106 units of mouse leukaemia inhibitory 
factor (mLIF, ESGRO®, Merck Millipore, Billerica, MA, USA). For EV isolation, media were 
changed 24 h after seeding to either OptiMEM (Life Technologies), pre-spun media or to 
fresh stem cell media for iPSCs. Pre-spun media is DMEM supplemented with 10% FBS 
that had been pre-spun at 120,000g for 70 min prior to making up the vesicle devoid 
media. All media were supplemented with P/S. Conditioned media was then collected for 
EV isolation 48 h after incubation. For large-scale experiments, conditioned media 
collected from multiple flasks were pooled prior to isolation of EVs. 
 
 
Transfection of HEK293T cells 
6x106 cells were seeded one day prior to transfection in a 15 cm culture dish in complete 
media. Transfection of the CD63-EGFP plasmid was done using polyethyleneimine (PEI, 
Sigma) at a 1:4 pDNA: PEI ratio. Briefly, 25 µg of plasmid and 100 µg of PEI were diluted 
in 500 µl of OptiMEM in separate tubes. After 5min of incubation at room temperature 
(RT), the pDNA and PEI solutions were combined and incubated for a further 30 min at 
RT to form the DNA/PEI complexes. The complexes were then added dropwise to cells. 
After 4 h, the cell growth media containing the complexes was removed; the cells were 
washed with phosphate buffer saline (PBS, Life Technologies) and fresh OptiMEM, 
supplemented with P/S antibiotics was added on the cells. After 48 h of incubation, the 
conditioned media was collected for EV isolation.   
 
 
Ultracentrifugation (UC) for isolation of EVs 
The EV isolation method by UC was adapted from Théry et al(1). Briefly, supernatants 
collected were subjected to two low speed spins, 300g for 5 min followed by 1200g for 
10 min to get rid of cell debris and larger particles. The supernatant was subsequently 
filtered through a 0.22 μm syringe filter (Merck Millipore) before the final 
ultracentrifugation step at 120,000g for 70 min. The EV pellet was resuspended in PBS 
and subjected to an additional PBS wash at 120,000g for 70 min.  
 
Ultrafiltration (UF) for isolation of EVs 
The UF protocol, as shown in figure 1a, involves the same initial low-speed spins as that 
of the UC protocol. Instead of a high-speed ultracentrifugation at the final step, the cell 
culture supernatants were spun at 3,500g for 15 min in 100-kDa molecular weight cut-off 
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(MWCO) Amicon spin filters (Merck Millipore). PBS was then added onto the filters and 
spun to wash the samples. 
 
Size-exclusion liquid chromatography fractionation of UF samples (UF-LC) from cell 
culture medias  
UF samples were loaded onto a S-400 column (GE Healthcare, Uppsala, Sweden), on an 
ÄKTA prime (GE healthcare) equipped with a UV 280nm flow cell. Each individual fraction 
was collected based on the UV absorbance as indicated in supplementary figures. For all 
cell culture samples, 2ml fractions were pooled and concentrated using a 10-kDa MWCO 
Amicon Ultra spin filter (Merck Millipore).  
 
Western blotting (WB) 
WB was performed using either the Bio-Rad® Mini-PROTEAN® Tetra cell (Bio-Rad, 
Hercules, CA, USA) or the iBlot® system (Invitrogen, Life Technologies) according to the 
manufacturer’s instructions. To cross-compare the yield of EVs, we proceeded to load 
equal volumes of the re-suspended EV pellet or filtrate on the gel.  
 
For the Bio-Rad system, 15 μl of EV samples with 15 μl of 2X Laemilli sample buffer (Bio-
Rad) containing 5% β-mercaptoethanol (Sigma) were mixed and heated at 100°C for 10 
min. Samples were then loaded in a 1.5 mm, 10% Tris/Glycine SDS-polyacrylamide gel 
and ran at 170 V for 60-70 min in running buffer, until the dye front reached the bottom 
of the tank. Proteins on the gel were then transferred to a polyvinylidine fluoride (PVDF) 
membrane (Merck Millipore) at 100 V for 60-70 min in transfer buffer containing 20% 
methanol. Membranes were then incubated in blocking buffer (5% fat-free milk in Tris 
buffer saline with 0.1% Tween-20 (TBS-T) for 60 min at room temperature (RT) with 
gentle shaking.  
 
For the iBlot® system, 30 μl of sample was mixed with a sample buffer, containing 0.5 M 
ditiothreitol (DTT), 0.4 M sodium carbonate (Na2CO3), 8% SDS and 10% glycerol, and 
heated at 65 °C for 5 min. Samples were then loaded in a NuPAGE® Novex® 4-12% Bis-
Tris Gel and ran at 120 V in running buffer until the dye front reached the bottom of the 
gel. The proteins on the gel were transferred to an iBlot nitrocellulose membrane 
(Invitrogen, Life Technologies) for 7 min with the iBlot system. Membranes were stained 
with Ponceau S dye that was later washed away with PBS before blocking with Odyssey 
blocking buffer for 60 min at RT with gentle shaking (LI-COR, Lincoln, NE, USA).  
 
After the blocking step, the membrane was incubated with freshly prepared primary 
antibody solution (anti-CD9 and anti-PDC6I (Alix), both at 1:1,000 dilution from Abcam, 
Cambridge UK) overnight at 4°C or 2 h at RT. Membranes were washed three times, 10 
min each using washing buffer (TBS-T) with vigorous shaking before adding the secondary 
antibody solution (anti-mouse IgG DyLight-800 at 1:10,000 dilution if detecting Alix; anti-
rabbit IgG DyLight-800 at 1:10,000 dilution for detecting CD9 (LI-COR)) and incubated for 
1 h at RT. After the secondary antibody incubation, membranes were washed three times, 
10 min each and visualised by scanning both 700- and 800-nm channels on the LI-COR 
Odyssey CLx infrared imaging system. For subsequent probing of other proteins on the 
same membrane, the membrane was washed three times, 10 min each before re-
incubation with the next primary antibody.  
 
Nanoparticle tracking analysis (NTA) 
For particle size determination, NTA was performed with a NanoSight NS500 instrument 
(Malvern Ltd, Worchestershire, UK) equipped with the NTA 2.3 analytical software. For 
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all our recordings, we used a camera level of 13 or 15 and automatic function for all post-
acquisition settings: blur and minimum expected particle size, except in the detection 
threshold where we fixed it at 5. Samples were thawed on ice and diluted in PBS between 
1:500 to 1:20,000 to achieve a particle count of between 2 x 108 and 2 x 109 per mL. Once 
the dilution of the sample was determined, sample was loaded in the sample chamber 
and the camera focus was adjusted to make the particles appear as sharp dots of light. 
Using the script control function, we recorded five 30 or 60 s videos for each sample; 
incorporating a sample advance and 5 s delay between each recording. For GFP positive 
EVs the same set up was used with one minor alteration, which was that the sample was 
under constant flow in the sample chamber not to bleach the GFP signal. These 
measurements were then analysed using the batch process function and results were 
exported to Microsoft Excel for further analysis.  
Quantification of proteins and RNA in EVs 
Protein quantities in EVs were quantified using the microBCA assay kit (Thermo Scientific, 
Waltham, MA, USA) and levels of RNA were measured using the Quant-iT™ RiboGreen® 
RNA assay kit (Life Technologies), according to the manufacturer’s instructions. 
 
Transmission Electron Microscopy 
5μl of EV suspension was diluted 1:1 with PBS and added on formvar-carbon coated 
electron microscopy grids (Agar Scientific, Elektron Technology UK Ltd, Essex, UK) for 20 
min. The grid was blotted with filter paper and 15 μl of 2% uranyl acetate (UA, Sigma) was 
added on the grid for 1 min. Next, UA was removed and 15 μl of distilled water was added 
for 1 min. The water droplet was then removed and the grid was left to air dry for 15 min. 
The grids were then visualized in the transmission electron microscope (JEM-1010, JEOL 
Ltd, Tokyo, Japan). 
 
Fluorescence microscopy 
CD63-EGFP positive EVs were generated as described above. The particles were 
quantified by NTA and the UF-LC and UC samples were diluted to the same concentration 
of particles/ml. Before any measurements, the EVs were re-suspended with a 27G 
needle. The samples were positioned on a microscope slide and covered with a coverslip 
and analysed Microscopy was performed using Olympus IX-81 inverted microscope 
(Olympus America, Center Valley PA, USA) equipped with 20X objective. The following 
fluorescence filter-set (Chroma Technology Corp., Bellows Falls, VT, USA) was used, with 
the central wavelength and bandwidth of the excitation and emission filters as indicated: 
GFP (Ex. 470/40 nm; Em. 525/50 nm) 
 
Liquid chromatography tandem mass spectrometry (LC-MS/MS) of EVs 
EVs from UC and UF-LC were concentrated by speedvac and lysed with 1% SDS, 25 mM 
HEPES, 1 mM DTT. Lysates were heated to 95°C for 5 min followed by sonication for 1 
min and centrifugation at 14,000g for 15 min. The supernatant was mixed with 1 mM 
DTT, 8 M urea, 25 mM HEPES, pH 7.6 and transferred to a 10-kDa cut-off centrifugation 
filtering unit (Pall, Nanosep®, Port Washington, NY, USA), and centrifuged at 14,000g for 
15 min, followed by an addition of the 8 M urea buffer and centrifugation again. Proteins 
were alkylated by 50 mM iodoacetamide (IAA) in 8 M urea, 25 mM HEPES for 10 min, The 
proteins were then centrifuged at 14, 000g for 15 min followed by 2 more additions and 
centrifugations with 8 M urea, 25 mM HEPES. Trypsin (Promega, Madison, WI, USA) in 
250 mM urea, 50 mM HEPES was added to the cell lysate at a ratio of 1:50 trypsin:protein 
and incubated overnight at 37°C. The filter units were centrifuged at 14,000g for 15 min 
followed by another centrifugation with MQ and the flow-through was collected. 
Peptides were cleaned by a strata-X-C-cartridge (Phenomenex, Torrence, CA, USA).  
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Before analysis on the Q Exactive (Thermo Fischer Scientific), peptides were separated 
using an Agilent 1200 nano-LC system. Samples were trapped on a Zorbax 300SB-C18, 
and separated on a NTCC-360/100-5-153 (Nikkyo Technos., Ltd) column using a gradient 
of A (3% ACN, 0.1% FA) and B (95% ACN, 0.1% FA), ranging from 7% to 40% B in 240 min 
with a flow of 0.4 µl/min. The Q Exactive was operated in a data dependent manner, 
selecting top 5 precursors for fragmentation by HCD. The survey scan was performed at 
70,000 resolutions from 300-1700 m/z, using lock mass at m/z 445.120025, with a max 
injection time of 100 ms and target of 1 x 106 ions. For generation of HCD fragmentation 
spectra, a max ion injection time of 500 ms and AGC of 1 x 105 were used before 
fragmentation at 30% normalized collision energy, 17,500 resolution. Precursors were 
isolated with a width of 2 m/z and put on the exclusion list for 70 s. Single and unassigned 
charge states were rejected from precursor selection.  
 
Proteome discoverer 1.3 with sequest-percolator was used for protein identification. 
Precursor mass tolerance was set to 10 ppm and for fragments to 0.02 Da. Oxidized 
methionine and was set as dynamic modification, and carbamidomethylation as static 
modification. Spectra were matched to a combined mus musculus and bos taurus 
ensembl 72 database, and results were filtered to 1% FDR. Identifications in bos taurus 
was considered to originate from FBS and removed. GO term enrichment analysis was 
done using Panther(2).  
 
Fluorescence correlation spectroscopy (FCS) 
In FCS, EV hydrodynamic radius, concentration and changes in biophysical properties (e.g. 
fusion or fragmentation) were determined by measuring diffusion and intensity of CD63-
eGFP positive EVs from HEK293T cells. FCS was performed on a Clarina II Reader (Evotec 
Technologies, Perkin Elmer, Waltham, MA, USA) with 488 nm argon ion laser excitation 
at 50 µW to minimize photo bleaching, a 40x water emersion 1.15 N.A. objective (UAPO 
Olympus), a 488/633 nm major dichroic mirror in the excitation path and a HQ535/50m 
filter in the emission path. In-focus light was collected through a 50 μm pinhole using a 
SPCM-AQR-13FC avalanche photodiode (Perkin-Elmer Optoelectronics). The confocal 
volume was calculated in approximation according to(3) using the measured diffusional 
correlation time diff of fluorescent Alexa488 free dye standard, the known translational 
diffusion coefficient of Alexa488 (Molecular probes; D = 280 μm2/s) and the axis ratio 
fitted from calibration measurements.  
 
HEK293T and N2A cells were plated in 15 cm dishes and transfected at 50% confluency 
with CD63-EGFP using Lipofectamine 2000 (Life Technologies) in DMEM supplemented 
with 10% FBS. After 4 h, cells were washed and medium was replaced with OptiMEM and 
cultivated for further 48 h. Conditioned medium was subjected to either UC or UF 
purification as described in Fig. 2a. The conditioned medium (post 0.22 μm), UF retentate, 
UF flow-through (FT), UC pellet and post-UC supernatant was re-suspended in PBS 
supplemented with EDTA free Complete Protease inhibitor (Roche, Basel, Switzerland) 
and analyzed by FCS.  For each sample, several dilutions were made and measured in a 
96-well glass bottom plate (Whatman, GE Healthcare) with 30 repetitive measurements 
of 10 s each. NP-40S at 1% v/v (Cambridge Bioscience, Cambridge, UK) was used to induce 
vesicle disruption. Disruption of vesicles was confirmed by dynamic light scattering. 
Autocorrelation curves were fitted with a one- or two-component two-dimensional 
diffusion model(4, 5) to extract translational diffusion times, particle numbers and 
molecular brightness’s. For a two-component two-dimensional diffusion model we made 
the assumption that the two major CD63-EGFP positive components in the isolations are 
intact EVs/large vesicles and a secondary subpopulation of smaller, potentially disrupted 
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vesicles. We then analyzed all detergent treated samples with a one component fit to 
derive the translational diffusion time of disrupted vesicles. Alexa488 measurements in 
an EV sample with and without NP40s confirmed that under these conditions changes in 
measured translational diffusion times due to viscosity and refractive index changes were 
negligible (data not shown). Vesicle disruption by NP40s indeed resulted in almost 
identical CD63-EGFP translational diffusion times in all samples, including conditioned 
medium. The average value from these measurements was then defined as the 
translational diffusion time of the putative small, disrupted particles in a two-component 
fit of the detergent free samples. This allowed to fit the data with significantly improved 
Chi2 and delivered a reasonably homogeneous second population with translational 
diffusion times corresponding to a hydrodynamic radius in the range of ca. 70-100 nm. 
Data from one experiment representative of at least three independent experiments are 
shown. Error bars represent Standard deviations from the 30 FCS measurements. 
 
Total internal reflection fluorescence microscopy (TIRF) 
TIRF microscopy experiments were performed on a Zeiss Laser TIRF 3 system using a 100x 
objective. Glass inserts (P35G-1.5-14-C) were from MatTek Ashland, MA, USA. TIRF angle 
was set at 70 degrees (depth of penetration = 86 nm) Experiments was performed at 
37°C. Before assaying the EVs were mixed with FAST DiO™ Solid; DiOΔ9,12-C18(3), ClO4 
(3,3'-Dilinoleyloxacarbocyanine Perchlorate) (Life Technologies). Images were recorded 
after a brief refocusing. 
 
EV biodistribution in mice 
Conditioned cell supernatants were filtered through a 0.22 μm syringe filter and 
incubated with 1μM DiR (1,1'-Dioctadecyl-3,3,3',3'-Tetramethylindotricarbocyanine 
Iodide) (Invitrogen, Life Technologies). The conditioned media with DiR was then 
ultracentrifuged at 120,000g for 70 min (UC) or concentrated with a 100-kDa MWCO 
Amicon Ultra spin filter (UF) (Merck Millipore). The UC pellet was re-suspended and spun 
again in PBS to purify away-unbound DiR and UF samples LC fractionated as described 
above. Purified EVs were quantified with NTA and equal amounts of particles from both 
UC and UF-LC preparations were injected in the tail vein of Balb/c mice (n=5). 24 h post 
injection, the organs were harvested and subjected to imaging in the In Vivo Imaging 
System (IVIS) Spectrum (Caliper, CA, USA). The IVIS was set to record the fluorescence for 
2 seconds (excitation 710, emission 760) and the data obtained was then analysed with 
the IVIS software. All animal experiments conducted were approved by The Swedish Local 
Board for Laboratory Animals. The experiments were performed in accordance with the 
ethical permission and designed to minimize the suffering and pain of the animals.
  
 
Statistics 
Statistical analyses of the data were performed using Prism 6.0 (GraphPad Software Inc.) 
by using the nonparametric Krusckal Wallis test followed by the Sidak post-test for the 
bio-distribution data (Figure 3B). A One-way Anova followed by the Dunn’s post-test was 
applied to the molecular brightness data (Figure 1G). All error bars used in this report are 
mean + s.d. 
 
Supplementary figure legends 
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Supplementary figure S1. WB of vesicle markers and FCS of CD63-eGFP labeled EVs. 
(A) WB of Alix and CD9 of EVs from NSC-34 conditioned media. (B) Translational 
diffusion times (τdiff) (left y-axis) and the hydrodynamic diameters (right y-axis) of 
vesicles from UC, UF, post-UC supernatant (UC SN) and post-UF flow-through (UF-FT) 
are shown, with (white bars) and without (black bars) NP-40 treatment. The 
hydrodynamic diameter was calculated based on extrapolation of the measured diff for 
Alexa488 and the reported hydrodynamic radius of 5.8 Å(6). Based on these 
measurements, UC-purified EVs were shown to have a larger average vesicle radius 
than UF. This is most likely due to the fusion/aggregation of vesicles during the UC 
process, corroborating with EM results in Figure 1E. The difference in radius (UC versus 
UF) was lost upon NP-40 detergent treatment. NP-40 treatment disrupts membranes 
and the observation with decreased vesicle diameter post-treatment confirmed that all 
FCS measurements were done on membrane vesicles, as opposed to aggregated CD63-
EGFP molecules. Here, NP-40 treatment decreased the hydrodynamic radius of UC and 
UF vesicles to around 2 nm, which is in accordance with the putative size of free CD63-
EGFP(7), hence confirming the disruption of the vesicles and the release of free CD63-
EGFP.  
 
 
 
77  
Supplementary figure S2. UF-LC permits high-yield isolation of intact EVs with good 
recovery and little non-vesicular protein contamination. 
 
(A) Table comparing the mode size, particle concentration, protein concentration and 
RNA concentration of particles isolated from B16F10 cells. Both particle and RNA 
concentration are around 6-fold higher with UF than in UC samples. However, this is not 
correspondingly seen with protein concentrations (20-fold difference). (B) To investigate 
this discrepancy, WB was done comparing the expression of vesicle markers (Alix and 
CD9) between UC and UF samples when loading the same amount of particles (left panel) 
or the same amount of protein (right panel). 4 different amounts of particles were tested: 
0.125 x1010, 0.25 x1010, 0.5 x1010 and 1.0 x1010 of the same sample quantified by NTA. 
When loading the same amount of particles the intensity of both Alix and CD9 bands 
appear to be similar for the UC and UF samples. In contrast, when an equal amount of 
total protein (1, 2 and 3μg) was loaded, based on the microBCA measurements, the 
intensity of both Alix and CD9 were much higher for the UC compared to the UF samples. 
This suggests that the protein quantification is highly overestimated in measuring the EV 
yield of UF samples, and indicates that a huge majority of the proteins detected in the UF 
sample did not originate from the vesicles but is mostly from the presence of protein 
aggregates trapped in the spin filters. (C) To work out the extent of overestimation, we 
loaded the same volume of UF samples and recalculated the protein quantification to 
match with the number of particles. Our data shows that 1.0x1010 particles from the UF 
samples correspond to 35μg of protein. From the UC samples, the same volume of EVs: 
1.0x1010 particles correspond to 3μg of protein. Hence, under the assumption that all 
particles contain the same amount of protein and that there is no large difference in the 
particles isolated from UC or UF as seen by the mode size in NTA and western blot 
markers in (B), we propose that the protein quantification of UF samples to be about 10 
to 11-fold overestimated. Therefore, using the protein concentration as a gauge of vesicle 
yield after UF purification (or with any other similar precipitation methodology) is highly 
not recommended as any protein contamination can largely skew the quantification. (D) 
LC chromatograph showing two distinct peaks as measured by UV 280; collections from 
these two peaks were pooled to derive two fractions; fraction 1 and 2 (Lines represent 
approximately the collected volume for fraction 1 and 2). (E) NTA graph showing that 98% 
of the total number of particles detected after UF-LC was eluted in fraction 1. The 
particles in fraction 1 have a mode size of slightly less than 100 nm, which is in accordance 
with the reported size of EVs. (F) NTA graph showing that the size distribution of EVs 
isolated post-LC is similar to UF. Also, the recovery of EVs post-LC is maintained at 69%. 
(G) NTA of UF-LC fraction 1 from three individual purifications. The mode size in all three 
replicates is consistently around 90-100 nm with minimal particles larger than 200 nm, 
indicating that the methodology is reproducible.  
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Supplementary figure S3. Correlation and complete GO enrichment (p-value and fold 
enrichment) for UC and UF-LC EVs derived from N2a cells.  
 
(A) Correlation of protein abundance between UC and UF-LC preparations. All data is 
presented in the following groups: (B) cellular components, (C) molecular functions, (D) 
biological processes and (E) panther protein classes showing both UC (black bar) and 
UF-LC (grey bar) samples 
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Supplementary figure S4. TIRF imaging of UC and UF-LC EVs derived from N2a cells 
 
(A) Representative TIRF images of FAST DiO™ stained EVs from UC and UF-LC 
preparations. (B) Graph showing fraction of particles with an area 2 SD above the mean 
size of particles in UC (black bar) and UF-LC (grey bar) -purified EVs. Each bar represents 
the results (mean+/-s.d.) of three random image fields from three experiments. 
 
 
 
Supplementary figure S5. UF-LC data for complex media sources (N2a pre-spun 
conditioned media and mouse iPSCs media) 
 
LC 280nm chromatograph of conditioned pre-spun media from N2a cells (A) and 
conditioned stem cell media from iPSCs (C).  For N2a, a total of 3 peaks were detected 
while a total of 2 peaks were detected for iPSCs. Collections across the eluate were 
pooled as indicated by the bars on the chromatograph and analysed by WB and NTA. (B) 
Based on NTA, the majority of the total number of particles for N2a prespun samples 
was eluted in fraction 1, where the mode size is around 99 nm. (D) For iPSCs, the 
majority of the total number of particles was eluted in fraction 1, where the mode size 
is around 82nm.  
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Supplementary table 
 
Supplementary Table S1 
Table showing all the proteins found in all 3 replicates for both UC and UF-LC. Proteins 
ranked according to number of Peptide spectrum matches (PSMs). 
Legend: UC=Ultracentrifugation and UF-LC=Ultrafiltration with subsequent Liquid 
Chromatography purification. R=replicate.  
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4.3 Manuscript I (Quantitative profiling of exosome parent-
recipient cell pairing by high content screening using 
CD63-emGFP vesicle labeling)  
 
Exosomes are recognized as delivery vehicles and a role in the immune system, 
cancer cell environment manipulation 119 7, miRNA delivery and even metastatic 
niche formation 22 120 has been shown. These and other examples indicate that 
exosomes have the potential to target cells, tissues or organs in a highly specific 
manner. A systematic investigation though is still lacking most likely due to the 
unspecific and unreproducible quantification methods like total protein content 
or lipid dyes as described earlier. In manuscript I (Quantitative profiling of 
exosome parent-recipient cell pairing by high content screening using CD63-
emGFP vesicle labeling.) we describe the highly specific fluorescent exosome 
labeling with a CD63-emGFP marker. We extensively characterize labeled and 
unlabeled exosome vesicles and show that there are no relevant differences in 
density, morphology and protein content detectable. With this labeling strategy, 
the sensitive quantification method and the above described gentle isolation 
method we finally had the required enabling technologies in our hands to 
quantitatively profile exosome uptake efficiencies. In this manuscript (manuscript 
I (Quantitative profiling of exosome parent-recipient cell pairing by high content 
screening using CD63-emGFP vesicle labeling)) we then identified preferences in 
cell pairing by screening across a panel of parent and recipient cells. 
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Abstract. Cellular communication by exosomes is thought to be highly efficient 
but quantitative characterization of their interaction with recipient cells is lacking. 
Such studies demand for a labelling strategy that allows to specifically and 
quantitatively trace exosomes on the background of co-purifying extracellular 
vesicles and particles, while minimizing alterations of the vesicle physicochemical 
properties. Here we provide extensive characterization of exosome labelling by 
emerald GFP (emGFP) tagged CD63. Overexpression in parent cells yields 
fluorescent exosomes that carry 10-30 CD63-emGFP molecules per vesicle. In 
addition, a second species of free emGFP, truncated from CD63 is released into 
the extracellular space which is co-purified by ultrafiltration but largely removed 
by gel filtration. Based on sedimentation density fractionation, size exclusion 
chromatography, fluorescence correlation spectroscopy, cryo-electron 
microscopy and proteomics we demonstrate that neither the parent cell 
transfection, CD63-emGFP overexpression nor UF-GF isolation significantly 
compromise measured physicochemical integrity of the vesicles, including their 
density, size, protein cargo repertoire as well as morphology. Quantitative single 
vesicle imaging further reveals that ultrafiltration recovers single, intact vesicles 
whereas ultracentrifugation gives rise to a fraction of vesicle fusion and/or 
aggregation. Using these extensively characterized vesicles we further describe a 
high content screening assay allowing to quantify exosome cell uptake with high 
statistical power and at the single cell level. As a direct application of this assay 
we provide the first quantitative profiling of exosome uptake across an array or 
parent-recipient cell pairs to reveal preferences in exosome internalization by 
different cell types. 
 
 
Keywords 
Exosomes; Extracellular vesicles; Microvesicles; Exosome labelling; Fluorescence 
correlation spectroscopy; CD63-GFP; Exosome uptake; High content screening; 
Tissue targeting. 
 
 
Introduction 
Cell to cell communication by exosomes is gaining increasing traction in basic cell 
biology research, biomarker discovery and therapeutic drug delivery alike. Thus 
there is high demand for an increased understanding of how exosomes interact 
with recipient cells. Furthermore, a quantitative characterization is still lacking. 
Fluorescence imaging is a method of choice to monitor exosome uptake dynamics 
and efficiency, but demands for fluorescence labelling of the vesicles. The main 
issues to address are a selective labelling of exosomes on the background of other 
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extracellular vesicles and particles, with minimal perturbation of their 
physicochemical and biological properties. The two general approaches can be 
classified into post-isolation labelling versus modification of the parent cells, 
whereas the fluorescence can be introduced via exosome cargo, lipids or protein 
markers. A relatively straightforward approach is to stain exosomes post isolation 
with lipophilic carbocyanine dyes such as DiI, DiO or DiD. These compounds are 
lipid-like molecules with fluorescent head groups and long aliphatic tails capable 
of inserting into the vesicle membranes. Alternative lipid stains that might be used 
are FM4-64, R18, CFSE, PKH-26 [1], PKH-67 [2], as well as Top Fluor Sphingomyelin 
or Top Fluor Cholesterol (Heusermann et al, unpublished data). Employing 
lipophilic carbocyanine dyes is experimentally straightforward and allows for the 
use of synthetic fluorophores with optimal photophysical properties as well as 
flexibility over the entire spectral range. This strategy has meanwhile become of 
widespread use for fluorescence microscopy based studies of exosomes [2]–[6]. 
The major drawback of lipophilic tracers however is that they are not exosome 
specific and indiscriminately stain all vesicles and lipid particles contained within 
the sample. Additionally, the integration of non-natural lipids may alter the 
physicochemical properties of the exosome membrane and thereby affect their 
functionality. To complicate matters, additional washing and ultracentrifugation 
steps needed to remove unincorporated tracers may introduce further bias (and 
yield issues). Thus, careful optimisation of labelling ratios as well as monitoring 
changes of exosome size and zeta potential may be required to allow for the least 
perturbing conditions. Another difficulty is that in salt-containing buffers or media 
most of these lipid stains rapidly form micelles or aggregates themselves. Since 
these lipid aggregates and micelles can have similar physicochemical properties 
as exosomes they can lead to erroneous results, and their efficient removal may 
require stringent purification conditions.  
  
The expression of fluorescent protein (FP) tagged exosome surface markers in 
parent cells therefore appears as a more specific and less invasive strategy, and 
first examples have been presented in recent studies [7], [8]. However, the 
selectivity of such markers for visualization of exosomes within complex samples 
of extracellular particles are a critical issue. In addition, it remains unclear whether 
a non-physiological overexpression of FP-tagged exosome markers within the 
parent cells may influence exosome biogenesis, release as well as their 
composition due to cell stress or simply altered surface marker abundance. 
Therefore, a careful characterization of labelled versus unlabelled exosomes is 
warranted. Here we provide an extensive quantitative and qualitative 
characterization of exosomes labelled via CD63-emGFP overexpression in parent 
cells to address specificity of labelling as well as potential perturbation of vesicle 
properties. Using fluorescence correlation spectroscopy, we quantitatively 
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characterize the vesicles at the single vesicle / single molecule level and monitor 
exosome release over time. Using these extensively characterized vesicles we 
further report a high content screening assay to quantify exosome uptake with 
high statistical power which we apply to quantitatively profile exosome parent - 
recipient cell pairing preferences across a panel of primary cells and cell lines.   
 
 
Results 
  
Exosome labelling by CD63-emGFP. To retain the natural function of CD63 in 
signal transduction or integrin complexation, emGFP was fused to the N-terminus 
of CD63 (Supplementary Figure 1a), thereby oriented to the luminal side of the 
exosome membrane (Figure 1a). CD63-emGFP was transiently overexpressed in 
HEK293 cells or Huh7 cells using lipofection for 5 hours. Following extensive 
washing, exosome free medium (OptiMEM) was added and conditioned for 48 
hours. To confirm the presence of CD63-emGFP in exosomes we first tested for 
co-fractionation of emGFP fluorescence with exosome markers based on density 
using a sucrose sedimentation gradient (Figure 1b), as well as based on size using 
gel filtration chromatography (Figure 1c). Exosomes have been widely established 
to float at 33-39 % (w/v) sucrose (corresponding to 1.14-1.17 g/mL). Of note, all 
previous studies using sucrose density gradients have analyzed the vesicles 
following at least one initial ultracentrifugation or ultrafiltration step, to the best 
of our knowledge. To analyze the vesicles without any prior concentration or 
ultracentrifugation steps we established conditions for fractionating conditioned 
medium directly onto a sucrose gradient. Our data for the first time confirm that 
also native exosomes, analyzed directly from medium, sediment at a density of 
32-40 % (1.13-1.18 g/mL) sucrose as assessed by Western blotting analysis for the 
exosomal marker proteins Alix and Tsg101 as well as by Nanoparticle Tracking 
Analysis (Supplementary Figure 1b). CD63 was not detected in the gradients from 
unconcentrated medium, most likely due to the poor antibody sensitivity. 
Exosomes from CD63-emGFP transfected HEK293 cells (Figure 1b) sedimented at 
a similar density as exosomes from untransfected cells. Fluorescence correlation 
spectroscopy (FCS) analysis in all fractions further confirmed the enrichment of 
emGFP positive particles with translational diffusion times (tdiff) of 2-10 ms, 
corresponding to a vesicle size of ca 50-120 nm, co-fractionating with Alix (Figure 
1b). 
 
To isolate CD63-emGFP vesicles in as native state as possible, we followed a 
successive ultrafiltration-gel filtration (UF-GF) protocol recently established by us 
and others [9]. Briefly, after removal of cell debris and filtration on a 0.22 um filter, 
conditioned medium was concentrated by ultrafiltration on a 100 kDa MWCO 
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filter and further fractionated on a size exclusion chromatography column 
(Superdex-200, Figure 1c). Consistent with our previous description of exosome 
isolation by GF [9], the UV chromatogram revealed two major peaks, one 
corresponding to the expected elution volume of vesicles (ca 1 MDa, 
Supplementary Figure 1c) and one peak at ca 82 kDa most likely comprising 
residual serum albumin and other serum proteins, as supported by Bradford 
protein quantification (Supplementary Figure 1d, upper panel). In line with the 
first peak comprising vesicles and the second peak comprising non-vesicular 
protein complexes, the ratio of 254/280 absorption was also markedly different 
with Abs254:Abs280 ~ 1.3 in peak 1, and Abs254: Abs280~ 2 in peak2 (Supplementary 
Figure 1d, bottom panel). Pooled samples of 4 fractions each (omitting one 
fraction between pools) were analyzed by Western blotting. The exosomal marker 
proteins Alix and Tsg101 eluted in a relatively sharp peak close to the void volume, 
as expected based on the upper size separation limit of the column at 600 kDa 
(exclusion limit 1.3 MDa). The still widely used exosomal marker Lamp2b also co-
eluted with the vesicles however showed a broad elution profile with two 
apparent maxima, suggesting its association with a different vesicle population. 
The emGFP fluorescence peaked with the exosomal markers, as well as with the 
CD63-emGFP fusion protein detected by anti-GFP western blotting. A second 
major GFP fluorescent peak was observed eluting at ca 26.8 kDa (Supplementary 
Figure 1c) and comprising emGFP truncated from CD63 according to Western 
blotting (Figure 1c).  
 
 
Quantitative characterization of CD63-emGFP labeling at the single vesicle level. 
To further characterize the emGFP positive species within these two major peaks 
at the single molecule / single vesicle level, we analyzed all fractions by FCS (Figure 
2a). Fractions of peak 1 comprised a relatively heterogeneous population of 
emGFP fluorescent, large particles with translational diffusion times ranging from 
ca 2-10 ms (mean of ca 4 ms), corresponding to ca 50-120 nm in size (mean of ca 
100 nm). A similar heterogeneity was observed in molecular brightness, ranging 
from ca 80 kHz to 1000 kHz per particle (mean of ca 250 kHz per particle). 
Treatment with the detergent NP40s resulted in a uniform population of 
molecules with a translational diffusion time of 300 us, corresponding to the 
expected tdiff of CD63-emGFP (based on extrapolation from data measured for 
free emGFP, tdiff = 160 us, data not shown). These data confirm a physical 
association of CD63-emGFP with ca 100 nm sized vesicles. Consistently, NP40s 
treatment also resulted in a drop of the molecular brightness of these species 
yielding a homogeneous population of molecules with similar brightness as 
measured for free, monomeric emGFP (ca 18 kHz, data not shown). The number 
of emGFP molecules independently diffusing through the confocal volume was in 
90  
turn increased upon vesicle disruption by NP40s. Together, these data reveal the 
presence of multiple CD63-emGFP molecules per vesicle, ranging between ca 10 
to 30 molecules for individual vesicles (Figure 2a, bottom). The second major 
eluting GFP peak in contrast comprised molecules of relatively homogeneous 
translation diffusion times and molecular brightness, insensitive to NP40s 
treatment and consistent with the size and brightness expected for monomeric 
GFP. This is in line with the Western blotting results in Figure 1c and corroborates 
that this second species contains mainly non-vesicular, truncated GFP. Similar 
data were obtained for Huh7 and B16 exosomes (Supplementary Figure 2a and b, 
and data not shown). The fractions comprising exosomal markers and GFP 
positive vesicles were pooled after gel filtration and are henceforth referred to as 
UF-GF enriched exosomes.  
 
Since FCS allowed to specifically quantify CD63-emGFP vesicles within 
heterogeneous samples, we reasoned it might be a straightforward method to 
monitor the release of CD63 positive vesicles. As the sensitivity in the nanomolar 
range was not sufficient for reliable quantification directly in medium, we 
enriched the conditioned medium by ultrafiltration (100 kDa MWCO) and then 
quantified the amounts of CD63-emGFP vesicle released at different time points 
by FCS. Using a 2-component fit with a diffusion time of free, non-vesicular GFP 
set to the measured value of 160 us allowed to specifically determine the 
concentration of GFP positive vesicles within the heterogenous samples (Figure 
2b). The total number of vesicles per ml of conditioned medium as determined by 
NTA increased over time, whereas the release of fluorescent vesicles was delayed 
by several hours, most likely reflecting the onset of expression the transfected 
CD63-emGFP. The relative fraction of CD63-emGFP vesicles was highest after 16 
hours and reached up to an apparent 80 % of all vesicles. While both, fluorescent 
and total vesicles numbers further increased over time, the relative fraction of 
fluorescent vesicles declined, which might be due to the reporter plasmid being 
diluted out with cell division, and/or an increased contribution of other types of 
vesicles being released at later time points. 
 
CD63-emGFP labelling results in minimal vesicle perturbation. In addition to 
their unchanged size and density, we next assessed the morphological integrity of 
exosomes from CD63-emGFP transfected parent cells. UF-GF enriched exosome 
samples with and without fluorescent markers were analyzed by cryo-electron 
microscopy (cryo-EM). In both conditions the samples contained a similar 
repertoire of predominantly double membrane enclosed, perfectly round, 
protein-coated vesicles with homogeneous structure and size of ca 50-140 nm in 
diameter (Figure 3a and Supplementary Figure 3a). Finally, we aimed to 
determine whether CD63-emGFP parent cell transfection might result in 
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significant changes of the exosome protein content. UF-GF enriched exosomes 
from CD63-emGFP transfected versus untransfected HEK293 cells were analyzed 
by MS-proteomics (Supplementary Table 1), which confirmed a high abundance 
of several canonical exosome markers (Figure 3b). Importantly, the proteome of 
HEK293 CD63-emGFP vesicles closed matched that of untransfected cells. Among 
the top 350 proteins, GFP was essentially the only different cargo (Figure 3c and 
Supplementary Table 1).  
 
UF-GF isolation yields single, intact vesicles. It has been an open question in the 
field whether certain isolation protocols might cause aggregation or fusion of the 
vesicles, which would compromise any studies of exosome uptake or function. To 
address this, we generated separate samples of CD63-emGFP and CD63-mCherry 
labelled exosomes from independently transfected HEK293 cells, and then mixed 
the two conditioned media prior to purification by UF-GF or a standard 
ultracentrifugation (UC) protocol [9]. Diluted vesicle samples were spotted onto a 
coverslip and imaged by confocal microscopy. Vesicles were detected as light 
diffraction limited GFP or mCherry fluorescent spots of uniform size, 
corresponding to the point spread function of the microscope. Following UF-GF, 
no double positive spots were detected, demonstrating that the exosomes 
remained intact and disperse after UF-GF purification, as well as confirming the 
detection of single vesicles (Figure 4a and Supplementary Figure 4a). In contrast, 
ultracentrifugation (UC) yielded a small population of double positive, slightly 
larger spots, revealing a certain degree of vesicle fusion and/or aggregation during 
the purification (Figure 4b and Supplementary Figure 4b) that furthermore varied 
between experiments. As positive controls, exosomes labelled with a CD63-
emGFP-mCherry fusion protein were predominantly detected as double positive 
spots (Figure 4c and Supplementary Figure 4c). Controls with exosomes from 
either CD63-emGFP or CD63-mCherry transfected cells were performed as well 
and confirmed exclusive detection in the correct channels (data not shown). 
These data directly demonstrate that CD63-emGFP labelled, UF-GF isolated 
exosomes remain and can be detected as single vesicles by confocal microscopy, 
whereas caution may be taken with UC isolation. 
 
Quantitative profiling of exosome uptake across a panel of parent - recipient cell 
pairs using high content screening. While gel filtration largely removed the 
extracellular non-vesicular GFP, residual amounts were still present in the 
exosomal fractions recovered by UF-GF according to Western blotting (Figure 1c) 
and FCS. We therefore wanted to exclude any potential artefacts in studying cell 
uptake of CD63-emGFP exosomes due to residual non-vesicular GFP and 
compared uptake of both species into HEK293 cells side by side using matched 
concentrations based on FCS analysis. While CD63-emGFP exosomes were taken 
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up well, virtually no uptake of free GFP was detected by high resolution confocal 
microscopy (Figure 5a).  We next tested the cell uptake of CD63-emGFP exosomes 
by directly adding conditioned medium to recipient cells. To quantify the exosome 
uptake over time the confocal images from live cell experiments were analyzed in 
Cell Profiler. Exosome internalization was most robustly quantified based on the 
number of fluorescent spots per cell. A low but significant level of internalized 
fluorescence was detected which increased over time (Figure 5b, left panel). Also 
the percentage of transfected cells increased over time and reached up to at least 
90 % of positive cells within 15 hours (Figure 5b, right panel and Figure 5c). 
Interestingly, exosomes from UF enriched samples showed remarkably identical 
uptake efficiency as compared to vesicles from direct addition of conditioned 
medium (Figure 5b). At the low, subpicomolar concentrations used in order to 
match those of CD63-emGFP exosomes within conditioned medium, no 
saturation was detected up to 15 hours. 
 
We next set up a quantitative high content screening assay for exosome uptake 
in a 384well format. For practical reasons we focused on Huh7 recipient cells for 
the assay development. Cells were fixed at various time points following CD63-
emGFP exosome addition, and imaged on an automated plate imaging station 
(Operetta, Perkin Elmer). Internalized GFP fluorescence was quantified based on 
the number of intracellular GFP fluorescent vesicles per cell using automated 
image analysis (Harmony, Perkin Elmer). At low picomolar concentrations of 
exosomes, uptake saturated with time (Figure 5d). Consistent with the imaging 
data in Figure 5a, also in the HCS assay the uptake detected for non-vesicular 
emGFP was negligible, even at increased concentrations of free GFP to match the 
number of fluorophores rather than vesicles.  
 
Using this assay, we next set out to assess quantitative differences in exosome 
uptake across a panel of parent cell - recipient cell pairs. CD63-emGFP labelled 
exosomes were isolated from HEK293, Huh7 and B16 cells and analyzed by FCS to 
confirm a similar brightness of the vesicles (Supplementary Figure 2 and data not 
shown). Uptake was then tested side by side across a panel of recipient cell lines 
and primary cells (HEK293, B16, Huh7, HeLa, human primary fibroblasts, human 
primary keratinocytes, human endothelial cells and human iPS derived neurons). 
Based on the data in Figure 5d exosomes were added at increasing concentrations 
(1-18 pM of CD63-emGFP vesicles) for 8 hours, and uptake was quantified using 
the automated plate imaging assay described above (Figure 6a). Relative uptake 
efficiency was scored semi-quantitatively based on the level of internalized GFP 
at the highest concentration, as well as the EC50. As summarized in Table 1 and 
illustrated in Figure 6b, exosomes from all three parent lines were taken up well 
into a variety of recipient lines. In most recipient cells we only observed minor 
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uptake differences between exosomes from different parent cells. However, in 
Huh7 cells there was a major difference with Huh7 exosomes being taken up with 
ca 4-fold reduced efficiency than B16 and HEK293 exosomes. An even more 
striking difference was observed between different recipient lines. Some cell lines, 
including B16 melanoma cells and primary human keratinocytes, even appeared 
to be resistant to exosome uptake, at least for the exosome types used in this 
study. Even after increasing the exosome concentration ~10,000 fold (200 nM 
instead of 18 pM), no uptake of HEK exosomes was detectable in keratinocytes 
(Supplementary Figure 5). These data support a highly specific mechanism for 
exosome cell uptake and suggest that preferential cell-cell pairing exists. 
 
 
Discussion 
 
To quantitatively study the interaction of exosomes with recipient cells a labelling 
strategy is needed that allows to specifically trace exosomes on the background 
of co-purifying ectosomes, apoptotic bodies and other types of extracellular 
vesicles and particles [10], while minimizing alterations of the vesicle 
physicochemical properties. CD63 is a tetraspanin glycoprotein that has been 
recognized as a relatively ubiquitous marker present in extracellular vesicles, with 
growing evidence for selective enrichment in exosomes [10]–[13]. While first 
examples of using CD63 reporters for fluorescent labelling of exosomes have been 
reported [7], [13] and exosome labelling kits based on FP tagged CD63 reporters 
have now even become commercially available, a thorough characterization of 
these vesicles is still lacking. Here we use labelling through emerald GFP (emGFP)-
tagged CD63 and provide an extensive characterization of the fluorescent vesicles. 
Overexpression of our construct in parent cells yields vesicles with typically 10-30 
CD63-emGFP molecules per vesicle that are sensitive to detergent treatment, 
whereas a second species of free emGFP, truncated from CD63 is released into 
the extracellular space and co-purified by ultrafiltration but largely removed by 
gel filtration.  
Since CD63-emGFP vesicles showed a size, sedimentation density and morphology 
consistent with that of exosomes, co-fractionated with Alix and Tsg101 on sucrose 
gradients as well as gel filtration, and were enriched together with Alix, CD81, 
CD9, Tsg101 and CD63 as determined by proteomics, we conclude that CD63-
emGFP vesicles are predominantly exosomes. Based on a comparative 
characterization of vesicles from transfected and untransfected cells by 
sedimentation density fractionation, size exclusion chromatography, 
fluorescence correlation spectroscopy, cryo-EM and proteomics, our results 
demonstrate that neither the parent cell transfection, CD63-emGFP 
overexpression nor UF-GF isolation significantly compromise measured 
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physicochemical integrity of the vesicles, including their density, size, morphology 
and, importantly, proteome. Consistent with previous data [9], single vesicle 
imaging now provide direct evidence that UF-GF recovers single vesicles, whereas 
UC gives rise to a variable extent of vesicle aggregation/fusion. We therefore 
recommend UF-GF as a preferred method whenever isolating exosomes for 
functional studies. Furthermore, we demonstrate the power of FCS for exosome 
quantification. This provides a significant advance towards commonly used 
quantification based on total protein or Nanoparticle Tracking. The first is subject 
to large variation depending on the isolation method, and does not give any 
information on exosome or even vesicle concentrations. The latter detects all 
vesicles within the sample that share a similar size. In contrast, FCS enables the 
quantification of concentration and size of CD63 positive vesicles specifically 
within complex samples. In addition, single vesicle parameters such as the 
number of fluorophores per vesicle can be derived. Finally, our data also unravel 
that when using FP tagged exosome reporters care must be taken with assigning 
the total fluorescence signal to vesicles, since a significant fraction of non-
vesicular GFP is recovered from conditioned medium - at least for CD63. 
 
Previous quantification of exosome uptake has largely been based on FACS [1], 
[14]–[16], which does however not discriminate between truly internalized 
vesicles and vesicles simply adhering to the cell surface. We here report the first 
HCS assay to quantify exosome uptake with high statistical power and medium 
throughput using automated confocal plate imaging. We are using this assay to 
provide a first systematic and quantitative profiling of exosome uptake efficiency 
across a panel of parent - recipient pairs. At large, cells either did or did not take 
up the three exosome types used in this study. While most cell types tested 
showed significant uptake of HEK293, Huh7 as well as B16 exosomes that 
saturated with time and dose, human primary keratinocytes and B16 melanoma 
cells appeared virtually resistant to uptake of these exosomes. It is conceivable 
that this might in part be due to the lack of cognate receptors and that these cells 
might take up exosomes from other cell types that were not included in this small 
pilot study. In particular the deficiency of B16 cells to take up B16-derived 
exosomes was nonetheless surprising and it will be interesting to study whether 
these cells may take up exosomes only under specific conditions such as hypoxia. 
Interestingly however, also Huh7 cells showed a significantly reduced uptake of 
Huh7 derived exosomes. This may suggest that the fluorescent vesicles generally 
compete with autocrine reuptake of unlabelled exosomes constantly released 
from the recipient cells. Alternatively, a true lack of allo-exosome uptake would 
suggest that exosomes are primarily targeted to home to different cell and tissue 
types rather than a function in auto- and paracrine signalling - at least for B16 and 
Huh7 exosomes. In either case these data support the model that highly specific 
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receptor-ligand interactions between exosomes and recipient cells determine 
parent-recipient cell pairing. We anticipate that the described assay will be 
valuable for the community to grow our systematic and quantitative 
characterization of exosome cell/tissue targeting, as well as provide a starting 
point for interrogating exosome function by high throughput biology such as 
through genetic and small molecule screens.  
 
Figure 1. Native isolation of CD63-emGFP labeled exosomes by successive 
ultrafiltration and gel filtration. (a) Exosome labeling by transfection of parent 
cells. (b) Sucrose gradient fractionation of conditioned medium from CD63-
emGFP transfected HEK293 cells without prior ultracentrifugation. X-axis: 
measured sucrose concentrations in collected fractions. GFP fluorescent particles 
of ca 50-120 nm diameter (measured by FCS) co-fractionate with the exosomal 
marker Alix, peaking at ca 32-36 % sucrose. (c) Following UF on a 100 kDa MWCO 
membrane, enriched medium was loaded onto a Superdex200 column for size 
exclusion chromatography, with continuous UV detection (blue line). The total 
GFP fluorescence count rate was measured in each of the 60 fractions by FCS 
(upper panel, green line). Western blots against different exosomal markers were 
performed after pooling of 4 fractions each into samples A-L as indicated, omitting 
one fraction in between pools. CD63-emGFP fusion protein bands (multiple 
glycosylated isoforms) versus truncated GFP bands detected on an anti-GFP 
western blot are indicated by arrows and asterisks, respectively.  
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Figure 2. Single molecule characterization of CD63-emGFP labelled UF-GF 
isolated exosomes. (a) Individual fractions from gel filtration of HEK293 CD63-
emGFP exosomes in Figure 1c were analyzed by FCS with (red data points) and 
without (blue data points) vesicle disruption by the detergent NP40S. The 
translational diffusion time (tdiff, upper panel), molecular brightness (CPP, second 
panel) as well as absolute number of fluorescent molecules within the confocal 
volume (n, third panel) are depicted across the fraction number from the gel 
filtration. The ratio of freely diffusing GFP fluorescent particles before and after 
NP40S treatment (third panel) yields the average number of CD63-emGFP 
molecules per particle (bottom panel). Frames indicate fractions comprising the 
two main fluorescent populations. The first peak comprises a relatively 
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heterogeneous population of emGFP fluorescent, large particles with tdiff ranging 
from ca 2-10 ms (mean of ca 4 ms), corresponding to ca 50-120 nm in size (mean 
of ca 90 nm). A similar heterogeneity was observed in molecular brightness CPP, 
ranging from ca 80 kHz to 1’000 kHz per particle (mean of ca 250 kHz). Treatment 
with the detergent NP40S resulted in a uniform population of molecules with a 
tdiff of ca. 300 us and CPP of 20 kHz, corresponding to the expected values for 
free CD63-emGFP (based on extrapolation from data measured for free 
monomeric emGFP, t-diff = 160 us, CPP = 18 kHz). The number of emGFP 
molecules independently diffusing through the confocal volume in turn increased 
upon vesicle disruption by NP40S. The second major eluting GFP peak comprises 
molecules of relatively homogeneous t-diff and CPP, insensitive to NP40S 
treatment and consistent with the size and brightness expected for monomeric 
GFP. (b) Time course of CD63-emGFP vesicle release. The concentration of CD63-
emGFP positive vesicles in UF enriched samples from HEK293 cells recovered was 
determined by FCS, the total number of vesicles between 70-140 nm in size was 
determined by NTA (upper panel). Time points represent hours of conditioning, 
starting 5 hours after transfection. The ratio of fluorescent and total vesicle 
numbers is shown in the bottom panel. 
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Figure 3. Morphology and proteome of extracellular microvesicles recovered 
from CD63-emGFP transfected and untransfected HEK293 cells. (a) Cryo-EM 
analysis of UF-GF isolated CD63-emGFP versus native exosomes (representative 
images). Scaling bar: 100 nm. (b) LC-MS proteomics of native versus CD63-emGFP 
HEK293 exosomes. Spectral counts for a subset of proteins from the list in 
Supplementary Table 1 are shown. (c) Venn diagram comparing the top 500 
proteins, ranked by total spectral count (left panel), or all proteins detected at a 
< 1 % FDR (right panel). Of the 1079 identified proteins with 2 unique peptides in 
at least one of the samples, 86 % (932) were identified in both samples, 119 were 
unique to the emGFP-CD63 and 28 unique to the untransfected cells.  
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Figure 4. Single vesicle imaging of exosomes isolated by UF-GF or UC. 
Conditioned media from HEK293 cells transfected with either CD63-mCherry or 
CD63-emGFP were mixed prior to exosome isolation by ultrafiltration (UF) or 
ultracentrifugation (UC). Exosomes were imaged by confocal fluorescence 
microscopy after spotting onto coverslips. Vesicles were detected as light 
diffraction limited GFP or mCherry fluorescent spots of uniform size, 
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corresponding to the point spread function of the microscope. Colocalization was 
quantified based on overlap of the point spread functions in the two fluorescent 
channels to derive the number of GFP (G), mCherry (R) and GFP/mCherry (RG) 
double positive vesicles. Following UF-GF, almost no double positive spots were 
detected, demonstrating that the exosomes remained intact and disperse after 
(a) UF-GF purification, as well as confirming the detection of single vesicles. (b) In 
contrast, ultracentrifugation (UC) yielded a subpopulation of double positive, 
slightly larger spots, revealing a certain degree of vesicle fusion and/or 
aggregation during the purification. (c) As controls, UF-GF isolated vesicles from 
cells transfected with a CD63-emGFP-mCherry fusion protein were predominantly 
detected as double positive spots. Data for individually isolated CD63-emGFP or 
CD63-mCherry exosomes are not shown and confirmed exclusive detection in one 
color only.  
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Figure 5. Quantification of exosome cell uptake by HCS. (a) Live cell imaging of 
HEK293 cells after 24 hour incubation with 10 nM of either CD63-emGFP vesicles 
(left panel) or non-vesicular GFP truncated from CD63 (right panel). Scaling bar: 
20 um. (b) Quantification of HEK293 CD63-emGFP exosome uptake time course 
into HEK293 cells using a 96-well automated high content screening assay. 
Recipient cells were incubated with CD63-emGFP exosomes either by addition of 
conditioned medium of UF enriched samples at matched concentrations, and 
fixed at various time points up to 15 hours. Whole wells were then imaged on an 
automated confocal plate imaging station (Operetta, Perkin Elmer) and 
internalized GFP fluorescence was quantified based on the number of intracellular 
GFP fluorescent vesicles per cell using automated image analysis (left panel). 
Single cell data of (b) were analyzed to quantify the fraction of exosome targeted 
cells (right panel) (c) Confocal images illustrating the uptake of UF enriched CD63-
emGFP HEK293 exosomes into HEK293 cells after 15 hours (green: GFP; red: Cell 
Mask DeepRed) (d) Time course of uptake of UF-GF enriched CD63-emGFP 
exosomes into Huh7 cells in 384well format. Non-vesicular GFP was recovered 
from the gel filtration (Figure 1, peak 2) and uptake was tested at fluorophore 
matched concentrations based on FCS quantification. All data represent averages 
and standard deviations from 3 biological replicates, with at least 1000 cells 
analysed per sample. 
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Figure 6. Profiling of exosome uptake efficiency across an array of parent and 
recipient lines. UF-GF isolated CD63-emGFP exosomes from HEK293, Huh7 and 
B16 cells were added to a variety of recipient lines in 384well format in a dose 
response assay (1-18 pM) and uptake was quantified after 8 hours by whole well 
automated fluorescent imaging. At least 5’000 cells were analyzed per sample. 
Error bars represent standard deviations from three biological replicates. (b) 
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Confocal images of cells incubated without (background) or with exosomes at 18 
pM for different combinations of exosome parent and recipient lines as indicated 
(green: CD63-emGFP signal; red: CellMask Deep Red; Scaling bar: 20 um; Zeiss 
LSM710 inverted confocal microscope). Notably, no uptake was detected in iPS 
derived motor neuron cultures, however the cell morphology and 3D-network 
complicated the automated quantification as well as visual evaluation of truly 
internalized signal, and we can thus not rule out low levels of uptake. 
 
 
 
 
Table 1. Scoring of exosome parent - recipient cell pairing. UF-GF isolated CD63-
emGFP exosomes from HEK293, Huh7 and B16 cells were added to a variety of 
recipient lines in a dose response assay (1-18 pM, 3 biological replicates) and 
uptake was quantified after 8 hours by whole well automated fluorescent imaging 
(Figure 6). Relative uptake efficiency was scored based on both, the level of 
internalized GFP at the highest dose, as well as the EC50. 
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Supplementary Figure 1. Supplementary data of CD63-emGFP exosome 
characterization. (a) Map of the CD63-emGFP expression vector. (b) Conditioned 
medium from untransfected HEK293 cells was directly fractionated on a sucrose 
sedimentation gradient without any prior ultracentrifugation step. X-axis shows 
measured sucrose concentrations in the collected fractions. Particles with a size 
of 70-140 nm (as measured by NTA) co-fractionate with the exosome markers Alix 
and Tsg101, peaking at ca 32-36 % sucrose. (c) Retention time analysis of gel 
filtration of exosome samples using a size standard. Upper size separation limit of 
the column: 600 kDa. Exclusion limit: 1.3 MDa. (d) Fractions from gel filtration of 
CD63-emGFP HEK293 exosomes shown in Figure 1c were analyzed for total 
protein concentration by a Bradford assay (upper panel). The ratio between the 
254/280 traces is shown in the lower panel. 
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Supplementary Figure 2. Single molecule characterization of CD63-emGFP 
labeled UF-GF isolated exosomes. Individual fractions from gel filtration of B16 
CD63-emGFP exosomes and Huh7 CD63-emGFP were analyzed by FCS with (red 
data points) and without (blue data points) vesicle disruption by the detergent 
NP40S. The translational diffusion time (tdiff, upper panel) and molecular 
brightness (CPP, second panel) are depicted across the fraction number from the 
GF. Frames indicate fractions comprising the two main fluorescent populations. 
(a) B16 medium isolation: The first peak comprises a relatively heterogeneous 
population of emGFP fluorescent, large particles with tdiff ranging from ca 2-10 ms 
(mean of ca 3.5 ms), corresponding to ca 50-120 nm in size (mean of ca 80 nm). A 
similar heterogeneity was observed in molecular brightness CPP, ranging from ca 
9 kHz to 500 kHz per particle (mean of ca 70 kHz). (b) Huh7 medium isolation: The 
first peak comprises a relatively heterogeneous population of emGFP fluorescent, 
large particles with tdiff ranging from ca 2-10 ms (mean of ca 4.8 ms), 
corresponding to ca 50-120 nm in size (mean of ca 100 nm). A similar 
heterogeneity was observed in molecular brightness CPP, ranging from ca 9 kHz 
to 270 kHz per particle (mean of ca 110 kHz). In both samples the treatment with 
the detergent NP40S resulted in a uniform population of molecules with a tdiff of 
ca. 300 us and CPP of 9-15 kHz (B16) or 15-24 kHz (Huh7), corresponding to the 
expected values for free CD63-emGFP (based on extrapolation from data 
measured for free monomeric emGFP, tdiff = ca 160 us, CPP = 8-10 kHz). The 
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second major eluting GFP peak comprises molecules of relatively homogeneous 
tdiff and CPP, insensitive to NP40S treatment and consistent with the size and 
brightness expected for monomeric GFP.  
 
Supplementary Figure 3. Comparison of exosomes from CD63-emGFP 
transfected and untransfected parent cells. (a) Cryo-EM analysis of UF-GF 
isolated CD63-emGFP versus native Huh7 exosomes (representative images). 
Scaling bar: 100 nm. (b) SDS PAGE (Colloidal Coomassie Blue stain) of exosome 
samples used for LC-MS proteomics in Figure 3 and Supplementary Table 1. The 
16 gel slices for in gel digestion are indicated by red boxes.   
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Supplementary Figure 4. Single vesicle imaging. The data in Figure 4 are shown 
with a more stringent threshold to limit the analysis to the 100 brightest vesicles. 
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Supplementary Figure 5. Lack of HEK293 exosome uptake in human primary 
keratinocytes. (a) Confocal live cell image (fluorescence and DIC overlay) of 
human primary keratinocytes 100 minutes (left panel) and 13 hours (right panel) 
after incubation with HEK293 CD63-emGFP exosomes (green) at 200 nM, 
demonstrating lack of uptake even at high exosome concentrations. An x-z 
orthoview of the image in the left panel of (a) is shown in (b), visualizing the high 
concentration of exosomes floating in the medium. CellMask Deep Red is shown 
in red. 
 
 
 
Supplementary Table 1.  MS-proteomics analysis of UF-GF enriched exosomes 
from CD63-emGFP transfected versus non-transfected HEK293 cells. Spectral 
counts are listed for all proteins detected at a < 1% FDR. Among the top 350 
proteins, GFP was the only difference. 
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Materials and Methods 
 
Parent cells. Human hepatocellular carcinoma cells (Huh7, ATCC), human 
embryonic kidney cells (HEK293T, ATCC), and a mouse melanoma cell line 
(B16F10, ATCC) were cultured in complete media comprised of Dulbecco's 
Modified Eagle Medium (DMEM, Life Technologies), supplemented with 10 % 
fetal bovine serum (FBS, Cellgro) and penicillin/streptomycin (5 mg/ml, Cellgro). 
All cells were cultured at 37°C with 5 % CO2. For fluorescent exosome labeling, the 
full length coding sequence of human CD63 isoform A (RefSeq NM_001257390.1) 
was TOPO cloned into the pcDNA 6.2 N-emGFP vector (Promega) to result in an 
N-terminal fusion of emGFP to CD63. pcDNA 6.2 N-mCherry-CD63 and N-mCherry-
emGFP-CD63 vectors were then subcloned by replacing the emGFP CDS in 
between the Ava I sites by gene synthesized inserts (Solvias) comprising the CDS 
of either mCherry or an emGFP-mCherry fusion.  For exosome isolation, 5-8 x 10
6
 
HEK293, 4-5 x 10
6
 Huh7 or 4-5 x 10
6 
B16 cells were seeded in a 15 cm culture dish 
with complete media and transfected with CD63 expression constructs the next 
day. Cell transfection was done in complete medium using Lipofectamine2000 
(Life Technologies; 1 mg DNA/2.2 ml LF2000) following the manufacturer's 
instructions. After 4 hours, cells were washed and medium was replaced by 
OptiMEM. Conditioned media were collected after 48 hours if not indicated 
otherwise for exosome isolation. Typically, 100-200 ml of conditioned medium 
(pooled from multiple dishes) was used in most experiments. 
 
Exosome isolation.  
Exosome isolation via UF/GF was essentially performed as described elsewhere 
[9]. Briefly, conditioned medium was pre-cleared of cell debris and larger particles 
by consecutive centrifugation at 300 g for 5 minutes followed by 3’000 g for 10 
minutes, as well as filtration over a 0.22 mm filter. Typically, 100-200 ml of the 
pre-cleared conditioned medium was then concentrated to a volume of 0.5-1 ml 
on an AMICON ultrafiltration device using a 100-kDa MWCO membrane 
(Millipore). Enriched medium was then loaded onto a Superdex200 column (GE 
Healthcare) connected to an ÄKTA prime FPLC instrument (GE healthcare) 
equipped with a UV flow cell. Gel filtration was performed at 4°C using sterile 
filtered 50 mM Tris-buffer (flow rate 0.5 ml/min). Ninety-six individual fractions 
of 200 ml each were collected. NTA and FCS was performed directly in all fractions. 
For Western blotting, fractions were pooled (4 fractions each, omitting one 
fraction in between pools) and further concentrated to a volume of 30 ml on an 
Amicon 10-kDa MWCO spin columns (Millipore). UC isolation for the experiment 
in Figure 4 was performed following the protocol specified in [9]. 
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Sucrose gradients. 
 Ten 350 ml fractions with increasing sucrose density (8-80 %) were overlaid via 
freezing between each step and topped with 12 ml conditioned, pre-cleared 
medium. The gradient was centrifuged for 65 hours at 120’000 g at 4°C and 
fractions were collected by snap freezing the gradient on dry ice and slicing into 
10 or 20 fractions from the bottom. The sucrose concentration in each fraction 
was then determined by refractive index measurements. 
 
Western Blotting.  
Aliquots of sucrose gradient fractions or pooled and spin column concentrated gel 
filtration fractions were heated in SDS sample buffer for 10 minutes at 70°C and 
electrophoresed on 4‑12 % NuPage gels (Life Technologies). Proteins were 
transferred to Protran nitrocellulose membranes (Whatman) using a SD Transblot 
system (BioRad) and blocked for 1 hour in PBS with 5 % (w/v) milk powder 
(BioRad) at RT prior to primary antibody incubation either for 2 hours in blocking 
buffer at RT or overnight at 4°C. Immune complexes were visualized using HRP-
conjugated secondary antibodies (Santa Cruz) on a Biorad XRS system. Antibodies: 
PDC6I/Alix (ab117600, Abcam, 1/500 dilution), Tsg101 (ab83, Abcam, 1/500 
dilution); Lamp2b (ab25631, Abcam, 1/500 dilution); GFP (ab290, Abcam, 1/1000 
dilution). 
 
Fluorescence Correlation Spectroscopy (FCS).  
Exosome quantification and characterization via FCS was essentially performed as 
described elsewhere [9]. Briefly, samples were measured on a Clarina II Reader 
(Evotec Technologies) with 488 nm argon ion laser excitation, a 40x water 
immersion 1.15 N.A. objective (UAPO Olympus), 50 mm pinhole and a SPCM-AQR-
13FC avalanche photodiode (Perkin-Elmer Optoelectronics). The confocal volume 
was calculated in approximation according to [17] using the measured diffusional 
correlation time tdiff of free dye (Alexa488, Life Technologies), the known 
translational diffusion coefficient of Alexa488 (Molecular Probes; D = 280 mm
2
/s) 
and the axis ratio fitted from calibration measurements. For each sample, several 
dilutions were made and measured in a 96-well glass bottom plate (Whatman) 
with 30 repetitive measurements of 10 seconds each. NP-40S at 1% v/v 
(Biosciences) was used to induce vesicle disruption for determination of detergent 
sensitivity and quantification of CD63-emGFP molecules per exosome. Data from 
one experiment representative of at least three independent experiments are 
shown. Error bars represent standard deviations from the 30 FCS measurements. 
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Cryo-Transmission Electron Microscopy (Cryo-TEM). 
 A 4 l aliquot of sample was adsorbed onto glow-discharged holey carbon coated 
grid (Quantifoil, Germany), blotted with Whatman filter paper and vitrified into 
liquid ethane at −178°C using a Vitrobot (FEI, Endhoven, Netherlands). Frozen 
grids were transferred onto a Philips CM200-FEG electron microscope (FEI, 
Endhoven, Netherlands) using a Gatan 626 cryo-holder (GATAN Inc, Pleasanton, 
USA). Electron micrographs were recorded at an accelerating voltage of 200 kV 
and a nominal magnification of 50’000x, using a low-dose system (10 e−/Å2) and 
keeping the sample at −175°C. Defocus values were ranging from −2 m to 3 m. 
Micrographs were recorded at 4K × 4K CMOS camera (TVIPS, Germany). 
 
Single vesicle imaging. 
 Exosomes from CD63-emGFP/CD63-mCherry double transfected HEK293 cells 
were imaged by confocal fluorescence microscopy after spotting onto coverslips. 
Vesicles were detected as light diffraction limited GFP or mCherry fluorescent 
spots of uniform size corresponding to the point spread function of the 
microscope, confirming recovery of single vesicles. Co-localization was quantified 
based on overlap of the point spread functions in the two fluorescent channels to 
derive the number of GFP (G), mCherry (R) and GFP/mCherry (RG) double positive 
vesicles. 
  
Nanoparticle Tracking Analysis (NTA). 
 Label-free particle size and concentration determination was performed on a LM 
NTA instrument (NanoSight). With a camera gain of 500, full detection range and 
90 second recordings all camera settings as well as analyses parameters 
(detection threshold of 2, minimum expected particle size of 50 nm, fixed minimal 
track length of 4) where kept constant throughout all measurements. For 
quantitative analysis of particle size distribution and concentration, a dilution row 
of samples between 1:100 to 1:10’000 was analyzed to hit the dynamic range of 
the instrument (1 - 4 x 108 particles/ml). 
 
MS-Proteomics.  
UF-GF isolated exosomes were separated by SDS-PAGE on a NuPAGE 4-12 % (Life 
Technologies) gel and stained with a Colloidal Coomassie stain (Sigma). Sixteen 
equal sized slices were excised from each of the gel lanes (Supplementary Figure 
3b). In-gel digestion and subsequent identification by liquid chromatography 
coupled with tandem mass spectrometry was performed as described [18], with 
the exception that a mix of Trypsin and Endopeptidase Lys-C (Promega) was used 
instead of trypsin alone. Database searches were done with Mascot (version 2.4, 
Matrix Science) against the UniProt database (release of April 2013) concatenated 
with a reversed version and supplemented with known contaminants (such as 
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trypsin, BSA and commonly used tags). Protein identifications were validated and 
summarized in Scaffold (version 4.0.3, Proteome Software Inc.), setting the 
protein identification threshold at a 1 % false discovery rate (FDR) in the reversed 
database. At these settings peptide FDR was 0.05 %. The resulting protein list is 
provided as Supplementary Table 1. Keratin contaminants were removed and are 
listed separately. Trypsin and Lys-C were also removed from the list. Total spectral 
count is provided as a semi-quantitative measure, as well as the number of unique 
peptides for each protein (Supplementary Table 1). The spectral count is shown 
without correction for the total number of assigned spectra in each sample 
(24’626 for GFP-CD63 and 21’234 for the untransfected sample). 
 
Recipient cells. 
 Human primary fibroblasts from a healthy donor (Life Technologies, #C-013-5C) 
were grown in MEM (Life Technologies) supplemented with 15 % fetal bovine 
serum and penicillin/streptomycin (5000 mg/ml, Cellgro) in 0.1% gelatine (Sigma 
Aldrich) coated T150 flasks. Human hepatocellular carcinoma cells (Huh7, ATCC), 
human embryonic kidney cells (HEK293T, ATCC), and a mouse melanoma cell line 
(B16F10, ATCC) were cultured in complete media comprised of Dulbecco's 
Modified Eagle Medium (DMEM, Life Technologies), supplemented with 10 % 
fetal bovine serum (FBS, Cellgro) and penicillin/streptomycin (5 mg/ml, Cellgro). 
All cells were cultured at 37°C with 5 % CO2. For exosome exosome uptake 
screening assay, these cell lines were either plated in 96-well or 384-well uclear 
plates (ibidi) at a density of 60 %. Human primary keratinocyte progenitors 
(CELLnTEC Advanced Cell Systems AG, Bern, Switzerland) were kindly provided by 
Gabi Schutzius (Novartis Basel) and cultured in Epithelial Culture Medium 
(CELLnTEC Advanced Cell Systems AG) under sub-confluent culture conditions to 
prevent differentiation. For the exosome uptake assay cells at passage 6 were 
detached with Accutase (CELLnTEC Advanced Cell Systems AG), and plated 48 
hours prior to exosome addition at a density of 20’000 cells per 96-well. Human 
iPS cells from a healthy donor (Coriell) were kindly provided by Claudia Merk 
(Novartis Basel) and differentiated into motor neurons following a protocol 
adapted from[19], [20] , plated in Matrigel coated 96-well plates (ibidi) and 
cultivated for 3 weeks prior to exosome uptake studies. HUVEC primary human 
endothelial cells (Promocell) were kindly provided by Giorgia Jurisic (Novartis 
Basel) cultivated in Endothelial Cell Growth Medium (Promocell) and plated in 96-
well plates (ibidi) coated with Collagen (50 mg/ml, PureCol™ Advanced 
BioMatrix). HEK293 cells (ATCC), B16-F10 cells (ATCC), Huh7 cells (HSRRB) and 
HeLa cells (ATCC) were cultivated in DMEM (Life Technologies) supplemented 
with 10 % fetal bovine serum and 1x L-Glutamine 200 mM (100X; Life 
Technologies) and penicillin/streptomycin (Life Technologies) and plated in 96-
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well plates (ibidi) at a cell density of 40-60 % confluency one day prior to exosome 
addition. 
 
Confocal live cell microscopy.  
For the combined confocal fluorescence and DIC live cell imaging cells were 
seeded into an 8-well m-slide (ibidi) and pre-stained prior to exosome addition as 
indicated in each experiment; Cell membrane: CellMask Deep Red (dilution 
1:1000 for at least 2 minutes, Life Technologies); 
 Images were acquired on a confocal LSM710 microscope with Big-detector (Zeiss) 
with a 100x or 63x oil 1.4 NA PlanApochromat DIC objectives and temperature, 
gas and humidity control unit (Life Imaging Services). Differential interference 
contrast (DIC) was set up using the transmitting laser light of excitation as light 
source and the TPMT as detector. 
 
Automated imaging assay for exosome uptake.  
Cells were seeded into a 96-well Ibidi plate and incubated with exosomes as 
indicated in each experiment. Cells were fixed for 20 minutes at room 
temperature with PenFix (Thermo Scientific) in presence of 1 mg/ml Hoechst (Life 
Technologies) and 0.02 % (v/v) CellMask Deep Red (Life Technologies). Following 
extensive washing with PBS, wells were imaged on an automated confocal plate 
scanning instrument (Operetta, Perkin Elmer) at 40x magnification. Image analysis 
was done using the Harmony software, by first identifying the nuclei (Hoechst), 
defining the cell boundaries (CellMask Deep Red) and finally quantifying the 
number of GFP spots per cell. At least 5,000 cells were analyzed by condition. Data 
are shown from one representative experiment from at least three independent 
experiments, and represent averages with error bars indicating standard 
deviations from three independent samples. 
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4.4 Manuscript II (Exosomes surf on filopodia to enter cells 
at endocytic hot spots, and shuttle with endosomes to 
scan the endoplasmic reticulum – a highway to the cell)  
 
Finally, we focused on quantitative and mechanistic characterization of exosome 
mediated cell uptake and uncovered a new analogy to some viruses by high 
resolution imaging and single vesicle dye tracing in live cells.  We discovered that 
exosomes enter cells as single vesicles within minutes of addition, and are actively 
recruited to the cell body by surfing on filopodia, as well as via filopodial grabbing 
and pulling. In 98% of events, exosomes enter cells at the filopodia base, regions 
of active actin remodeling and considered endocytic hot spots. Following 
internalization, exosomes enter and shuttle with endocytic vesicles and scan 
along the ER before they end up in lysosomes. Exosomes have been shown to 
carry specific and active miRNA cargo. This indicates that exosomes may not only 
target cells specifically but additionally deliver their miRNA cargo directly to the 
site of RNA silencing (paper II). This model could explain how a rare miRNA 
communication vehicle nonetheless does have an impact in cell behavior by a 
direct delivery to the site of action at the ER. However, mechanisms of exosome 
cargo release remain to be investigated. 
 
Exosomes surf on filopodia to enter cells at endocytic 
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Abstract. Exosomes are nanovesicles released by virtually all cells which 
act as intercellular messengers by transfer of protein, lipid and RNA cargo. Their 
quantitative efficiency, routes of cell uptake and subcellular fate within recipient 
cells remain elusive. We quantitatively characterize exosome cell uptake which 
saturates with dose and time and reaches near 100 % ‘transduction’ efficiency at 
picomolar concentrations. Highly reminiscent of pathogenic bacteria and viruses, 
exosomes are recruited as single vesicles to the cell body by surfing on filopodia, 
as well as filopodia grabbing and pulling motions to reach endocytic hot spots at 
the filopodial base. Following internalization, exosomes shuttle with endocytic 
vesicles to scan the endoplasmic reticulum before being sorted into the lysosome 
as their final intracellular destination. Our data quantify and explain the efficiency 
of exosome internalization by recipient cells, establish a new parallel between 
exosome and virus host cell interaction and suggest unanticipated routes of 
subcellular cargo delivery. 
 
Introduction. Exosomes are extracellular vesicles that mediate cell-to-cell 
communication (Colombo et al., 2014), sometimes at a distance (Hood et al., 
2011) and even between organisms (Corrigan et al., 2014; Twu et al., 2013). They 
modulate recipient cell gene expression and physiology by induction of cell 
signaling as well as intercellular transfer of protein, lipid and RNA cargo (Ratajczak 
et al., 2006; Valadi et al., 2007). They also have clinical significance due to their 
potential use as biomarkers (Properzi et al., 2013) or next generation therapeutics 
(Alvarez-Erviti et al., 2011; Kordelas et al., 2014). Hence there is need for a better 
understanding of how these vesicles target and enter recipient cells. The current 
model postulates exosome uptake via energy-dependent, receptor-mediated 
endocytosis (Svensson et al., 2013; Tian et al., 2013) or macropinocytosis (Fitzner 
et al., 2011; Tian et al., 2014). However, there are opposing models proposing 
direct fusion with the plasma membrane (Conde et al., 2005; Parolini et al., 2009) 
or phagocytosis (Feng et al., 2010). It remains to be seen whether different entry 
routes reflect cell specialization or conditions, or whether multiple entry routes 
co-exist in the same cell. Further, the subcellular fate of exosomes within recipient 
cells and in particular their mechanisms of cargo release remain largely enigmatic. 
Here we report by single vesicle dye tracing in live cells that exosomes enter cells 
primarily via filopodia to sort into endocytic vesicle circuits that are targeted to 
scan the endoplasmic reticulum (ER) before being directed to the lysosome. 
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Results and Discussion. 
 
Exosomes are efficiently taken up as single vesicles. Exosomes were labeled by 
transient transfection of HEK293 parent cells with CD63-emGFP and/or CD63-
mCherry and isolated by ultrafiltration-gel filtration (Nordin et al., 2015). An 
extensive characterization of these vesicles is described elsewhere (Heusermann 
et al., 2015) confirming selective exosome labeling with minimal perturbation of 
physicochemical properties and cargo loading. Exosome concentrations were 
determined by fluorescence correlation spectroscopy (FCS) to enable 
quantification at the single vesicle level. To quantify exosome cell uptake over a 
statistically significant number of cells, we set up a high content screening assay 
on a plate scanning microscope with automated image analysis. To avoid any 
major cell line bias, we selected cells based on a systematic profiling of parent – 
recipient cell pairing preferences (Heusermann et al., 2015) and focused on 
uptake of HEK293 exosomes primarily in human primary fibroblasts, as well as 
Huh7 and HEK293 recipient cells for selected experiments. Exosome uptake levels 
were similar for different cell densities when confluency was low, but declined 
with cell density beyond an estimated threshold of ~60 % confluency 
(Suppl.Fig.1a). Uptake was time and dose dependent (Fig.1a and c, left panels), 
targeting up to 95 % of Huh7 cells at 30 pM exosomes within less than 6 hours 
(Fig.1a and c right panels and Suppl.Fig.1b). The saturating characteristics indicate 
that specific molecular interactions are involved in mediating exosome uptake. 
Similar data were obtained for human primary fibroblasts (Fig.1b). 
 
We next studied exosome uptake dynamics at the single cell level using confocal 
live cell imaging. Since exosomes share several physicochemical properties with 
liposomal delivery vehicles including their size and lipid composition, we 
compared the uptake dynamics of CD63-emGFP fluorescently labeled exosomes 
with a representative cationic lipid nanoparticle formulation with encapsulated 
Cy3 labeled siRNA. Similar vesicle concentrations were independently applied to 
Huh7 cells and time lapse confocal microscopy movies were recorded at different 
confocal planes. Liposomes accumulated into islands at the cell surface that 
became larger over time, with only a minor fraction being endocytosed within the 
first few hours (Suppl.Fig.1c and Suppl.Movies 1 and 2). In contrast, exosomes 
appeared to enter cells as single vesicles within minutes of addition without 
accumulation at the cell surface (Suppl.Fig.1d). We therefore next monitored 
uptake of CD63-emGFP/CD63-mCherry double labeled UF-GF isolated vesicles 
(Fig.1d) using single particle tracking (SPT), which confirmed that exosomes 
entered cells as single vesicles in virtually all recorded cell entry events (Fig.1e). 
Analyzing trajectories from 1600 internalized exosomes showed that the 
observation time of double labeled vesicles was statistically not shorter than that 
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for the single labeled vesicles (Fig.1f), demonstrating that no separation of the 
two labels occurred, at least within the time of max 20 minutes that we were able 
to trace single particles. These data indicate that vesicles remain intact during and 
after cell entry and rule out a plasma membrane fusion, at least under the 
conditions studied.  
 
Exosome uptake is clustered into filopodia active regions. To trace a statistically 
significant number of single exosomes throughout cell entry, we recorded 5-60 
minute live cell movies of CD63-emGFP labeled HEK293 exosomes following their 
addition to either human primary fibroblasts (Fig.2a, and Suppl.Movies 3 and 4), 
HEK293 (Suppl.Fig.1e and g) or Huh7 recipient cells (Suppl.Fig.1f and h) with 
confocal and TIRF microscopy. Fig.2a shows the cumulative trajectories of single 
exosomes followed over an 80 minute time frame (dragon tail visualization). 
Rather than being randomly distributed across the cell, exosome residency 
clustered into hotspot areas. This was not a consequence of intracellular 
segregation since cell entry events also clustered into the same regions. 
Interestingly, these uptake hotspots were near the tips of cortical actin bundles 
(Fig.2a, left panel) and coincided with filopodia and lamellipodia active regions 
(Fig.2a, right panel and Suppl.Fig.1e-h). To uncouple the localization of filopodia 
from the lamellipodium we used human primary fibroblasts grown on a line 
substrate (Martin et al., 2014). The cell body and filopodia were visualized by 
adenoviral expression of actin-RFP. As had been demonstrated before, cells 
became highly polarized and showed persistent migration in one direction, with a 
defined lamellipodium at the front end, filopodia distributed across the lateral 
regions of the cell surface and retraction fibers at the back end (Fig.2b). Uptake of 
CD63-emGFP HEK293 exosomes was monitored by TIRF microscopy to focus at 
the bottom 200 nm layer where filopodia are typically localized. Uptake through 
the lamellipodium of the migrating cell should result in a time-space correlation, 
as exemplified for podosome positions which re-form at the front end over time 
(Fig.2d, right panel). In contrast, exosome cell entry trajectories were uncoupled 
in space and time from the lamellipodium. Instead they redistributed, together 
with filopodia, to the lateral regions (Fig.2c and Fig.2d left panel). This pointed to 
a possible direct involvement of filopodia in exosome uptake. 
 
Exosome recruitment and cell entry is facilitated by filopodia surfing, grabbing, 
and pulling. Filopodia are cellular protrusions formed by actin filaments that 
constantly scan the environment and thus interact with substrate and ligands 
(Bornschlögl, 2013; Mattila and Lappalainen, 2008). Their highly dynamic 
movement increases the effective surface area of a cell and facilitates interaction 
with extracellular ligands. Moreover, the filopodial base is an area of active actin 
remodeling and thus a hotspot for endocytosis (Lehmann et al., 2005; Mattila and 
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Lappalainen, 2008). The possibility of exosomes entering cells via filopodia is thus 
plausible. In fact previous reports revealed that filopodia facilitate efficient cell 
entry of certain pathogens including enveloped viral particles (Lehmann et al., 
2005; Zamudio-Meza et al., 2009). Indeed we observed a prominent occurrence 
of direct contact of exosomes with filopodia by confocal fluorescence microscopy, 
which was almost mirror imaged in scanning electron microscopy images (Fig.3a). 
We next used high resolution live cell imaging with detection of both fluorescence 
as well as differential interference contrast (DIC) to monitor dynamics of 
exosomes simultaneously with filopodia and other light diffracting, fine 
structures. This revealed different types of filopodia-facilitated exosome 
recruitment. Exosomes moved along filopodia and retraction fibers towards the 
cell body (Fig.3b, Suppl.Fig.4a-e and Suppl.movies 5 and 6) – in striking analogy to 
a process previously introduced as filopodia surfing in studies of viral uptake 
(Lehmann et al., 2005). We also documented examples where exosomes 
associated with tunneling nanotubes and moved back and forth along fibers 
connecting two cells (Suppl.Fig.2f and g). Individual exosomes surfed on filopodia 
with relatively constant speed in the range of 0.1-0.3 0.3 ividual exosomes surfed 
on filopodia with relatively constant speed in the range of 0.1ack and forth along 
fibers connecting two cells (6027225", "abs(Lidke et al., 2005) or MLV particles 
(Lehmann et al., 2005) and suggests a movement with F-actin retrograde flow 
(Bornschlögl, 2013; Sheetz et al., 1989; Forscher and Smith, 1988; Mitchison and 
Kirschner, 1988). Analyzing trajectories of 100 individual exosome filopodia 
surfing events from 13 live cell movies recorded in 6 independent experiments, 
we found in at least 90 % of the cases that the exosomes moved towards the cell 
body immediately after filopodial contact. In rare cases however, we documented 
an initial short movement in the opposite direction, followed by a transient 
stalling and redirection towards the cell body (Suppl.Fig.2j-k) – another parallel to 
previously published data for viral particles (Lehmann et al., 2005). Once 
redirected towards the cell, exosomes again moved with relatively constant speed 
matching that of F-actin retrograde flow. Together these characteristics indicate 
that after exosome attachment, additional molecular interactions or receptor 
recruitment might be required to trigger an eventual coupling with F-actin 
retrograde flow, rather than directly hitchhiking onto a running conveyor belt. In 
analogy it has been demonstrated that systematic retrograde transport of EGF 
receptors present in filopodia is triggered upon binding of EGF and activation of 
the receptor tyrosine kinase (Lidke et al., 2005). Likewise, extensive studies of 
filopodia surfing with artificial beads have identified receptors of the integrin and 
CAM protein receptor families to couple with the filopodial actin filament. 
Intriguingly, both had previously been implicated as receptors involved in 
exosome uptake (Morelli et al., 2004; Rana and Zöller, 2011).  
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In addition to filopodia surfing, two further modes of filopodia-mediated exosome 
recruitment were observed: contractile filopodia bound exosomes at their tips 
and pulled them actively to the cell surface (Fig.3c, Suppl.Fig.2h and Suppl.Movie 
7), whereas laterally moving filopodia fished exosomes from the medium and 
actively hinged the vesicles to the cell body (Fig.3d, Suppl.Fig.2i, and Suppl.Movie 
8). Further, our movies documented examples demonstrating that all three 
modes of filopodia interaction can also result in exosome cell entry (Fig.2 and 3, 
Suppl. Fig.2, and Suppl.Movie 4. Next to quantify the overall contribution of 
filopodia recruitment for exosome internalization in an unbiased manner, 394 
individual exosome cell entry trajectories from several independent experiments 
were classified based on filopodia and non-filopodia mediated uptake as 
illustrated in Fig.4. Strikingly, over 98 % of all exosome entry events occurred at 
the base of filopodia and retraction fibers (Fig.4a). In approximately one third of 
these cases we were able to indeed document filopodia mediated exosome 
recruitment prior to cell entry. This number might be an underestimate due to the 
technical limitation of visualizing these small and highly dynamic structures over 
a sufficiently long time frame. The predominant mode of exosome filopodia 
interaction resulting in confirmed cell entry was surfing, detected in ~25 % of all 
analyzed cell entry trajectories (Fig.4b and d). Filopodia pulling and grabbing were 
only detected in ~3 % and 1 % of all cases, respectively. However, due to the rapid 
dynamics in 3D space of laterally moving filopodia as well as the shorter length of 
contractile filopodia, numbers of pulling and grabbing events might be 
underrepresented.  
Since filopodia mediated exosome uptake implies dependence on actin 
polymerization, we tested the effect of Cytochalasin D on the dynamics of 
exosome recipient cell interaction. Time lapse imaging showed no major loss of 
exosome cell binding but an inhibition of directed and rapid movement as well as 
uptake (Suppl.Fig.2l). This suggests that actin inhibition stalls exosome uptake 
during recruitment to the cell body and that filopodia activity is required 
upstream of exosome internalization. In line with these data it is intriguing to 
speculate that also the decrease of exosome uptake with cell confluency in 
Suppl.Fig.1a might be due to reduced filopodia numbers and activity. However, 
this effect may also be a consequence of a number of other effects under contact 
inhibition, such as changed endocytic rate or simply smaller accessible cell surface 
area. 
 
Of note it has been demonstrated that filopodia-surfing viruses such as human 
papilloma virus can additionally promote an increased filopodia formation in their 
host cells through PI3K activation, thereby reinforcing invasion by the virus (Smith 
et al., 2008; Nobile et al., 2010). By analogy it has been reported that exosome 
treatment increases the number of tunneling nanotubes (Thayanithy et al., 2014). 
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It is thus conceivable that exosomes might use similar mechanisms for directly 
modulating filopodial activity in recipient cells for feedback control of their own 
uptake. Likewise it will be interesting to see how the direct interaction of 
exosomes with filopodia revealed in this study may relate to their recently 
reported modulation of cell migration (Harris et al., 2015; Salomon et al., 2013; 
Sung et al., 2015), and whether different types of filopodia specialize in either 
exosome recruitment versus cell migration. 
 
Exosomes shuttle with endosomes to undergo a stop-and-go movement along 
the ER and are sorted to the lysosome. At the base of filopodia, single CD63-
emGFP labeled exosomes were encapsulated into larger, CellMask Deep Red 
labeled endocytic vesicles and were shuttled onwards following cell entry 
(illustrated in Fig.4e, also apparent in Fig.4b-d and Suppl.Movie 9). Together with 
the continued association of exosomal CD63-emGFP and CD63-mCherry in Fig 1e 
and f these data imply that the vesicles either remain stable over time within the 
cell, or at least their membranous components remain within the same endocytic 
vesicle. While this does not completely rule out that exosomes might utilize 
mechanisms for endosomal escape, this would imply a massive dilution of 
exosomal cargo into the cytoplasmic volume. In fact even for liposomal delivery 
vehicles (Sahay et al., 2013) the concept of endosomal escape as a productive 
route for siRNA delivery has been challenged (Gilleron et al., 2013). Quantification 
of the specific activity of exosomal cargo at the level of molecular concentrations 
is still lacking. Basic theoretical considerations of the volume of an 80 nm sphere 
and the average volume requirement per RNA or protein cargo molecule imply 
that a single exosome cannot even carry one copy of each cargo from the large 
proteome and transcriptome repertoire typically found in an exosome sample. 
Indeed, a recent study determined experimentally that on average, at least 100 
exosomal vesicles need to be sampled to cover one copy of a given miRNA 
(Chevillet et al., 2014). Although RNA silencing is a highly efficient process and 
requires only a small number of RISC loaded siRNA or miRNA molecules per cell 
(Stalder et al., 2013) the above numbers imply that 1000 exosomes would be 
required to deliver 10 copies of a miRNA into one cell. Even if specialized vesicle 
subpopulations exist that are enriched for certain cargo, it is conceivable that 
exosomes have evolved highly effective mechanisms to deliver their miRNA (and 
possibly mRNA) cargo directly to the site of action. We therefore hypothesized 
that exosomes might sort into specific endosomal trafficking circuits to reach their 
subcellular sites of action, and set out to further characterize intracellular 
trafficking of these endocytic, exosomal vesicles. Statistical analysis of 312 
intracellular trajectories (Suppl.Fig.3a and b) suggested that the vesicles did not 
primarily proceed on straight intracellular routes, with frequent transient stalling. 
Consistently, the speed variation of single vesicles over time revealed a stop-and-
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go movement (Fig.5a and Suppl.Fig.3c) with peak velocities reaching up to ~1  
with peak velocities reaching up to ~1 marily proceed on straight intracelome 
trajectories overlaid with DIC further suggested that exosomal vesicles largely 
followed intracellular filamentous and mesh-like structures (Fig.5b right panel) 
which were identified as endoplasmic reticulum based on labeling with ER Tracker 
(Fig.5b left panel and Fig.5c). Moreover, the pauses in the movement of exosomal 
vesicles typically occurred in close proximity to or at the ER, whereas the vesicles 
showed fast movement between ER sites (illustrated by examples in Fig.5d, 
Suppl.Fig.3d-j and Suppl.Movies 8 and 10). A guided movement by the ER mesh is 
further in line with the lack of highly straight paths apparent in the trajectory 
statistics. Highly reminiscent of the recently revealed interaction between 
endosomal vesicles and the ER (Friedman et al., 2013), exosome-containing 
endosomes showed close association with ER filaments, tips, branches and 
cavities (Fig.5e and Suppl.Fig.3d-j). Even though both ER as well as exosomal 
vesicles were highly dynamic, contact events of several seconds were recorded 
(Suppl.Movies 8 and 10). Since live cell movies further show a transiently 
coordinated movement rather than random crossing of their paths, this suggests 
a true interaction of ER and exosome containing vesicles.  
We and others have recently revealed that siRNA as well as miRNA loading into 
RISC, target mRNA complexation and mRNA slicing/silencing are nucleated at the 
rough ER membrane (Stalder et al., 2013; Li et al., 2013). In addition the ER is 
increasingly recognized as a nucleation site for translation in general - rather than 
only for secreted proteins as had long been assumed (Reid and Nicchitta, 2015; 
Reid et al., 2014; Jagannathan et al., 2014). A directed transport of exosomes to 
the ER membrane would therefore allow for an efficient entry of exosomal miRNA 
and mRNA cargo into the RNAi and translation machineries. Some viruses also 
need to reach the ER for their replication (Spooner et al., 2006), however within 
the cell they seem to use routes that are different from those of exosomes.  For 
example, Hepatitis C virus (HCV), which also retracts along filopodia (Coller et al., 
2009), utilizes the endosomal system for retrograde transport through the ER-
Golgi intermediate compartment (ERGIC) into the ER lumen and eventual 
transport across the ER membrane to reach the cytosolic ER surface (Dubuisson 
and Cosset, 2014). In contrast we show that exosomes shuttle with endosomal 
vesicles that are directed to, scan along and transiently interact with the ER. Since 
such ER scanning vesicles were recently identified as Rab5 and Rab7 positive 
endosomes  (Lehmann et al., 2005), we finally wanted to assess an eventual 
sorting of exosomes to compartments of the late endosome. We quantified the 
co-localization of CD63-mCherry exosomes with LysoTracker Green based on 
(Bolte and Cordelières, 2006). Pearson’s and Mander’s coefficients both 
confirmed a partial co-localization of exosomes with lysosomes, increasing over 
time up to ~50-60 % after 48 hours in fibroblasts (Suppl.Fig.3k and l). 
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Our data demonstrate that exosomes (i) enter cells as individual vesicles within 
minutes upon addition, (ii) show no accumulation at the cell surface but rather a 
seemingly ‘barrierless’ cell penetration with (iii) a majority of detectable cell 
contact events leading to internalization, resulting in (iv) over 95 % of cells being 
targeted within only a few hours and (v) reaching saturation at low picomolar 
concentrations. We therefore conclude that exosome cell uptake is highly 
efficient. Since these characteristics are highly reminiscent of effective pathogen 
infection rather than lipid or liposomal delivery vehicles we propose to use the 
term ‘transduction’ rather than ‘transfection’ for exosome recipient cell targeting. 
The filopodia-facilitated exosome recruitment to endocytic hotspots revealed in 
this study provides a plausible explanation for the efficient cell entry of exosomes 
and adds another layer to their previously noted convergence with viral pathways 
(Wurdinger et al., 2012). Based on our data we propose a new physiological 
function of filopodia as highways for cell entry of exosomes which are hijacked by 
viruses and other pathogens. At the base of filopodia however, exosomes sort into 
endosomal trafficking circuits that appear to diverge from known viral trafficking 
routes, whereas we uncover that the ER plays a major role in intracellular 
exosome fate. The molecular details of how exosomes interact with filopodia, as 
well as whether and how exosomal cargo may be released, or functionally 
displayed at the ER across the endosomal (and exosomal) double lipid membranes 
will be important questions for future studies. 
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Figure 1. Quantitative exosome cell uptake dynamics.  
(a-c) HEK293 CD63-emGFP exosome uptake using quantitative high content 
screening. (d) Exosomes from CD63-emGFP/CD63-mCherry double transfected 
HEK293 cells were imaged by confocal fluorescence microscopy after spotting 
onto coverslips. Vesicles were detected as light diffraction limited GFP or mCherry 
fluorescent spots of uniform size corresponding to the point spread function of 
the microscope, confirming recovery of single vesicles. The number of GFP (G), 
mCherry (R) and GFP/mCherry (RG) double positive vesicles was derived based on 
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co-localization quantification. (e)Single particle tracing of CD63-emGFP/CD63-
mCherry HEK293 exosome uptake in primary human fibroblasts (confocal live cell 
imaging, 50 s/z-stack) and (f) Frequency distribution of the duration of 1’600 
individual SPT trajectories of exosomes detected either in the GFP, mCherry or 
coloc channel. 
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Figure 2. Exosome uptake is clustered into filopodia active regions.  
(a) SPT of exosome uptake dynamics by confocal live cell imaging of actin (left 
panel) or plasma membrane labeled (right panel) human primary fibroblasts. 
Exosomes at 100 pM; 50 s/frame. (b) TIRF live cell microscopy of stable actin-RFP 
expressing human fibroblasts (black) grown on line substrates. (c) Exosome 
uptake dynamics in fibroblasts on line substrates with single vesicle trajectories 
from TIRF live cell movies (2 frames/min). SPT trajectories documenting cell 
uptake events are highlighted in white, intracellular vesicle trajectories in green 
or yellow. The spatial distribution of cell entry events in the migrating cell is shown 
in (d) with trajectories pseudocolored for absolute time within the movie (left 
panel). In contrast to the lack of time-space correlation for exosome entry, 
podosomes remain at the front end over time (right panel).  
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Figure 3. Exosome cell entry is facilitated by filopodia surfing, grabbing and 
pulling. Representative examples from human primary fibroblasts incubated with 
HEK293 CD63-emGFP exosomes (green). Time points represent absolute times 
after addition of 100 pM exosomes. (a) SEM (left panel) or live cell DIC/confocal 
fluorescence microscopy (right panel) visualization of apparent contacts of 
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nanovesicles/exosomes with filopodia (arrows). (b) Exosome surfing on filopodia 
documented by live cell DIC/confocal fluorescence microscopy (Suppl. movie 5, 
12 frames/min). Vesicle trajectories are color coded for speed as indicated (0-0.5 
um/sec). (c) Exosome pulling by filopodia documented by TIRF live cell microscopy 
of actin-RFP (black) expressing human fibroblasts grown on a line substrate (2 
frames/min). Successive filopodia outreach and pulling movements are indicated 
by blue and pink arrows, respectively. Exosome trajectory in pink. (d) Grabbing of 
exosomes by filopodia by live cell DIC/confocal fluorescence microscopy. 
Additional examples are shown in Suppl.Fig.4.  
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Figure 4. Exosomes are taken up at the filopodia base and shuttle with 
endosomes. (a) 394 individual HEK293 CD63-emGFP exosome cell entry events in 
human primary fibroblasts documented by DIC/confocal fluorescence or TIRF 
microscopy (Suppl.Movies 4, 5, 6) were classified as indicated. (b) ‘Ernie’ and 
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‘Bert’ represent typical examples for exosomes classified as either filopodia 
surfing or entering at the filopodia base, respectively. Further examples of 
exosome cell entry following filopodia surfing are shown in (c) and (d). Examples 
for exosome cell entry following filopodia pulling or grabbing are shown in Suppl 
Fig.4h-i. Representative examples of exosomes entering plasma membrane 
derived endocytic vesicles are highlighted in (e). All images represent single 
frames from DIC/confocal fluorescence live cell movies. Red: plasma membrane 
labelling (CellMask Deep Red), green: CD63-emGFP exosomes. Exosome 
trajectories color coded for speed. 
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Figure 5. Internalized exosomes undergo a stop-and-go movement along the ER. 
(a) Examples for intracellular speed traces of HEK293 CD63-emGFP exosomes in 
human primary fibroblasts from confocal live cell movies (Suppl.movie 8). (b) 
Cumulative intracellular exosome trajectories color coded for exosome speed (0-
0.5 um/s) in an overlay of DIC with confocal fluorescence images, with and 
without visualization of ER tracker (red). (c) A close up view of the overlay, 
showing the ER tracker fluorescence and DIC image side by side. (d) 
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Representative exosome trajectory with stop-and-go movement along the ER, 
color coded by speed (0-0.3 um/s). The corresponding speed trace is shown in the 
upper left panel. (e) Overlay of DIC with confocal fluorescence images taken 150 
minutes post exosome addition show exosomes localizing closely to ER filaments, 
tips, cavities and branches (arrows). Green: CD63-emGFP exosomes; Red: ER 
Tracker; Scaling bars: 10 um. (f) Exosomes from the medium are actively recruited 
to the cell body via different modes of filopodia activity (surfing, pulling, grabbing) 
to reach endocytic hotspots at the filopodia base, where they are internalized as 
intact vesicles into endosomes. Within the cell, exosome containing vesicles 
undergo a stop-and-go movement scanning the endoplasmic reticulum, before 
being finally directed to the lysosome. 
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Materials and Methods 
 
Parent cells. Human embryonic kidney cells (HEK293, ATCC) were cultured in 
complete media comprised of Dulbecco's Modified Eagle Medium (DMEM, Life 
Technologies), supplemented with 10 % fetal bovine serum (FBS, Cellgro) and 
penicillin/streptomycin (5 mg/ml, Cellgro) at 37°C with 5 % CO2. For fluorescent 
exosome labeling, the full length coding sequence of human CD63 isoform A 
(RefSeq NM_001257390.1) was TOPO cloned into the pcDNA 6.2 N-emGFP vector 
(Promega) to result in an N-terminal fusion of emGFP to CD63. pcDNA 6.2 N-
mCherry-CD63 and N-mCherry-emGFP-CD63 vectors were then subcloned by 
replacing the emGFP CDS in between the Ava I sites by gene synthesized inserts 
(Solvias) comprising the CDS of either mCherry or an emGFP-mCherry fusion.  For 
exosome isolation, 5-8 x 106 HEK293 cells were seeded in a 15 cm culture dish 
with complete media and transfected with CD63 expression constructs the next 
day. Cell transfection was done in complete medium using Lipofectamine2000 
(Life Technologies; 1 ug DNA/2.2 ul LF2000) following the manufacturer's 
instructions. After 4 hours, cells were washed and medium was replaced by 
OptiMEM. Conditioned media were collected after 48 hours for exosome 
isolation. Typically, 100-200 ml of conditioned medium (pooled from multiple 
dishes) was used in most experiments.  
Recipient cells. Human primary fibroblasts from a healthy donor (Life 
Technologies, #C-013-5C) were grown in MEM (Life Technologies) supplemented 
with 15 % fetal bovine serum and penicillin/streptomycin (5 ug/ml, Cellgro) in 0.1 
% gelatine (Sigma Aldrich) coated T150 flasks. For exosome uptake experiments, 
cells were either plated in 8-well slides (ibidi) at a density of 40-60 % (confocal and 
DIC live cell imaging experiments) or 96-well plates (ibidi) at a density of 60 % 
(exosome uptake high content screening assay). Transient expression of Adeno-
Lifeact-mCherry in human fibroblast cells was obtained by adenoviral 
135  
transduction, and cells were seeded onto line substrates or 2D substrates 
(Fibronectin coated coverslips) at least 6 hours prior to TIRF life cell imaging. Line 
substrate microfabrication was performed as described elsewhere (Martin et al., 
2014). Huh7 cells (HSRRB) and HEK293 cells (ATCC) were cultivated in DMEM (Life 
Technologies) supplemented with 10 % fetal bovine serum and 1x L-Glutamine 
200 mM (Life Technologies) and penicillin/streptomycin (Life Technologies) and 
plated in 96-well plates (ibidi) at a cell density of 40-60 % confluency one day prior 
to exosome addition. 
 
Exosome isolation. Exosome isolation via UF/GF was essentially performed as 
described elsewhere (Nordin et al., 2015). Briefly, conditioned medium was pre-
cleared of cell debris and larger particles by consecutive centrifugation at 300 g 
for 5 minutes followed by 3’000 g for 10 minutes, as well as filtration over a 0.22 
um filter. Typically, 100-200 ml of the pre-cleared conditioned medium was then 
concentrated to a volume of 0.5-1 ml on an AMICON ultrafiltration device using a 
100-kDa MWCO membrane (Millipore). Enriched medium was then loaded onto 
a Superdex200 column (GE Healthcare) connected to an ÄKTA prime FPLC 
instrument (GE healthcare) equipped with a UV flow cell. Gel filtration was 
performed at 4°C using sterile filtered 50 mM Tris-buffer (flow rate 0.5 ml/min). 
Ninety-six individual fractions of 200 ul each were collected. NTA and FCS was 
performed directly in all fractions. For Western blotting, fractions were pooled (4 
fractions each, omitting one fraction in between pools) and further concentrated 
to a volume of 30 ul on an Amicon 10-kDa MWCO spin columns (Millipore). 
 
 
Fluorescence Correlation Spectroscopy (FCS). Exosome quantification and 
characterization via FCS was essentially performed as described elsewhere 
(Nordin et al., 2015). Briefly, samples were measured on a Clarina II Reader 
(Evotec Technologies) with 488 nm argon ion laser excitation, a 40x water 
immersion 1.15 N.A. objective (UAPO Olympus), 50 m pinhole and a SPCM-AQR-
13FC avalanche photodiode (Perkin-Elmer Optoelectronics). The confocal volume 
was calculated in approximation according to (Culbertson et al., 2007) using the 
measured diffusional correlation time tdiff of free dye (Alexa488, Life 
Technologies), the known translational diffusion coefficient of Alexa488 
(Molecular Probes; D = 280 um2/s) and the axis ratio fitted from calibration 
measurements. For each sample, several dilutions were made and measured in a 
96-well glass bottom plate (Whatman) with 30 repetitive measurements of 10 
seconds each. NP-40S at 1 % v/v (Biosciences) was used to induce vesicle 
disruption for determination of detergent sensitivity and quantification of CD63-
emGFP molecules per exosome.  
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Single vesicle imaging. Exosomes from CD63-emGFP/CD63-mCherry double 
transfected HEK293 cells were imaged by confocal fluorescence microscopy after 
spotting onto coverslips. Colocalization was quantified based on overlap of the 
point spread functions in the two fluorescent channels to derive the number of 
GFP (G), mCherry (R) and GFP/mCherry (RG) double positive vesicles. 
 
Scanning Electron Microscopy (SEM). Cells were grown on Thermanox coverslips 
(Thermo Scientifc Inc, Nunc). After a quick wash (less than 10 seconds) in fresh 
culture medium without protein, cells were fixed with 2 % paraformaldehyde 
(Electron Microscopy Science, Hatfield, USA) and 2.5 % glutaraldehyde (Electron 
Microscopy Science, Hatfield, USA) in 0.1 M cacodylate buffer (Sigma Aldrich), pH 
7.4. Cells were rinsed in 0.1 M cacodylate buffer (3 x 5 minutes). Dehydration was 
performed in a graded ethanol series (30, 50, 70, 90, 95, 100 % ethanol, 3 x 2 
minutes each step). After dehydration, specimens were rinsed with 
hexamethyldisilizane (Sigma Aldrich) and dried in an oven (60°C for 2 hours). 
Samples were mounted on aluminum stubs by fixing the coverslip with carbon 
double-sided carbon tape, and sputter coated (Quorum SC7620) with 
gold/palladium (5-8 nm). Cells were examined with a scanning electron 
microscope (Versa 3D, FEI, Endhoven, Netherlands) using the ETD detector. 
 
Nanoparticle Tracking Analysis (NTA). Label-free particle size and concentration 
determination was performed on a LM NTA instrument (NanoSight). With a 
camera gain of 500, full detection range and 90 second recordings all camera 
settings as well as analyses parameters (detection threshold of 2, minimum 
expected particle size of 50 nm, fixed minimal track length of 4) where kept 
constant throughout all measurements. For quantitative analysis of particle size 
distribution and concentration, a dilution row of samples between 1:100 to 
1:10’000 was analyzed to hit the dynamic range of the instrument (1 - 4 x 108 
particles/ml). 
 
Automated imaging assay for exosome uptake. Cells were seeded into a 96-well 
ibidi plate and incubated with exosomes as indicated in each experiment. Cells 
were fixed for 20 minutes at room temperature with PenFix (Thermo Scientific) in 
presence of 1 g/ml Hoechst (Life Technologies) and 0.02 % (v/v) CellMask Deep 
Red (Life Technologies). Following extensive washing with PBS, wells were imaged 
on an automated confocal plate scanning instrument (Operetta, Perkin Elmer) at 
40x magnification. Image analysis was done using the Harmony software, by first 
identifying the nuclei (Hoechst), defining the cell boundaries (CellMask Deep Red) 
and finally quantifying the number of GFP spots per cell. At least 5,000 cells were 
analyzed by condition. Data are shown from one representative experiment from 
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at least three independent experiments, and represent averages with error bars 
indicating standard deviations from three independent samples. 
Confocal, TIRF and DIC live cell microscopy. For combined confocal fluorescence 
and DIC live cell imaging cells were seeded into an 8-well m-slide (ibidi) and pre-
stained prior to exosome addition as indicated in each experiment; Cell 
membrane: CellMask Deep Red (dilution 1:1000 for at least 2 minutes, Life 
Technologies); MVB: N-rhodamine-labelled phosphatidylethanolamine (NRhPE) 
(2.5 uM, for at least 60 minutes; Avanti Polar Lipids); Endoplasmic reticulum: ER 
Tracker Red (500 nM, for at least 15 minutes, Life Technologies); Lysosomes: 
LysoTracker Green (dilution 1:1000, for at least 60 minutes, Life Technologies). 
Actin was labeled by transfection with CellLight Actin-RFP (Life Technologies) 24 
hours prior to imaging. Images were acquired on a confocal LSM710 microscope 
with Big-detector (Zeiss) with a 100x or 63x oil 1.4 NA PlanApochromat DIC 
objective and temperature, gas and humidity control unit (Life Imaging Services, 
Basel, Switzerland). Differential interference contrast (DIC) was set up using the 
transmission of the excitation laser as a light source and the TPMT as detector. 
For live cell TIRF imaging, human fibroblasts were transiently transduced with 
Adeno-Lifeact-mCherry and seeded onto line substrates or 2D substrates 
prepared as described in (Martin et al., 2014) 4 hours prior to acquisition. TIRF 
microscopy (Roper Scientific) was performed with a Nikon TI Eclipse inverted 
stand equipped with a PlanApo  60x TIRF Objective, a Photometrics Evolve EMCCD 
camera, 491 nm and 561 solid-state laser diodes and was controlled using 
Metamorph imaging software. Fluorescent exosomes were quantified and 
characterized by FCS and typically added 5-10 minutes prior to image acquisition 
unless specified otherwise. 
 
Image analysis. Confocal image stacks time series, confocal image plane time 
series and TIRF time lapse data were imaged with frame rates and time frames as 
indicated. Particles tracking and trajectory analysis was performed with the Imaris 
x64 (Bitplane) Particle Tracking Analysis module. Unless specified otherwise, SPT 
trajectories are shown as dragontail visualization with a max of 20 frames. Speeds 
were derived from relative exosome displacement between two frames. For co-
localization studies stacks were imaged with a Leica Sp5 HyD imaging setup using 
60x 1.4 NA PlanApo Objective with 2 color sequential line scanning, 130 nm z-
sectioning and 40 nm xy oversampling. Stacks were deconvolved with Huygens 
remote manager (automatic threshold) and then analysed with the JACoP plugin 
(Bolte and Cordelières, 2006)  for Fiji (Rasband).  
 
Lipid nanoparticle formulations. 5’-Cy3 labeled siRNA (Stalder et al., 2013) was 
mixed in a 1:5 ratio with unlabeled siRNA and formulated as described in detail in 
(Baryza et al., 2014). Briefly, the LNPs were formed by mixing equal volumes of 
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lipid solution dissolved in ethanol with siRNA dissolved in a citrate buffer by an 
impinging jet process. The lipid solution contained a cationic lipid (Baryza et al., 
2014) , a helper lipid (cholesterol) and a PEG lipid in a ratio of 50:46:4 at a siRNA 
concentration of 1 mg/ml. The LNP solution was then diafiltered with a MWCO-
100 kDa membrane, sterile filtered and stored at 4°C. The vesicles typically had a 
diameter of ca 150 nm. 
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Supporting online material. This manuscript contains three Supplementary 
Figures, and ten Supplementary videos. 
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Supplementary Figure 1. Supplementary data to quantification of CD63-emGFP 
uptake. (a) HEK293 CD63-emGFP exosome uptake into Huh7 cells was quantified 
as a function of cell density using the same 96-well automated high content 
screening assay as in Fig.1. Number of cells plated per 96-well (0.143 cm2) is 
shown on the x-axis. Exosome uptake was quantified 20 hours post addition of 10 
pM CD63-emGFP exosomes based on the number of GFP vesicles per cell. At least 
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5’000 cells were analyzed per condition. Error bars represent standard deviations 
from three biological replicates. (b) Single cell analysis of data in Fig.1a-c. To 
illustrate the determination of the fraction of positive cells, the single cell 
histograms are shown for the examples of untreated Huh7 cells (dark grey bars) 
and Huh7 cells treated for 24 hours with CD63-emGFP HEK293 exosomes at 5 pM 
(light grey bars). The background fluorescence in the untreated cells was used to 
define a threshold fluorescence signal (red line) for positive cells based on a 90 % 
confidence for true negative assignment in the untreated cells. In the example 
shown, all cells at the right side of the blue line were counted as positive. Panels 
(c) and (d) show a side by side comparison of exosome versus lipid nanoparticle 
uptake. Huh7 cells were exposed to (d) 0.5 nM CD63-emGFP HEK293 exosomes 
or (c) a lipid nanoparticle formulated Cy3-labeled siRNA (SSB19, (Stalder et al., 
2013)) at similar vesicle concentrations (200 nM siRNA, 20 % labeled siRNA, ca 
1000 siRNA molecules per liposome) and uptake was monitored by combined DIC 
with confocal fluorescence live cell microscopy. Z-stacks were taken every 10 
minutes over 12 hours. Images of individual time points from the movies are 
shown for two confocal planes corresponding to the cell surface (top rows) or the 
cell interior (bottom rows). Scaling bars: 10 um. Additional examples for exosome 
uptake clustering in filopodia active regions (Fig.2) are shown for (e) HEK293 
recipient cells or (f) Huh7 recipient cells. Images were taken by combined DIC with 
confocal fluorescence live cell microscopy at time points post exosome addition 
(200 pM) as indicated. White rectangles highlight areas shown in close up views 
(as indicated by numbers). GFP fluorescence is pseudocolored in green. Scaling 
bars: 20 um. Panels (g) and (h) show uptake dynamics from corresponding live cell 
movies for HEK293 recipient cells and Huh7 recipient cells, respectively. Single 
exosome trajectories from 30 minutes live cell movies (starting 90 minutes post 
addition of exosomes at 200 pM; 20 s/frame) are illustrated in a dragontail 
visualization (max 20 frames) with pseudocoloring for exosome speed as 
indicated. 
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Supplementary Figure 2. Exosome filopodia surfing, grabbing and pulling. 
Additional examples to Fig.3 illustrating CD63-emGFP HEK293 exosomes (green) 
surfing on filopodia (a-e) or tunneling nanotubes (f and g), exosome recruitment 
by filopodia pulling (h) or grabbing (i). Individual images from time lapse movies 
are shown at selected time points as indicated. Exosome trajectories are shown 
in a dragontail visualization (max 20 frames), pseudocolored for speed as 
indicated. (a): human primary fibroblasts stably expressing actin-RFP (white) 
grown on a line substrate, imaged by TIRF live cell microscopy. Scaling bars: 5 um; 
(b): human primary fibroblasts stably expressing actin-RFP (white) grown on a 2D-
substrate, imaged by TIRF live cell microscopy. Scaling bars: 20 um; (c): human 
primary fibroblasts labeled with CellMask Deep Red (red) imaged by combined 
DIC with confocal fluorescence live cell microscopy. Scaling bars: 20 um; (d): 
human primary fibroblasts stably expressing actin-RFP (black) grown on a line 
substrate, imaged by TIRF live cell microscopy. Scaling bars: 5 um; (e) and (f): 
HEK293 cells imaged by combined DIC with confocal fluorescence live cell 
microscopy. Scaling bars: 10 um; (g): Huh7 cells stained with CellMask Deep Red 
(red) imaged by combined DIC with confocal fluorescence live cell microscopy. 
Scaling bar: 10 um; (h) and (i): human primary fibroblasts imaged by combined 
DIC with confocal fluorescence live cell microscopy. Scaling bars: 5 um. Examples 
illustrating different types of exosome movement on filopodia are shown in (j) 
and (k). Typically, exosomes were directed towards the cell body immediately 
after apparent contact with the filopodium, and migrated with relatively constant 
speed (j). In rare cases, this was preceded by an initial short movement in the 
opposite direction, followed by a stalling and redirection towards the cell body 
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(k).  (l) Cytochalasin D inhibition of exosome uptake. CD63-emGFP HEK293 
exosomes (10 pM) were added to human primary fibroblasts pretreated with 
DMSO (left panel) or Cytochalasin D (50 uM for 20 minutes, right panel). Uptake 
was monitored by combined DIC with confocal fluorescence live cell imaging. 
Exosome trajectories are shown in a dragontail visualization, pseudocolored for 
exosome speed as indicated. Scaling bar: 20 um.  
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Supplementary Figure 3. Characterization of intracellular exosome fate. 
Intracellular trajectories of a total of 312 single HEK CD63-emGFP exosomes in 
fibroblasts from a 75-minute movie (5 s/frame) were analyzed for different 
motion parameters. The frequency distributions of individual exosome trajectory 
parameters are shown in (a).  x-y scatter plots showing the relation between 
different parameters for each individual vesicle are shown in (b). Fifty percent of 
the vesicles were traced for 20 to 50 seconds, with a median total trajectory 
length of 3.5 um. Trajectory length showed a good correlation with the time a 
vesicle was observed. The wide distribution of the maximum speed with no 
apparent upper cut off confirms that our frame rate is sufficient to trace the 
majority of intracellular movements. More than 80 % of the vesicles showed a 
minimum speed of close to zero suggesting that transient stalling was a common 
characteristic. Seventy-five percent of the vesicles showed an at least 5-fold 
higher maximum than minimum speed, with a mean of 30-fold. Together these 
characteristics argue for a stop-and-go movement. The displacement length was 
significantly shorter than the absolute trajectory length, demonstrating that the 
vesicles did not primarily proceed on straight intracellular routes. This can also be 
seen in the histogram of track straightness. A 2D correlation analysis for each 
individual vesicle suggested that straight tracks are under-represented in 
trajectories of long duration or length, and over-represented in the population of 
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fast vesicles. In addition, vesicles moving on straight tracks showed larger 
displacements. Track length:  total length of trajectory. Displacement distance: 
absolute distance of particle displacement within duration of trajectory. Track 
straightness: relative measure for track straightness with 0 representing random 
diffusion and 1 representing a straight line. Linear regression analysis with 
regression coefficient (R) as indicated. (c) Additional examples for intracellular 
speed traces of HEK293 CD63-emGFP exosomes in human primary fibroblasts 
from confocal live cell movies. Data points represent speeds derived from relative 
exosome displacement between two frames. (d-j) Additional examples for 
exosome trajectories with stop-and-go movement along the ER: CD63-emGFP 
exosomes in green, ER tracker in red, dragontail visualization (max 20 frames) 
color coded by speed as indicated. (k) Co-localization of CD63-mCherry exosomes 
with lysosomes increases over time. Human primary fibroblasts, stained with 
LysoTracker (green) were imaged by confocal live cell microscopy 12, 24 and 48 
hours upon addition of HEK293 CD63-mCherry exosomes (red). High resolution z-
stacks with oversampling (x-y: 40 nm; z: 130 nm) were recorded of perinuclear 
regions. Stacks were deconvolved by Huygen’s remote manager and 
co-localization was quantified using JaCoP (Fiji) to derive Pearson’s coefficients 
(left panel) and Mander's coefficients (middle and right panels). M1: green in red. 
M2: red in green. Projections of the deconvolved z-stacks are shown in (l).  Scaling 
bars: 10 um   
 
 
Supplementary Movies.  
The exosome concentration in all movies was 100 pM unless specified otherwise. 
 
Supplementary movies 1 and 2: Lipid nanoparticle formulations accumulate at 
the cell surface. Cationic lipid nanoparticle formulation (1nM) with encapsulated 
Cy3 labelled siRNA (200 nM, green) were added to Huh7 cells and 2 min post 
addition uptake was monitored over 12 h with by live cell confocal imaging with 
optical sections and DIC transmitted light channel. Alexa647 labeled Transferrin 
(red) was additionally applied to monitor endosomal uptake. Movie 1 shows an 
upper optical section representing the cell surface and movie 2 shows an optical 
section representing the interior of the cell. 
 
Supplementary movie 3: Exosome uptake in human primary fibroblasts is 
clustered into filopodia active regions. CD63-emGFP labeled HEK293 exosome 
(green) uptake was monitored over 80 min in Actin-RFP (red) labeled human 
primary fibroblasts. Exosome trajectories (dragontail) are shown with color 
coding for absolute time to visualize the progressive distribution of the 
intracellular movement and the cellular entry points of the exosomes. 
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Supplementary movie 4: Exosomes are endocytosed in human primary 
fibroblasts at filopodia active regions. CD63-emGFP labeled HEK293 exosome 
(green) uptake was monitored over 28 min in CellMask deep red (red) labeled 
human primary fibroblasts by live cell confocal imaging with optical sections and 
DIC transmitted light channel. Movie shows speed color coded exosome tracks 
(dragontail) to visualize the intracellular movement and entry points. CellMask 
labels the plasma membrane and gets internalized with endocytic vesicles. 
 
Supplementary movies 5 and 6. Exosome surf on filopodia of human primary 
fibroblasts. CD63-emGFP labeled HEK293 exosome (green) movement along 
filopodia of CellMask Deep Red (red) labeled primary fibroblasts or was monitored 
for 8 minutes by live cell confocal imaging and DIC transmitted light channel with 
a frame rate of 5 s/f 1 h after transduction (Supplementary movie 5). Surfing along 
F-actin labeled primary fibroblast filopodia (white) and uptake of CD63-emGFP 
labeled HEK293 exosome (green) was tracked for 1 h by live cell TIRF imaging with 
a frame rate of 30 s/f 2h after transduction (Supplementary movie 6). Trajectories 
are color coded by speed as indicated. 
 
Supplementary movie 7: Fibroblast pulls exosome to cell surface. CD63-emGFP 
labeled HEK293 exosome (green) were added to F-actin (black) labeled primary 
fibroblasts grown on a line substrate. The movie starts 60 min after exosome 
addition and documents the scenery for 20 min by live cell TIRF imaging with a 
frame rate of 10 s/f. 
 
Supplementary movies 8: Exosomes scan along the ER. CD63-GFP labeled 
HEK293 exosomes (green) were tracked and ER movement is monitored for 
75 min in human primary fibroblasts with a framerate of 5 sec/f by live cell 
confocal and DIC transmitted light channel imaging. The movie starts 150 min 
after exosome addition. Exosome trajectories are visualized as dragontails 
(dragontail of 4 images) with color coding for speed as indicated. 
 
Supplementary movie 9: Exosome uptake in human primary fibroblast recipient 
cells. CD63-emGFP labeled HEK293 exosome (green) are taken up in CellMask 
deep red (red) labeled primary fibroblast. Time lapse movie was recorded for 10 
minutes by live cell confocal optical section imaging and DIC transmitted light 
channel with a frame rate of 9 s/f, starting 5 min upon exosome addition. 
 
Supplementary movie 10: Intracellular exosome movement. The movement of 
CD63-mCherry labeled HEK293 exosomes (red) in human primary fibroblasts was 
monitored for 5 min with a framerate of 1.5 s/f by live cell confocal and DIC 
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transmitted light channel imaging. The movie starts 165 min after transduction. 
The DIC channel visualizes the movement of intracellular vesicles, ER membrane 
and the outline of the cell with filopodia. The fluorescently labeled exosomes 
move within these larger vesicles and scan along the ER. 
 
Supplementary movies 8 and 10 demonstrates the motion of fluorescently 
labeled exosomes within larger DIC, contrast rich, intracellular vesicles that scan 
along the ER, which is visualized as membraneous web either in the DIC or 
confocal fluorescence channel (ER Tracker red) as indicated. 
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5 Conclusions and Future Perspectives 
 
In the course of this thesis we have established a toolbox of reagents and methods 
for isolation, labeling and characterization of exosomes. Benchmarking different 
isolation methods revealed significant shortcomings of state of the art protocols 
in providing sufficient yields, purity and vesicle integrity to enable functional 
exosome studies. Addressing these issues, we established a new gentle and 
scalable protocol based on a combination of ultrafiltration and gel filtration and 
compared this method with sequential ultracentrifugation, the gold standard 
isolation method in the field. Using single vesicle detection techniques, we report 
for the first time a characterization of vesicle integrity following different 
purification protocols. The main advantages of the new isolation method include 
a significant increase in yield, reproducibility and purity while preserving 
physicochemical properties and biological composition. We next established a 
strategy for fluorescent exosome labeling by transiently expressing fluorescent 
MVB and exosome marker proteins in the parent cells and extensively 
characterized labeled exosomes in comparison to unlabeled exosomes. We 
further adapted the sensitive single molecule fluorescence fluctuation correlation 
spectroscopy (FCS) method for quantitative exosome characterization. At the 
same time FCS allowed a discrimination of vesicular and nonvesicular fluorescent 
populations within the same sample. These experiments revealed that a number 
of GFP and mCherry tagged endomembrane proteins (including CD63, Lamp2, 
Alix, and Ago2) end up in the medium as freely diffusing proteins in surprisingly 
high concentrations, whereas FCS allows to specifically determine the 
concentration of vesicular particles within the same sample. By taking advantage 
of detergent induced vesicle disruption we further quantify the number of 
fluorescent molecules per exosome at the single vesicle level. Our preferred 
expression construct resulted in fluorescent exosomes with 10-30 CD63-emGFP 
molecules per vesicle, thereby enabling monitoring the dynamics of single 
exosomes by live cell imaging. This part of the work set the stage for a quantitative 
investigation of the dynamics and routes of exosome uptake.  
 
Using these tools, we set up a high content screening assay to quantify exosome 
uptake by automated imaging, and apply this assay to report a first systematic and 
quantitative profiling of exosome parent - recipient pairing. It should now be 
straightforward to extend this small pilot to a more extensive array of cell types 
and conditions, which would provide a resource of general value for the cell 
communication field. In particular this information may guide studies of exosome 
tissue homing in vivo. Experiments in this direction seem to be quite 
straightforward based on the toolbox, methods and data contributed by this 
work. Fluorescence labeled exosomes of different flavor (different parent cell 
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origins, different vesicle subpopulations or even engineered vesicles with 
different extravesicular ligands) may be administered to mice for analyzing tissue 
homing by microscopy of histological sections or even whole organ imaging with 
a serial two-photon tomography technique (eg. Tissue Visions), whereas it will be 
interesting to assess for a correlation with in vitro cell targeting preferences. 
Likewise the finding that certain cell types (human primary keratinocytes as well 
as B16 mouse melanoma cells) turned out to be refractory for exosome uptake 
has some interesting implications; It would be worthwhile to screen more 
extensively for potential exosome sources that might be taken up into these cells. 
Such highly specific pairing would provide new clues to molecular mechanisms 
and receptor-ligand interactions both necessary and sufficient for exosome cell 
targeting, e.g. by differential proteomic profiling of the cognate and inert 
exosomes. Alternatively, should these cells indeed confirm to be refractory to 
exosome uptake in general, it would be of high interest to elucidate why. From a 
practical perspective such exosome uptake inert cells would provide valuable 
tools for gain of function assays to identify exosome receptors. The high content 
exosome screening assay described in this work may directly enable the 
systematic search for exosome uptake receptors as well as modulators. shRNA or 
CRISPR based exosome uptake inhibition or enhancer screens would allow to 
systematically dissect the major players in exosome cell uptake. For a more 
targeted study, a more comprehensive comparison of exosome and viral particle 
literature might be a good place to start for a list of candidate receptors. Likewise, 
the HCS assay now enables small molecule screens to identify tool compounds for 
further exosome research. Finally, the fact that B16 melanoma cells were 
refractory even to uptake of their own exosomes sheds interesting new light on 
the role of exosomes in tumorigenesis and may suggest that such cells have 
specialized in unidirectional exosomal communication. 
 
In the main part of this work we characterized the cell uptake dynamics of 
exosomes at the single vesicle and single cell level to reveal characteristics that 
parallel those of some viruses. We demonstrate that exosome uptake saturates 
with dose and time to reach near 100 % ‘transduction’ efficiency at picomolar 
concentrations and that exosome uptake is largely mediated by active 
recruitment and surfing on filopodia to reach endocytic hotspots for their 
internalization at the filopodia base. While this provides a cell biological 
explanation for the, virus-like, high efficiency of exosomes in recipient cell 
targeting, a great concern in a read out based on pure cell internalization is that 
we are following the average, bulk behavior of the vesicles without knowing 
anything about whether this population is reflective of the functional uptake 
route that leads to functional activity. One can look to the HIV field, where the 
majority of HIV particles taken up by the cell are trafficked to lysosomes and 
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degraded, without ever leading to a productive infection, whereas only a very 
minor fraction of cell- virion interactions leads to productive infection of the cell.  
A similar lesson in this regard was learned in siRNA delivery field, where liposomal 
delivery vehicles have for years been optimized primarily optimized for general 
target cell delivery and endosomal escape, which now turns out to be completely 
unrelated to the pool of siRNA responsible for activity. Consistent with this notion, 
previous work from our laboratory (Stalder et al. 2013) (Paper II in the appendix), 
revealed that, while the bulk of liposome delivered siRNA delivered gets degraded 
in Lysosomes only a few molecules are sufficient for effective target mRNA 
knockdown if trafficked to the site of action- the ER.  
An emerging issue in the exosome field is the notion that miRNAs are of much 
lower abundance in exosomes than anticipated, with an estimate of ca 1 copy per 
100 vesicles. This questions whether at physiological exosome concentrations it is 
ever possible to achieve effective miRNA concentrations within recipient cells, 
unless their uptake route is highly effective in delivering directly to the subcellular 
target site 121. Interestingly in this work we revealed that exosomes licensed 
through the flilopodia pathway enter into endocytic vesicles destined to directly 
home to the ER – the site of RISC loading 122. Again clues might be provided by 
viruses which replicate at this organelle. 
 
The work within this thesis unravels yet another facet of exosome biology 
converging with virus biology. This is in line with an increasing notion of viruses 
having potentially hijacked mechanisms that originally evolved for exosome 
function, ranging from biogenesis, release, and recipient cell interaction. 
Therefore it is conceivable that we may in turn take advantage of decades of 
research in the virology field to enhance our understanding of exosomes. This 
faces however the challenge that viral mechanisms are highly divergent, making 
it difficult to prioritize candidate strains. The filopodia mediated uptake route 
revealed in this work now shortlists those viruses and pathogens that are known 
to also surf on filopodia. Intriguingly HIV, one such virus, has previously been 
noted to share a number of similarities in intracellular pathways and some overlap 
in host derived proteins to exosomes. Consistently it was reported that exosomes 
compete with HIV for virus entry into endocytic compartments 123. At the same 
time, there is also emerging evidence for cross regulation between exosomes and 
HIV; exosomes isolated from semen but not from blood were recently shown to 
have anti HIV-infectious properties. In turn, the exosome pathway can also 
contribute to pro-viral activity, such as by using exosomes as Trojan horses to 
escape from the immune system 124. Further research in convergence and 
parallels between exosomes and in particular HIV would therefore be warranted.  
Apart from HIV, also other pathogens are able to subvert the exosome pathway. 
In particular the use of exosomes by pathogens for hide and seek from the 
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immune system seems to be a prevalent theme. miRNAs secreted by Epstein Barr 
virus (EBV)-infected cells are transferred by exosomes and act in uninfected 
recipient cells 31. Also prions are being distributed by exosomes 19 125 and many 
different parasitic diseases are connected to exosomes or the exosomal pathway 
in a pro or anti pathogenic manner (reviewed in 54).  
 
The ultimate goal of this work in translating the learnings of highly efficient 
exosome delivery towards a synthetic delivery vehicle will now require to revisit 
strategies for exosome cargo loading in light of the results from this work. Since 
our data suggest that cargo might be subject to highly controlled release 
mechanisms at sites such as the ER this implies that it is likely crucial to mimic 
endogenous cargo loading. Of note it is still unclear whether miRNA and RISC are 
residing within the lumen or instead are being embedded within the inner or 
outer leavelet of the vesicle membrane – a question imperative to answer for 
effective exosome based therapeutic strategies.  
 
Finally, in the course of this project we also stumbled over two independent 
additional hints which are under further investigation at the moment, and which 
are not detailed in this thesis. Based on an observation of autophagy receptors 
and cargo (LC3, p62, FIP200) being present in exosomes a follow up project in the 
lab now investigates a potential connection between exosome biogenesis and the 
autophagy pathway. Another line of investigation in the lab now follows up on a 
set of data which suggest the existence of a population of vesicles deriving from 
the lysosome, positive for Lamp2, carrying truncated proteins and inactive in 
targeting other cells.  
 
Personally I feel that this work brings together several pieces in the exosome 
puzzle and adds a new facet to exosome biology, I hope my input in exosome 
characterization and quantification on one hand and the uptake and intracellular 
routes on the other hand may prompt new directions in basic research of 
exosome biology as well as their translation into clinical applications. 
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Abstract 
 
Despite of progress in mechanistic understanding of the RNA interference (RNAi) 
pathways, the subcellular sites of RNA silencing still remain under debate. Here 
we show that loading of lipid-transfected siRNAs and endogenous microRNAs 
(miRNA) into RISC (RNA induced silencing complexes), encounter of the target 
mRNA, and Ago2-mediated mRNA slicing in mammalian cells are nucleated at the 
rough endoplasmic reticulum (rER). Although the major RNAi pathway proteins 
are found in most subcellular compartments, the miRNA- and siRNA- loaded Ago2 
populations co-sediment almost exclusively with the rER membranes, together 
with the RISC loading complex (RLC) factors Dicer, TRBP and PACT. Fractionation 
and membrane co-immune precipitations further confirm that siRNA-loaded Ago2 
physically associates with the cytosolic side of the rER membrane. Additionally, 
RLC-associated double-stranded siRNA, diagnostic of RISC loading, and RISC-
mediated mRNA cleavage products exclusively co-sediment with rER. Finally, we 
identify TRBP and PACT as key factors anchoring RISC to ER membranes in an RNA-
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independent manner.  Together, our findings demonstrate that the outer rER 
membrane is a central nucleation site of siRNA-mediated RNA silencing. 
 
 
 
Introduction 
Since the discovery of RNA interference (RNAi), the interest in small RNAs as both 
therapeutic targets and agents has been growing rapidly. The effective and safe 
delivery of small RNA therapeutics into cells still remains one of the biggest 
challenges, which is partially linked to the still incomplete picture of the 
intracellular sites of endogenous RNA silencing. Small interfering RNAs (siRNAs) 
and microRNAs (miRNAs) exhibit their functions once they are loaded into RNA 
induced silencing complexes (RISCs) (Carthew and Sontheimer, 2009). Proteins 
from the Argonaute (Ago) family are the core of RISC complexes, and Argonaute2 
(Ago2) is the only of the four mammalian Ago proteins with the ability to slice the 
target mRNA by endonucleolytic cleavage (Liu et al., 2004;Meister et al., 2004). 
Although Ago2 can bind single stranded siRNAs in vitro (Rivas et al., 2005), 
endogenous loading of double stranded small RNAs is thought to require the RISC 
loading machinery (Liu et al., 2004;Yoda et al., 2010). The canonical, minimal 
human RISC loading complex (RLC) comprises Ago2, Dicer and TRBP (TAR binding 
protein) (Gregory et al., 2005;MacRae et al., 2008;Maniataki and Mourelatos, 
2005;Noland et al., 2011). This triad of proteins is capable of binding and 
processing dsRNA into 21-23nt siRNAs or miRNAs, loading of Ago2 and removing 
the passenger strand (MacRae et al., 2008). As Dicer knockout mouse embryonic 
stem cells (ES) – while devoid of mature miRNAs – are however proficient of 
siRNA-mediated gene silencing (Kanellopoulou et al., 2005), it has been suggested 
that this canoncial mode of RISC loading can be bypassed by other mechanisms, 
one of them involving the Heat shock cognate 70 (Hsc70) and Heat shock protein 
90 (Hsp90) chaperones (Iki et al., 2010; Iwasaki et al., 2010; Johnston et al., 2010; 
Miyoshi et al., 2005; Miyoshi et al., 2010). Once Ago2 is loaded with the double-
stranded siRNA, only one strand (guide) is retained and the other strand 
(passenger) gets removed and degraded (Leuschner et al., 2006;Matranga et al., 
2005;Miyoshi et al., 2010;Rand et al., 2005), which can be facilitated by a complex 
consisting of TRAX and translin (C3PO, component 3 promoter of RISC)(Liu et al., 
2009;Ye et al., 2011).  
The specific subcellular sites of the RISC loading, target association, and silencing 
steps still remain under debate. Ago2, miRNAs and target mRNAs that are 
targeted for translational inhibition have been found to localize to P-bodies 
(Jagannath and Wood, 2009; Liu et al., 2005; Pillai et al., 2005), and it has been 
suggested that miRNAs and RNAi proteins guide their target mRNAs to P-bodies 
(Eulalio et al., 2007b; Jakymiw et al., 2005; Pillai et al., 2005). However, 
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microscopically visible P-bodies do not seem to be required for RNAi (Chu and 
Rana, 2006;Eulalio et al., 2007b), but have been proposed to be rather a 
consequence than a cause of silencing (Eulalio et al., 2007a; Eulalio et al., 2007b). 
Moreover, siRNAs have been found to localize to P-bodies as double strands in an 
at least partially Ago2-dependent manner (Jagannath et al., 2009; Jakymiw et al., 
2005). Other reports have demonstrated a link between RNAi and membranes 
(Cikaluk et al., 1999; Gibbings and Voinnet, 2010; Gibbings et al., 2009; Lee et al., 
2009; Tahbaz et al., 2001; Tahbaz et al., 2004). In early reports, Dicer and Ago2 
have been shown to fractionate with membranes (Tahbaz et al., 2004) and to co-
localize with the Golgi apparatus (Barbato et al., 2007; Cikaluk et al., 1999;Tahbaz 
et al., 2001). Furthermore, disruption of the Hermansky Pudlak 1 and 4 proteins 
(HPS1, HPS4), which are implicated in membrane trafficking and function (Huizing 
et al., 2000), accelerate the loading of Ago2 with siRNAs in flies (Lee et al., 2009). 
Additionally it has been proposed that RISC assembly and disassembly is linked to 
membranes of the endo-lysosomal sytem (Gibbings et al., 2010; Gibbings et al., 
2009; Lee et al., 2009). Given that there is still no clear picture about the sites of 
RISC loading, target mRNA association and silencing, in this work we aimed to 
quantitatively and spatially follow the siRNA fate within the cell upon lipid delivery 
from initial uptake and subcellular redistribution to its entry into the RNAi 
pathway, and to identify the sites of RNAi activity. 
 
Results 
Ago2, siRNAs and miRNAs localize to a number of different compartments 
To characterize the intracellular distribution of RNAi pathway proteins, 
exogenously added siRNAs, and endogenous miRNAs, HeLa cells were transfected 
by lipofection with siRNAs against SSB (Pei et al., 2010)  (Sjogren syndrome 
antigen B), lysed after 24 hours and the post-nuclear detergent-free supernatants 
were fractionated on continuous density sucrose gradients (Fig. 1A). Markers for 
lysosomes (Lamp2), endosomes and multi vesicular bodies (MVBs; Hrs, Rab5, 
Tsg101) were enriched in fractions 2-3 (20-33 % sucrose), markers for Golgi (b4-
GalT1) in fractions 3-5, the ER-Golgi intermediate compartment (ERGIC; p58), the 
endoplasmatic reticulum (ER; Calnexin) and ribosomes (RPS6) in fractions 4-7 (42-
64 % sucrose), confirming the expected fractionation pattern consistent with 
fractionation of cytoplasmic lysates in previous studies (eg (Gibbings et al., 2009; 
Jouannet et al., 2012)). Ago2 showed a broad distribution and was present 
throughout fractions 3-9. Similarly, Ago1, Dicer and PACT fractionated broadly, 
whereas only TRBP showed evidence for a more confined localization and co–
sedimented sharply with Golgi and ER marker proteins (Fig. 1A). The fractionation 
of the RNAi pathway proteins did not change upon the transfection of a siRNA, 
suggesting that a transfected siRNA does not induce a major redistribution of 
these proteins (Fig. S1A).  
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To confirm the general fractionation pattern of endogenous Ago2, we performed 
immune-fluorescence (IF) of Ago2 as well as the different organelle marker 
proteins in HeLa cells (Fig. 1B). The established high specifity of the Ago2-antibody 
(clone 11A9) (Rüdel et al., 2008) was validated also in our hands using a peptide 
comprising the antigenic epitope (Fig. S1B). Ago2 staining showed the typical 
diffuse punctuate pattern throughout the cytoplasm with the typical enrichment 
in the perinuclear region and a half-moon shaped structure (Golgi) and some 
individual strong foci (P-bodies). In accordance with the broad fractionation of 
Ago2, endogenous Ago2 also co-localized by IF partially with the ER, ERGIC, Golgi, 
P-bodies, and early endosomes (Fig. 1B). This intracellular distribution of 
endogenous Ago2 is consistent with previous publications, where Ago2 was 
shown to partially co-localize with Golgi (Cikaluk et al., 1999; Tahbaz et al., 2001), 
P-bodies (Jagannath et al., 2009; Leung et al., 2006; Liu et al., 2005; Ohrt et al., 
2008; Pare et al., 2009; Pillai et al., 2005; Sen and Blau, 2005; Zeng et al., 2008), 
or endosomes (Gibbings et al., 2009; Lee et al., 2009). Additionally, our data 
confirm the general notion that endogenous Ago2 appears to distribute 
differently than Ago2-GFP, which was shown to strongly accumulate in P-bodies 
(Jagannath et al., 2009;Leung et al., 2006;Liu et al., 2005;Ohrt et al., 2008;Sen et 
al., 2005). Consistent with an accumulation in P-bodies, we found overexpressed 
Ago2-GFP enriched in the Dcp1 containing fractions (4-6) of the continuous 
sucrose density gradient (Fig. S1C).  
As the overall Ago2 localization was not instructive about sites of RNA silencing 
activity, we next followed the siRNA during onset of uptake and a potential 
subsequent subcellular redistribution to monitor its putative entry into the RNAi 
pathway. HeLa cells were transfected with the SSB siRNA and a control siRNA with 
no target in human cells (pGL3), harvested after 1.3, 3.3, 5 and 28 h and 
fractionated as above. During the 5 hours transfection period, the SSB siRNA was 
increasingly enriched in the endo-/lysosomal fractions. After 28 hours, the cells 
were cleared of 75-90 % of the transfected siRNAs by secretion and/or 
degradation (Figs. 1C, S1D), whereas the remaining siRNA was now mostly in the 
non-endosomal fractions, suggesting that only 10-25 % of the transfected siRNA 
ever had the potential to load into RISC. In accordance with a strong accumulation 
and degradation of the siRNA in endosomes and lysosomes, respectively, a 
transfected TMR-labeled siRNA co-localized with endosomal (transferrin) and 
lysosomal (LysoTracker) markers in living cells and in sucrose gradients (Figs. 1D, 
S1E-G), suggesting that the bulk of transfected siRNA enters the cells through the 
endosomal system (Lu et al., 2009), and that the major fraction of the transfected 
siRNA is quickly targeted to lysosomes for degradation (Figs. 1D, S1E-G). 
Interestingly, the non-targeting pGL3 siRNA fractionated similar to the SSB siRNA, 
suggesting that trafficking of siRNAs is not driven by the presence of a target 
mRNA (Fig. S1D). Given this dramatic clearance of siRNA within the initial phase 
161  
of transfection, we reasoned that at late time points, the remaining amount of 
siRNA might better reflect the active population. Indeed, siRNA remaining at 28 
hours fractionated in a sucrose gradient similarly as endogenous miR-16 
(Fig. S1H), a representative and relatively abundant miRNA in HeLa cells, 
indicating that, once in the cytoplasm, siRNA is subject to similar protein 
interactions and trafficking events as endogenous miRNAs. However, both, miR-
16 as well as the SSB siRNA were present in all Ago2 containing fractions, 
suggesting that even after initial clearance, the co-fractionation of RNAi factors 
and siRNAs or miRNAs is also not indicative to discern the active siRNA/Ago2 
population.  
 
Excess of inactive siRNA masks active population 
Using Ago2 immune precipitations (IPs), we next quantified how much of the 
siRNA residing in the cell after the initial major clearance wave is loaded into Ago2. 
Ago2 IPs (Rüdel et al., 2008) were quantitatively highly reproducible (Figs. S2A-B), 
and importantly, showed a linear correlation between eluted Ago2 and the 
amount of input lysate over the relevant range of sample concentration (Fig. S2C). 
Also, the IP efficiency of Ago2 was independent of the sucrose concentration as 
confirmed for both, the continuous (Fig S2D) as well as discontinuous sucrose 
gradients (Fig 2E) used in this study. Additionally, to rule out that loaded siRNA 
might get lost during the IP procedure due to dissociation from Ago2 and to 
unambiguously confirm that the IP procedure allows to quantitatively determine 
the amount of complex, we used 5’TMR-labeled single-stranded HuR siRNA 
complexed to recombinant Ago2 in vitro as a standard to quantify siRNA recovery 
by RT-qPCR, which yielded a relative recovery of Ago2-siRNA complexes in the 
protein IP of 83 % (Fig. S2F). In addition, fluorescence anisotropy measurements 
confirmed that the recovered siRNA was still mostly complexed with Ago2 after 
native elution with the antigenic peptide (Fig S2G). This data demonstrates the 
stability of the complex throughout the IP procedure, consistent with the long 
half-life of Ago2-guide strand complexes in vitro (half-life of Ago2-guide strand > 
20 hours, Fig.S2H) and the high stability of the complex reported previously 
(Martinez J, Genes Dev 2004), and altogether unambiguously confirm that the IP 
procedure allows to quantitatively determine Ago2 loaded siRNA within a range 
of +/- 20 % accuracy. 
HeLa cells transfected with increasing doses of the very potent SSB siRNA reached 
saturation of the mRNA knockdown already at 0.25 nM transfected siRNAs, with 
an IC50 of 24±4 pM (Figs. 2A-B). In contrast, the amount of loaded guide strand in 
Ago2 increased almost linearly up to the highest transfected dose (6.25 nM; 
Figs. 2A, S2K, S2L). Consistent with observations emerging from previous in vivo 
studies (Pei et al., 2010), our data suggest that at siRNA concentrations beyond 
saturation of knockdown, a depot of loaded Ago2 may be formed and that the 
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capacity of the RISC loading machinery is not yet saturated, at least for SSB siRNA 
concentrations of up to 200 to 300-fold beyond the IC50 (Fig. 2A). Further 
calculations reveal that the IC50 of SSB mRNA knockdown is as little as 35-40 
molecules of siRISC per cell (Fig. 2B). To investigate whether these low numbers 
of siRISC per cell required for a 50 % mRNA knock-down is a general feature of 
siRNAs, we performed the analogous experiments with absolute quantification 
for three additional siRNAs of markedly different potency (Figs S2N-P).  Two 
siRNAs were targeting other mRNAs (GAPDH and HuR), the third siRNA (“SSB(53)”) 
targets another site within the same mRNA (SSB) but with significantly lower 
overall potency. Strikingly, for all of these siRNAs we find equally low numbers at 
IC50 ranging from 10-110 siRISC molecules per cell. These data suggest that RNA 
silencing is in general a remarkably efficient process once the siRNA is loaded into 
RISC. Additionally, we quantified the fraction of Ago2-loaded siRNA in relation to 
total intracellular siRNA followed a hyperbolic saturation curve with increasing 
siRNA dose, with less than 1 % fraction bound at the IC50 of knockdown and 
saturating at ca 4 % (Figs. S2I, S2J, S2M). This behavior suggests that either 
compartmentalization and/or other limiting factors prevent a quantitative loading 
of the intracellular siRNA material into Ago2. Considering estimate accuracies of 
our correction for the efficiencies of all experimental steps, the precision of these 
numbers is subject to a variation of at most 2-3 fold, suggesting that even at 
maximum experimental underestimation, a major fraction of intracellular siRNA 
but also miRNA (see Figures 4B, S1H and S3B) is non-RISC associated, which may 
appear counter intuitive to the current assumption in the field. Interestingly 
however, a recent publication (Janas et al., 2012) reports a conclusion perfectly 
consistent with our quantitative data. Based on an absolute quantification of Ago 
proteins and total miRNA copies per cell, the authors come to the conclusion that 
there is a 13-fold excess of miRNA over Argonaute molecules in HeLa cells, which 
implies that only a few percent of a given miRNA will be loaded in Ago proteins 
on average.  
 
Active siRISC co–sediments with ER and Golgi membranes 
Given that such a minor fraction of intracellular siRNA gets loaded into Ago2, we 
concluded that for localization of siRNA activity, tracing bulk siRNA with 
microscopy or fractionation becomes very misleading. Therefore we further 
refined the cell fractionation analysis of the siRNA by performing Ago2-IPs from 
continuous density sucrose gradients to quantify the amount of siRNA and miRNA 
loaded in Ago2 in each fraction. IP efficiencies were comparable across the 
gradient and well reproducible between independent fractionation experiments 
(Fig. S2D-E). Surprisingly and in contrast to the broad bulk distribution of siRNA, 
miRNA and RNAi pathway proteins, the Ago2 loaded SSB siRNA, miR-16 and miR-
21 all eluted in a sharp peak in the Golgi and ER fractions (fractions 4-6; Fig. 3A), 
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suggesting that the active siRNA/miRNA population may be associated with Golgi 
and/or ER membranes. To get further evidence for activity of the siRNA-Ago2 
complexes (siRISC) in these fractions, we next performed 5’RACE with RNA 
purified from each fraction to qualitatively assess the absence or presence of the 
cleavage product of the SSB mRNA. Consistent with the fractionation of the siRISC, 
a 5’RACE product was only detected in fractions 4-6 (Fig. 3B). Sequencing of the 
200 bp 5’RACE PCR product confirmed that all sequenced clones contained SSB 
mRNA cleaved at the expected position (Fig. S3A). Additionally, we tested the 
distribution of the cytoplasmatic 5’ to 3’ exonuclease Xrn1 in the same sucrose 
gradient fractions (Fig. 1A). Xrn1 was present in all non-endo/lysosomal fractions 
and enriched in fractions 4-6. This shows that the sliced mRNA can even be 
detected in fractions where it can be degraded and in turn excludes the possibility 
that the absence of 5’RACE products in the fractions 1-3 and 7-9 was due to 
immediate mRNA degradation after the siRNA-mediated mRNA slicing. In 
summary, these experiments show that siRISC as well as the sliced mRNA do co-
fractionate with Golgi and ER membranes.  
 
Active siRISC associates to the outside of the rough ER 
To investigate whether the active siRISC also physically associates with 
membranes, post-nuclear lysates of HeLa cells transfected with SSB siRNA were 
subjected to a membrane floatation assay on a discontinuous sucrose gradient 
(Tahbaz et al., 2004). After the centrifugation, membrane proteins of Lysosomes, 
Golgi and ER were enriched on the top (fraction 1 and partially 2), whereas non-
membrane bound material remained in the loading zone (fractions 3-5; Fig. 4A). 
Consistent with a previous report (Tahbaz et al., 2004), a portion of the 
cytoplasmatic population of Ago2 and Dicer, but also a fraction of Ago1 and PACT 
floated with membranes; Interestingly, TRBP was exclusively membrane 
associated. While the major siRNA, miRNA as well as Ago2 amounts were found 
in the non-membrane fractions, loaded siRISC as well as miRISC (miR-16 and miR-
21) were strongly enriched in the membrane fractions (Figs. 4B, S3B). Additionally, 
the SSB mRNA cleavage product floated exclusively with membranes (Fig. 4C), 
whereas again, Xrn1 was present in all fractions (Fig. 4A). Together, this suggested 
that the siRISC activity is not only co-fractionating with Golgi and ER membranes 
but is indeed membrane associated. To further characterize the Ago2 association 
with membranes, HeLa lysates were treated with RNAseA or ProteinaseK, and 
subsequently subjected to membrane floatation assays. RNAseA treatment did 
not lead to a detectable reduction of Ago2 in the membrane fraction (Fig. 4D, 
S3C), indicating that indirect association via the target mRNA does not play a 
major role for Ago2 membrane association (Fig. 4A). Additionally, given that Ago2 
membrane association is independent of RNA (Fig. 4D), this rules out that Ago2 
membrane association is mediated through polysomes.  
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Upon ProteinaseK treatment all Ago2 was lost from the membrane fraction 
(Fig. 4D). As controls, also Dcp1a which is not supposed to be encapsulated by 
membranes was fully susceptible to ProteinaseK treatment, whereas Calreticulin 
as an ER luminal protein was entirely protected from degradation and only 
detectable in the membrane fraction. In consequence and consistent with a 
previous report (Cikaluk et al., 1999), this data demonstrates that Ago2 associates 
to the cytosolic rather than the luminal side of membrane enclosed 
compartments.  
Finally, to unambiguously corroborate the physical association of Ago2 and RISC 
with membranes by an additional orthogonal method and to identify the 
membranes Ago2 associates with, HeLa cells were treated with Nocodazole and 
CytochalasinD to disrupt the cytoskeleton, lysed in the absence of detergents, and 
an IP against Ago2 was performed to pull down the Ago2-associated membranes. 
Species which were indirectly immune precipitated via membranes were 
subsequently recovered by mild elution with an NP-40 containing buffer. IP with 
the anti-Ago2 antibody brought down the ER membrane marker Calnexin, but no 
markers of Golgi or endosomal membranes, demonstrating a specific physical 
association of Ago2 with the membrane of the ER (Fig. 5A). As negative control, 
the anti-Ago2 IP was performed already in the presence of NP-40, thereby 
omitting any lipid mediated interactions. Under these conditions, no Calnexin was 
detectable in the eluate, which confirms that the interaction of Ago2 with 
Calnexin is membrane mediated. As additional control, in a similar IP with mouse 
IgG, none of the membrane marker proteins were detectable (Fig. 5A). To confirm 
that, as indicated by the fractionation (Fig. 4A), not only Ago2 but also the RISC 
and RLC factors associate with the ER, HeLa cells were subjected to sedimentation 
gradients optimized for purification of ER membranes (Fig. 5B). The fractions 
containing the membranes of the rough ER (fractions 8-10) were pooled and used 
for a membrane IP specific for the ER membrane protein calnexin (Fig. S4A). 
Strikingly, Ago2, TRBP and Dicer were all present in the eluate from the anti-
calnexin membrane IP, indicating that the factors constituting RLC and RISC 
associate with the rough ER membrane. Consistently, it has been shown by 
immune fluorescence that TRBP co-localizes with the ER (Eckmann and Jantsch, 
1997), and that TRBP and Dicer co-localize predominantly in the perinuclear 
region in HeLa cells (Daniels et al., 2009). As additional control, anti-Golgi 
membrane IPs were performed with the fractions containing Golgi membranes 
(fractions 2-4). Neither Ago2, nor Dicer, nor TRBP were enriched in the Golgi IP 
eluate compared to the IgG negative control IP (Fig. S4A). Altogether, these data 
provide strong evidence that RLC and siRISC are bound to the cytosolic surface of 
the rough ER membrane. 
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siRNA – mediated target mRNA cleavage occurs on the rER 
After having found that siRNA loaded Ago2 floats with membranes, that Ago2 
associates specifically with the ER membrane, and that siRNA loaded Ago2 as well 
as the slicing product co-fractionate with ER as well as Golgi markers, we wanted 
to further refine at which of these compartments siRNA mediated target cleavage 
occurs. HeLa cells tranfected with SSB, HuR and pGL3 siRNAs were subjected to 
sedimentation gradients optimized for purification of ER membranes. In these 
gradients, Golgi membranes were enriched in fractions 2-4, membranes of the 
smooth ER in fractions 5-7 and membranes of the rough ER (rER), revealed by the 
additional presence of the ribosomal protein RPS6, in fractions 8-10 (Fig. 5B). In 
agreement with the fractionation data in Fig. 1A, also after separation of Golgi 
from ER factions, Ago2 and Dicer indeed co-sedimented with both membranes 
(Cikaluk et al., 1999;Tahbaz et al., 2001). Interestingly, Ago1 and Ago2 were most 
abundant in the fractions of the rER, whereas Dicer peaked in the Golgi fractions. 
Consistently, Dicer had previously been observed to co-localize with Golgi and ER 
in rat primary neurons (Barbato et al., 2007). TRBP and PACT again showed a very 
confined localization and co-sedimented exclusively with the rER, in consistence 
with early work in X. laevis reporting cytoplasmic TRBP to localize to the ER and/or 
polysomes (Eckmann et al., 1997). Again, the bulk siRNA fractionated broadly 
throughout the gradient (Fig. S4B). After IP of Ago2 from the fractions however, 
we observed two distinct pools of siRNA loaded Ago2, the major population co-
sedimenting with the rER (Fig. 5C). A second, minor pool of siRISC was detected in 
fractions containing not only Golgi membranes but also the P-body marker Dcp1, 
which, in these gradients peaks together with the Golgi markers. In fact, in light 
of the absence of significant Golgi association as determined by Ago2 membrane 
IPs (Fig 5A), it appears more plausible that this second minor population of siRISC 
is P-body rather than Golgi associated. Interestingly, the non-targeting pGL3 
siRNA loaded into Ago2 also co-sedimented predominantly with rER, identical to 
the targeting siRNAs (Fig. 5C, HuR and SSB), further supporting that this 
fractionation is independent of a target mRNA and not dependent on polysomes. 
We next wanted to address whether these two spatially separated siRISC pools 
represent functionally different complexes or complexes of different maturation 
state. As, ex vivo, both pools of immune purified Ago2 were competent of in vitro 
mRNA slicing we concluded that both complexes comprise mature siRISC (Yoda et 
al., 2010), i.e. slicing competent RISC with single stranded guide siRNA (Fig. S4C). 
As this does not necessarily imply that alike ex vivo, slicing indeed occurs in both 
compartments within the cell, we again performed 5’RACE on all fractions to 
detect the endogenous slicing product. Strikingly, the endogenous mRNA 
cleavage product co-sedimented exclusively with membranes of the rER (Fig. 5D), 
strongly suggesting that the site of endogenous mRNA silencing, at least for siRNA, 
is the rER.  
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Canonical RISC loading occurs at the rER 
We next aimed to address whether the rER is also the site of RISC loading, or 
whether instead the additional, minor Golgi/P-body population of siRNA-Ago2 
might account for complexes engaged in loading. The canonical RLC was proposed 
to comprise Ago2, Dicer and TRBP (Chendrimada et al., 2007;Gregory et al., 
2005;MacRae et al., 2008;Maniataki et al., 2005;Noland et al., 2011). We have 
shown that all three proteins float with membranes (Fig. 4A), and can be pulled 
down in a membrane IP with an ER membrane protein (Fig. S4A). Furthermore, 
TRBP does exclusively co-fractionate with the rER, and also Ago2 and Dicer 
partially co-fractionate with the rER (Fig. 5B). This supports that a canonical RLC 
may form on the rER rather than at Golgi or P-bodies where TRBP and PACT are 
absent. To further corroborate this hypothesis, lysates of siRNA transfected HeLa 
cells were subjected to a Golgi/ER gradient as in Fig. 5B. For qPCR detection 
sensitivity reasons of the passenger strand, we focused on the HuR siRNA rather 
than the SSB siRNA in these experiments. After pooling each, the Golgi/P-body 
fractions (2-4) as well as the rER fractions (8-10), immune precipitations for TRBP, 
Dicer and Ago2 were performed (Fig. 5E). In the TRBP and Dicer IPs, both guide as 
well as passenger strand of the HuR siRNA were detectable in the rER fractions, 
suggesting that TRBP and Dicer are associated with double stranded siRNA in 
these fractions. Consistent with the Ago2 IPs from the other gradients, Ago2 
bound HuR siRNA guide strand was again detectable in both the Golgi/P-body as 
well as in the rER fractions, however, the Ago2 associated passenger strand was 
clearly enriched in the rER fraction. Moreover, despite the dramatically higher 
amounts of Dicer in the Golgi/P-body fractions, neither guide nor passenger 
strand were detectable in this pool but clearly enriched in Dicer immune 
precipitates from the rER fractions. Together, these data strongly suggest that the 
rER fractions comprise both, mature siRISC as well as full RLC associated with 
double stranded siRNA (and potentially single stranded siRNA as well), whereas 
the Golgi/P-body pool of loaded Ago2 consists to > 98 % of mature siRISC with 
guide strand only, as well as non-siRNA associated Dicer.  
To further corroborate this conclusion, we wanted to rule out the possibility that 
the detected HuR sense strand in the eluates resulted from sense strand 
misloaded as guide rather than siRNA duplex. While bioinformatic analysis 
supported a high asymmetry and therefore antisense strand selectivity for the 
HuR siRNA (data not shown), we additionally designed a Firefly/Renilla dual 
luciferase reporter containing either the target site of the antisense or the sense 
strand in the 3’ UTR, and co-transfected these plasmids together with the HuR 
siRNA into HeLa cells. With an IC50 of 0.2 nM the passenger strand was more than 
1000-fold less active than the guide strand which had an IC50 of 0.1 pM (Figs. 5F 
and S4D), confirming that strand selection for this siRNA is highly biased to the 
antisense strand and that loading of sense strand as guide can be neglected. 
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Therefore we conclude that Ago2 in the rER fractions is indeed partially associated 
with double stranded siRNA and comprises not only mature siRISC but also 
complexes engaged in loading, i.e. a “pre-RISC state” (Czech and Hannon, 
2011;Kawamata and Tomari, 2010). Altogether, this data suggests that also 
canonical RISC loading of Ago2 through Dicer and TRBP/PACT occurs at the 
membranes of the rER. 
 
Membrane anchoring of RISC is dependent on TRBP and PACT 
Given that TRBP and PACT did co-sediment with Golgi and ER membranes, we 
speculated that Ago2 might be anchored to the membranes (potentially 
indirectly) via TRBP and PACT. We thus depleted TRBP or PACT by RNAi (Fig. S5A), 
and subjected the post nuclear lysates to membrane floatation assays. The Ago2 
protein levels were similar in control cells and in the cells with TRBP or PACT 
knock-down (Fig. S5A), but in contrast to the RNAseA treated lysates (Fig. 4D), the 
amount of membrane associated Ago2 was strongly reduced after TRBP depletion 
and completely abolished after PACT depletion (Fig. 6A). Additionally, in a 
membrane IP with antibodies against Ago2, the amount of co-eluted marker 
proteins for the ER and ribosomes were reduced when TRBP or PACT were 
depleted as compared to mock treated cells (Fig. S5B). Interestingly, the smaller 
effect of TRBP knockdown on Calnexin association with Ago2 as compared to the 
more dramatic effect upon PACT knockdown mirror images the efficiency of the 
knockdown of the two proteins. This data suggests that Ago2 associates with 
membranes through TBRP and PACT, most plausibly indirectly through the 
complex of TRBP and PACT with Dicer.  
 
Nucleation of RISC loading and mRNA slicing at the rER membrane is important 
for kinetic and thermodynamic efficiency of RNAi 
Results from previous publications about whether TRBP and PACT are required 
for siRNA-mediated RNA silencing are contradictory (Haase et al., 2005;Kok et al., 
2007). Given that as little as 10-110 molecules of siRISC per cell are sufficient for 
50 % knock-down of three different, relatively abundant mRNAs (Fig. 2B and Fig. 
S2N-P), but that the onset of RNAi after transfection is extremely fast, we 
reasoned that the sequestration of active Ago2 to membranes may be responsible 
for accelerating the silencing kinetics. This would imply that TRBP and/or PACT as 
membrane anchors may not be qualitatively required for RNAi but might rather 
play a main role in the quantitative efficiency and particularly the kinetics of the 
onset of silencing. To test this hypothesis, we transfected the SSB siRNA into 
TRBP/PACT RNAi depleted versus mock treated cells. Consistent with our 
hypothesis, the onset of SSB mRNA knockdown was clearly delayed when TRBP or 
PACT had been depleted (Fig. 6B). After 24 hours, also in TRBP/PACT depleted 
cells knockdown had caught up to reach saturation, most likely explaining why 
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TRBP and PACT had not been found to be essential for RNAi in earlier reports. In 
addition, we tested whether perturbation of directional cytoskeleton-dependent 
cell transport to the ER would result in a similar delay in the onset of silencing. 
HeLa cells were pre-treated for 2 hours with Nocodazole (5 g/ml) prior to 
transfection with the SSB siRNA, and knockdown was quantified at various time 
points after transfection by RT-qPCR (Fig. 6C). Indeed, the onset of silencing was 
delayed. While this is again consistent with subcellular localization being 
important for the kinetic efficiency of RNAi, cytoskeleton perturbation is a rather 
harsh treatment which may also indirectly impair RNA silencing. We therefore 
hypothesized that a strategy to enhance RNAi by perturbation of anterograde 
transport and the resulting general accumulation and concentration of material 
at the ER by Brefeldin A treatment might allow addressing this question more 
specifically. Indeed, Brefeldin A pre-treatment (10 g/ml) resulted in the opposite 
effect and accelerated and increased SSB mRNA knockdown as compared to the 
DMSO control (Fig. 6C).  Interestingly, the IC50 of the SSB siRNA was additionally 
shifted to lower concentrations, resulting in an approximately 10-fold higher 
siRNA efficiency at 24 hours (Fig. S5D). Altogether these data show that nucleation 
of RISC loading and mRNA slicing at the ER membrane is not qualitatively essential 
but physiologally important for the kinetics and efficiency of this process. 
 
Discussion 
In this work we have demonstrated that Ago2 associates to the cytosolic side of 
the rER, that loaded and active Ago2 is mostly membrane associated, and that the 
slicing product as well as mature siRISC co-sediment with the rER. Additionally, 
also RLC bound to double-stranded siRNA is enriched at the rER. Our data 
therefore strongly suggests a model where canonical RISC loading of Ago2 
through Dicer and TRBP/PACT, encounter of RISC with target mRNA as well as 
siRNA-mediated mRNA slicing all occurs primarily at the cytosolic membrane 
surface of the rER (Fig. 7A). Altogether these data show that the 
compartmentalization and thereby the nucleation of RISC loading and mRNA 
slicing at the ER membrane is physiologally important for the kinetics and 
efficiency RNAi. While genomic analysis confirms the general textbook view that 
stable association and translation of mRNAs at the ER correlates well with 
predicted motifs for protein secretion or membrane anchoring (Diehn et al., 
2006), it has also been shown that most mRNAs at least transiently associate with 
the ER during their lifecycle (Chen et al., 2011;Gerst, 2008;Lerner et al., 2003). 
Given the high dynamics of peripheral ER, the nucleation site of siRNA-mediated 
silencing being on the cytosolic side of the rER membrane seems not at all 
incompatible with silencing of mRNAs of soluble proteins. Rather, this localization 
provides the ER-bound RISCs a privileged predisposition to dynamically sample 
over translationally active mRNAs. As an important note, based on our data we 
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cannot exclude that silencing would not function in other sites of the cell as well; 
however, from a quantitative point of view, compartmentalization of the initial 
steps of RNA silencing at endomembranes, and in particular at the rER is 
absolutely plausible given that only few molecules of active RISC per cell are 
sufficient to silence even relatively abundant mRNAs within less than one hour 
upon initial cell exposure to siRNA. Such efficiency would be thermodynamically 
and kinetically implausible if all partners were homogeneously distributed 
throughout the cytosol. As a side observation, our findings are also consistent 
with the site at which the hepatitis C virus (HCV) replicates using RISC 
components. HCV forms a replication complex in a membranous web derived 
from the rER, and requires both Ago2 and miR-122 for efficient replication (Jopling 
et al., 2005;Wilson et al., 2011).  
Previous investigations have largely been focused on localization and tracing of 
overexpressed bulk RNAi pathway proteins, miRNA or siRNA. In this work we show 
that after lipid delivery and endosomal entry of siRNA into mammalian cells, the 
lion’s share gets cleared within a few hours and a very small fraction (<< 0.25-
0.1%) is eventually loaded into Ago2 (Fig. 7B). As the small number of active siRISC 
molecules per cell is masked by such a huge excess of both, nonproductive siRNA 
as well as additional pools of Ago2, in this work we aimed to specifically trace 
functional RISCs and RNAi activity, which might explain the partially different 
conclusions compared to previous reports (Jagannath et al., 2009;Liu et al., 
2005;Sen et al., 2005). In a previous study which used fluorescence cross 
correlation spectroscopy to also explicitely trace the minute fraction of siRNA-
Ago2 complexes on the massive background of bulk Ago2 and siRNA (Ohrt et al., 
2008), cytoplasmic siRISC showed a slow translational diffusion time either 
reflecting a very large complex and/or confined movement, generally supporting 
a (dynamic) membrane anchoring of loaded RISC. Furthermore, our findings are 
also fully consistent with a recent report which shows that membrane association 
of Ago1 in A. thaliana is required for miRNA activity (Brodersen et al., 2012).  
After initial encounter and endonucleolytic cleavage of the target mRNA by Ago2 
at the rER, the sliced mRNA (or silenced miRNP) may likely be taken up by P-bodies 
to facilitate the degradation of the mRNA. This would be consistent with the 
repeated detection of siRNA as well as Ago2 and particularly Ago2-GFP in P-bodies 
(Jagannath et al., 2009;Leung et al., 2006;Liu et al., 2005;Ohrt et al., 2008;Sen et 
al., 2005), as well as the notion that P-bodies, while clearly involved in RNAi, are 
rather a consequence than cause of silencing. Interestingly, life cell microscopy 
supports a transient and dynamic association of Ago2-GFP, which is known to be 
primarily P-body associated, with the ER (Movie S1). Also, “consumed” RISC may 
dissociate from the mRNP after slicing and recycle back to the rER via the Golgi, 
and the second minor pool of mature siRISC which we detect in the Golgi/P-body 
fractions might reflect either of these possible downstream steps (Fig. 5C).  
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At least two studies have implicated membranes of the endo-/lysosomal system 
as important sites in the RNA silencing pathways in mammalian cells and flies 
(Gibbings et al., 2010;Gibbings et al., 2009;Lee et al., 2009). These studies 
reported that GW bodies, membrane enclosed granules rich in GW182/Tnrc6, 
miRNAs, and Ago proteins are MVB associated. Blocking MVB turnover enhanced, 
whereas blocking MVB maturation inhibited miRNA mediated target mRNA 
silencing, indicating that MVBs and GW bodies are functionally involved in miRNA-
mediated RNA silencing. As also RISC loading was enhanced upon inhibiting MVB 
turnover by Hps4 knock-down (Lee et al., 2009), the authors argued that MVBs 
might also be sites of RISC diassembly and, possibly RISC loading. However, the 
increased levels of loaded RISC might as well be an indirect consequence of 
enhanced RISC disassembly upon impaired MVB turnover, which would facilitate 
recycling to and de novo loading at another site. In light of our data it seems 
plausible that endo/lysosomal compartments rather play a role downstream of 
RISC loading. While our data shows that canonical RISC loading, initial RISC-mRNA 
binding and slicing happen at the rER, the siRNPs or miRNPs may then likely be 
sorted into different effector compartments for downstream events such as 
mRNA degradation in P-bodies or translational silencing in MVBs and MVB-
associated GW bodies, and that consumed RISC is continuously recycled back 
from such effector sites to the rER as the primary nucleation site of RNAi. This 
model not only reconciles much of the apparently controversial evidence in the 
literature, but most importantly may now enable the rational design of a new 
generation of therapeutic siRNA delivery strategies. 
 
Methods 
Cell culture, transfections and Plasmids 
HeLa cells were grown in RPMI (Invitrogen) supplemented with 10 % fetal bovine 
serum. For transfections, 2 x 105 or 1-2 x 106 cells were seeded into six well plates 
or 10 cm2 dishes, respectively, and transfected the next day. siRNAs were 
transfected with Lipofectamine 2000 (Invitrogen) according to the manufacturer’s 
protocol. For TRBP or PACT knock-downs, HeLa cells were transfected in 10 cm2 
dishes with 25 nM siRNA, and re-transfected with 25 nM siRNA 24 hours later. The 
cells were used for the experiments 48 – 96 hours after the first transfection. For 
luciferase reporters, a 1.2 kb fragment of the HuR mRNA starting at position +1 of 
the 3’UTR comprising the HuR siRNA binding site (position 1186 in GenBank 
acession number NM001419) in either sense or antisense orientation was 
generated by gene synthesis and cloned into the XhoI and NotI sites of psiCHECK-
2 plasmids (Promega).  
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Luciferase assays 
7000 HeLa cells/well were seeded into 96 well plates. The next day, 50 ng psi-
Check2 plasmid was co-transfected with siRNA using Lipofectamine 2000 
(Invitrogen) and 24 hours later renilla and firefly luciferase activities were 
measured using the Dual Luciferase Assay System from Promega on a GloMax®-
Multi+ Microplate Multimode Reader (Promega) according to manufacturer’s 
protocol.  
 
 
siRNAs and Antibodies 
The siRNAs have the following sequences:  
SSB (guide: 5’- UUACAUUAAAGUCUGUUGUUU -3’;  
passenger 5’- ACAACAGACUUUAAUGUAAUU -3’),  
HuR (guide: 5’- UUAAUUAUCUAUUCCGUACTT -3’;  
passenger 5’- GUACGGAAUAGAUAAUUAATT -3’),  
pGL3 (guide: 5’- UCGAAGUACUCAGCGUAAGUU -3’;  
passenger 5’- CUUACGCUGAGUACUUCGAUU -3’),  
SSB(53) (guide: 5’- CCUUUGUAAUAUGAGAAUGUU;  
passenger: 5’- CAUUCUCAUAUUACAAAGGUU-3’),  
GAPDH (guide: 5’- 5'GGCCAUCCACAGUCUUCUGdGdG -3’;  
passenger: 5’- CAGAAGACUGUGGAUGGCCdTdT-3’;),  
Renilla (guide: 5’- UCGAUGAACAUCUUAGGCATT -3’;  
passenger 5’- UGCCUAAGAUGUUCAUCGATT -3’),  
YFP (guide: 5’- CUUGUCGGCCAUGAUAUAGAC -3’;  
passenger 5’- CUAUAUCAUGGCCGACAAGTT -3’).  
 
TMR labeled HuR siRNA was labeled via a 5’terminal amino-C6 linker at the guide 
strand (Eurogentec). ON-TARGETplus SMARTpool siRNAs (Dharmacon) were used 
to deplete TRBP (L-017430-00) or PACT (L-006426-00).  
Antibodies against Ago2 (clone 11A9 or 4G8) were from Ascenion or Wako 
Chemicals, antibody against Ago1 (clone 4B8) was from Ascenion. Antibodies 
against Hrs (ab56468), Rab5 (ab18211), tsg101 (ab83), lamp2 (ab25631), calnexin 
(ab22595), Dcp1a (ab47811), TRBP (ab42018) were from Abcam, and antibodies 
against calreticulin (A301-130A), RPS6 (A300-557A), PACT (A302-016A) and Dicer 
(A301-936A) were from Bethyl laboratories. Antibodies against p58 (sc-66880), 
GM130 (sc-16268) were from Santa Cruz, antibodies against b4-GalT1 
(HPA010807) were from Atlas antibodies and antibodies against SmB (S0698) 
were from Sigma. A rabbit antibody against dicer was described previously (Haase 
et al., 2005). 
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Immune precipitations  
Magnetic protein G sepharose beads (GE Healthcare) were incubated at 4 °C with 
saturating amounts of antibody for 2 h or over night. Unless stated differently, 15 
mg anti-Ago2 antibody was coupled to 10 l beads in a total volume of IP buffer 
(0.1 % v/v Nonidet-P40, 100 u/ml RNasIn (Promega), 0.5 mM DTT, 20 mM TrisHCl 
7.4, 150 mM NaCl, 1 mg/ml heparin and complete EDTA-free protease inhibitor 
(Roche)). For the Ago2-IP in Figure 2, 22.5 mg anti-Ago2 antibody was coupled to 
20 ul beads. For whole cell extracts cells were incubated in lysis buffer (20 mM 
TrisHCl 7.4, 150 mM NaCl, 0.5 % v/v NP-40, 2 mM EDTA, 1 mg/ml heparin, 2.5 mM 
DTT, 500 u/ml RNAsin (Promega) and CompleteTM EDTA-free protease inhibitor 
(Roche)) and centrifuged at 1000 g for 5 min. For sucrose gradient fractions, 
200 l from each fraction were incubated with lysis buffer. For the IP in Figure 
S2F/G, 11.25 mg anti-Ago2 antibody was coupled to 10 l beads, then 2 M 
recombinant Ago2 was together with 5 M 3’TMR HuR guide strand. Immune 
precipitations were rotated head over tail for 2-4 h at 4 °C in IP buffer. Beads were 
washed twice with IP wash buffer (50 mM TrisHCl 7.4, 300 mM NaCl, 5 mM MgCl2, 
0.05 % v/v NP-40). Proteins were eluted by incubating the beads for 10 in at 70 °C 
in SDS loading buffer. For small RNA elution, beads were incubated for 10 min at 
95 °C in elution buffer (6 mM TCEP (tris(2-carboxyethyl)phosphine), 1 mM HCl, 
1 % v/v Triton X-100). For in vitro slicing reactions, beads were incubated for 45 
min at 37 °C with 1 M target RNA (5’-Cy3-
ACCGUCUAACAACAGACUUUAAUGUAAUUGUGGAA-3’) in RLC buffer (20 mM 
TrisHCl 7.4, 50 mM NaCl, 3 mM MgCl2, 2 mM DTT, 0.5 mg/ml tRNA, 2 u/ l RNAsin 
(Promega)). Slicing products were separated on 15 % denaturing polyacrylamide 
TBE urea gels and visualized using a Pharos FX (Biorad).  
For membrane IPs with post-nuclear supernatants, cells were incubated for 18 h 
at 37 °C with cytochalasinD (10 M) and nocodazole (13 M), trypsinized and 
washed with PBS pH 7.2 (Invitrogen), and incubated in hypotonic buffer for 10 min 
on ice. Cells were then lysed similar as for sucrose gradients (20 strokes, 12 m 
tungsten ball). Lysates were cleared for 5 min at 500 g, and the supernatant was 
incubated with 15 g antibody for 2.5 h at 4 °C in PBS pH 7.2 supplemented with 
CompleteTM EDTA-free protease inhibitor (Roche), cytochalasinD (25 M) and 
nocodazole (33 M), and respectively 0.4 % v/v NP-40 for the control sample. 
25 ul ProteinG dynabeads (Invitrogen) were blocked with 2.5 % w/v bovine serum 
albumine (BSA) in PBS pH 7.2, and antibody-protein complexes were captured for 
30 min at 4 °C. Beads were washed three times with IP wash buffer (without 
Nonidet P-40), and proteins were eluted by incubating the beads for 5 min at 
room temperature with 0.4 % v/v Nonidet P-40 in PBS pH 7.2. For membrane IPs 
out of sucrose gradients, 200 l of the fractions were used as input, and the IP was 
performed with 5 g antibody in the absence of nocodazole and cytochalasinD.  
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Immune blotting and RT-qPCR 
Whole cell lysates corresponding to 1-2 x 105 cells per lane or aliquots of sucrose 
gradient fractions or immune precipitations were heated for 10 min at 70 °C and 
electrophoresed on 4-12 % NuPage gels (Invitrogen). Proteins were transferred to 
Protran nitrocellulose membranes (Whatman) using a SD Transblot system 
(BioRad) and incubated with primary antibodies. Immune complexes were 
visualized using HRP-conjugated anti-rabbit, anti-mouse, anti-goat and anti-rat 
antibodies (Santa Cruz) on a Biorad XRS system.  
For mRNA quantifications, total RNA was isolated using the RNeasy Plus kit 
(Qiagen). One Step RT-qPCR reactions were performed using 40 ng RNA, 1 mM 
dNTPs, 0.5 U Multiscribe reverse transcriptase (Applied Biosystems), 0.03 U 
FastStart Taq polymerase (Roche) in GeneAmp PCR buffer I (Applied Biosystems). 
Samples were heated to 50 °C for 30 min, then 95 °C for 10 min, and then cycled 
40 times with 3 sec at 95 °C and 30 sec at 50 °C on a 7900HT Fast RT-qPCR System 
(Applied Biosystems). SSB and GAPDH mRNA were measured using Assay-on-
demand reagents from Applied Biosystems (hs00427601_m1 and 4333764, 
respectively). For small RNA quantifications an adapted RT-qPCR protocol from 
(Pei et al., 2010) was used.  
 
Sucrose sedimentation gradients 
2-4 confluent 10 cm2 dishes with HeLa cells were used for each gradient. Cells 
were washed with PBS pH 7.2, then incubated for 10 min at 4 °C in hypotonic 
buffer (HB; 10 mM Tris pH8, 10 mM KCl, 1.5 mM MgCl2, 10 mM DTT, 1x complete 
EDTA-free protease Inhibitors (Roche), 400 u/ml RNasIn (Promega)) and then 
lysed with 20 strokes in a cell homogenizer (Isobiotec) using the 12 m tungsten 
ball. Lysates were cleared for 5 min at 500 g, and the supernatant was loaded on 
top of a previously prepared continuous sucrose gradient. To generate the 
gradients, sucrose dissolved in HB was overlaid and frozen between each step, 
then the gradient was thawed over night at 4 °C to allow the formation of a 
continuous gradient. The gradient was centrifuged for 16 hours at 100’000 g at 4 
°C in a Beckman Optima Max, and fractions were collected from the top.  
 
Membrane floatation assays 
Membrane floatation assays were essentially performed as described elsewhere 
(Tahbaz et al., 2004). Sucrose solutions and cell lysates were prepared as for the 
sucrose sedimentation gradients.  
 
Immune cytochemistry 
Immune cytochemistry was essentially performed as described elsewhere 
(Stalder and Muhlemann, 2009). Briefly, 0.5 – 1.5 x 105 HeLa cells were seeded 
into an  – slide VI0.4 (Ibidi). The next day, the cells were washed with PBS, fixed 
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for 30 min at 37 °C in DSS-IF-buffer (PBS pH 7.2 containing 2 mM MgCl2, 10 % v/v 
glycerol, 0.5 mM disuccinimidyl suberate (DSS, Pierce)), and subsequently washed 
five times with DSS-IF-buffer without DSS and permeabilized for 20 min with PBS 
pH 7.2 containing 0.2 % v/v Triton X-100 and 0.2 M glycine. The cells were 
incubated for 30 min with Signal-iT FX Signal Enhancer (Invitrogen), washed with 
PBS containing 0.15 % w/v BSA and incubated with primary antibodies for 1 hour 
at room temperature. The cells were then washed five times with PBS containing 
0.15 % BSA and incubated with primary antibodies for 1 hour at room 
temperature and washed five times with PBS containing 0.15 % BSA. Anti-rat 
AlexaFluor488 (Molecular Probes) and anti-rabbit or anti-mouse AlexaFluor647 
(Molecular Probes) were used as secondary antibodies, images were taken on a 
Zeiss LSM710 confocal microscope with a 63x W 1.2 NA objective.  
 
Life cell imaging 
HeLa cells were seeded into an 8 well -slide (Ibidi) and at 60 % confluency 
transfected with 12 nM 5’TMR-labeled HuR siRNA (guide strand, Eurogentec) 
using Lipofectamine 2000 according to manufacturer’s protocol. To stain the 
endosomes or lysosmes, Alexa Fluor 647 labeled transferrin (2.5 M) or 
lysotracker green (10 M, Invitrogen) were added 30 min before the images were 
taken. Images were acquired on a confocal LSM710 microscope with GaAsp-
detector (Zeiss) with a 100x oil 1.4 NA objective and temperature, gas and 
humidity control unit (Life Imaging Services) and analyzed with Imaris64 
(Bitplane).  
 
5’RACE 
Total RNA was isolated from the sucrose gradient fractions with Trizol LS 
(Invitrogen). 5’ RACE was performed with the Generacer kit (Invitrogen) according 
to the manufacturer’s protocol. The following primers were used: RT-primer and 
first PCR primer (5’-GGCCAGGGGTCTCTACAAAT -3’), nested reverse (5’-
AGAGTTGCATCAGTTGGGAAG -3’).  
Fluorescence anisotropy measurements. 
Binding of HuR siRNA or miR-122 to recombinant Ago2 as well as off rates were 
measured with anisotropy determination by 2D-FIDA as described elsewhere 
(Kask et al., 2000;Meisner et al., 2004). For binding curves, 1 nM of 5’TMR labeled 
miR-122 (5’TMR-UGGAGUGUGACAAUGGUGUUUG, EuroGentec) or HuR siRNA 
(5’- UUAAUUAUCUAUUCCGUACTT -3’) was incubated with increasing 
concentrations of recombinant human full length Ago2 protein for at least 15 
minutes at room temperature (23 °C) in a buffer of PBS pH 7.2, 0.1 % (w/v) 
Pluronic F-127 (Molecular Probes), 1 mM MgCl2 and 1 mM DTT. 2D-FIDA 
measurements and anisotropy calculations were done as described previously 
(Meisner et al., 2004). Samples of Ago2 loaded 5’TMR HuR siRNA before and after 
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IP were measured under the same conditions. For off rate measurements, 1 nM 
of 5’TMR labeled miR-122 was incubated with hAgo2 at 2.6 M (corresponding to 
95 % complex formation according to the affinity determination) for 10 minutes. 
Unlabeled competitor guide (5’phosphorylated miR-16, 
UAGCAGCACGUAAAUAUUGGCG, Eurogentec) was added at 10 M and the 2D-
FIDA measurement was started, whereas the exact delay time between the 
addition of the competitor and the start of the measurement was taken with a 
chronometer. All curve fits were done by nonlinear regression in GraFit as 
described (Meisner et al., 2004). Off rates were fitted to a pseudo first order 
mono-exponential decay, binding curves were fitted to the equation describing 
the anisotropy in dependence of 1:1 complex formation.  
 
Data analysis 
All data are representatives from at least two to three independent experiments. 
Unless stated otherwise, error bars represent standard deviations from at least 
three technical replicates of one representative biological experiment. Nonlinear 
curve fitting was performed using GraFit 5.0. For absolute quantification of siRNA 
and siRISC molecule numbers per cell, cells used per IP were counted and related 
to the amount of siRNA in the whole IP, which was extrapolated from the siRNA 
amount in the RT-qPCR reaction with calibration to an external synthetic siRNA 
standard. Based on the combined errors of all steps, the overall accuracy of this 
analysis lies within a factor of ca 2-3.   
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Figure legends 
 
Figure 1 Ago2 and siRNAs localize to a number of different compartments 
a, Western blot analysis of sucrose gradient fractions. b, immune fluorescence of HeLa 
cells stained with anti-Ago2 and counterstained with antibodies against marker proteins 
for P-bodies (Dcp1), ER (Calreticulin), Golgi ( 4-GalT1), ERGIC (p58), early Endosome (Hrs). 
Settings were chosen so that no background was detected from cells stained only with 
secondary antibodies, all images were taken with the same settings.  c, RT-qPCR 
Quantification of total intracellular SSB guide strand (left panel) and in the sucrose 
fractions (right panel) at the indicated timepoints post transfection. d, Life cell imaging of 
HeLa cells transfected with 5’TMR-labeled HuR siRNAs (green) and counterstained with 
Lysotracker (lysosome marker; blue) or transferrin (endosome marker; red).  
 
 
Figure 2 Excess of inactive siRNA masks active population 
a, b, Ago2 IPs were performed in an quantitative manner 24 h after the HeLa cells were 
transfected with SSB siRNA. mRNA levels were determined by RT-qPCR from purified total 
RNA.  
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Figure 3 siRNA- and miRNA-loaded Ago2 complexes and mRNA slicing product co-
sediment with ER/Golgi membranes 
a, Ago2 IPs were performed from fractions of the sucrose gradient displayed in Fig. 1A, 
and SSB siRNA guide strand, miR-16 and miR-21 were quantified by RT-qPCR. b, 5’ RACE 
performed with total RNA from the sucrose gradient fractions of the gradient displayed in 
Fig. 1A. PCR products were separated on an agarose gel, a positive 5’RACE signal results 
in a 208 bp fragment.  
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Figure 4 Active siRISC associates to the outside of membranes 
HeLa cells were transfected with SSB siRNA and subjected to a membrane floatation 
assay. Fractions were analyzed by western blotting (a), Ago2 IP and RT-qPCR (b) and 
5’RACE (c) as in Fig. 3. d, HeLa lysates were treated with RNAseA or ProteinaseK and 
subjected to membrane floatation assays, fractions were analyzed by Western blotting. 
RNAse A activity was confirmed by analysis of GAPDH mRNA levels in the sucrose gradient 
fractions after the treatment (Fig. S3C).  
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Figure 5 siRISC loading and siRNA-mediated mRNA cleavage occur on the membrane of 
the rough endoplasmatic reticulum 
a, Membrane IPs were performed with HeLa lysates (as described in materials and 
methods) and eluates were analyzed by Western blotting. b, HeLa cells were transfected 
with SSB, HuR and pGL3 siRNA and subjected to a sucrose sedimentation gradient. 
Fractions were analyzed by Western blotting, Ago2 IP and RT-qPCR (c) and 5’RACE (d). e, 
HeLa cells transfected with HuR siRNA were subjected to a sucrose sedimentation gradient 
as in (a). The Golgi/P-body fractions (2-4) and rER fractions (8-10) were pooled and used 
for TRBP, Dicer and Ago2 IPs. The eluates were analyzed by RT-qPCR. Averages of one 
typical experiment are shown, error bars represent standard deviation of the RT-qPCR.. f, 
A dual-luciferase reporter plasmid was co-tranfected together with increasing 
concentrations of the HuR siRNA, luciferase activity was measured after 24 hours.  
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Figure 6 Membrane anchoring of RISC by TRBP/PACT accelerates RNA silencing 
a, HeLa cells depleted of TRBP or PACT were subjected to membrane floatation assays as 
in Fig 4a, fractions were analyzed by western blotting. b, HeLa cells depleted of TRBP 
and/or PACT were transfected with SSB siRNA and harvested after the indicated 
timepoints. Relative SSB mRNA levels, normalized to GAPDH mRNA, were quantified by 
RT-qPCR. c, HeLa cells were pre-treated with Nocodazole (5 g/ml) or Brefeldin A (10 
g/ml) for 2 hours, transfected with the SSB siRNA at 0.5 nM, and lysed at the indicated 
timepoints after the transfection. SSB mRNA levels were analyzed by RT-qPCR.  
 
 
Figure 7 Model for spatial organization of the RNAi pathway and quantitative fate of 
siRNA following transfection. 
a, Based on the data presented in this work, we propose that the central steps of RNAi 
occur at the cytosolic surface of the rough ER membrane. Exposure of ds siRNA to RLC, 
anchored to the membrane either directly or indirectly via TRBP and/or PACT, is nucleated 
by encounter of all partners at the rough ER (1). Upon transfer of the ds siRNA from RLC 
into Ago and passenger strand removal (RISC loading and maturation, (2)) mature RISC is 
formed. rER association provides mature RISC a privileged position to sample over 
translationally active mRNAs which either permanently (secreted/membrane proteins) or 
transiently (soluble proteins) associate with the rER (Chen et al., 2011;Gerst, 2008;Lerner 
et al., 2003). Upon encounter of a target mRNA, the formation of an siRNP or miRNP is 
nucleated (3a) and a perfect target gets endonucleolytically sliced by Ago2 (3b). 
Considering previous reports, it is likely that the RISC associated RNPs are then further 
directed to effector sites for downstream silencing events (4), such as P-bodies for 
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exposure to the mRNA degradation machinery (Eulalio et al., 2007a), or MVBs/GW bodies 
for interaction with GW proteins and/or RISC disassembly (Gibbings et al., 2010). Finally, 
“consumed“ RISC may get either eliminated, or reactivated and recycled back to the ER 
through the highly dynamic endomembrane apparatus or other routes (5). b, In summary 
of the data presented in Figures 1 and S2, following endosomal uptake of siRNA with 
cationic lipofection a lion‘s share of the intracellular siRNA is cleared again very quickly 
via lysosomes and potential additional secretion or degradation pathways. Even though 
the RISC loading machinery is not saturated (Fig. 2A), the residual intracellular siRNA is 
loaded very inefficiently into Ago (less than 0.1-1 % of the initial intracellular siRNA). This 
explains why, although as little as 10-110 loaded RISC molecules per cell are sufficient to 
promote knockdown of a relatively abundant mRNA such as SSB, the cell needs to be 
flooded with siRNA by exposure to nanomolar concentrations to sustain significant mRNA 
knockdown. 
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ABSTRACT. The increasing involvement of academic institutions and Biotech 
companies in drug discovery calls for miniaturized, cost effective methods to 
identify new bioactive molecules. Affinity based on-bead screening of one-bead 
one-compound combinatorial libraries aims at combining the advantages of 
miniaturized combinatorial split-mix library synthesis in generating large 
compound collections with a simple, cheap and generic protein binding assay 
format. However, due to the pronounced broad spectrum autofluorescence of 
library beads as well as the considerable miniaturization i.e. the need to sort objects 
of 50-100µm and possibly smaller, one bottle-neck in on-bead screening is still the 
unavailability of a widely accessible, technically simple, cheap and robust 
screening platform. Despite the development of all sorts of detection aids and 
contrast enhancement methods, a dye labeled protein in combination with 
fluorescence as a detection principle is arguably still the simplest assay system for 
on-bead screening. However, wide-field fluorescence microscopy has long been 
considered unsuitable due to detection of photons from outside the focal volume, a 
relatively broad excitation bandwidth and low detection sensitivity, all resulting in 
too low signal-to-noise ratios. Herein we describe the extension of a standard, 
commercially available wide field fluorescence microscope for on-bead screening. 
We demonstrate that the autofluorescence problem can be overcome by an optical 
image subtraction approach which leads to excellent signal-to-noise ratios and 
results in unambiguous detection of true hit-beads. The combination of modern 
sCMOS camera detection and LED based excitation with this image subtraction 
approach for autofluorescence correction results in a robust on-bead screening 
system. A polymer capillary based bead-picking device, mounted on a mechanical 
slider, very efficiently allows the operator to isolate individual hit beads in less than 
20 seconds. The system, while easily implementable on any high-quality 
fluorescence microscope, can be used for ultra-fast automated screening of > 200 
000 bead bound compounds in 1.5 hours, thereby making it an exceptionally fast 
and cost effective screening platform.  
INTRODUCTION. Today, academic institutions play an increasing role in the 
development of novel and innovative drugs.[1][2] The emergence of chemical 
biology as a new discipline in the post-genomic era is one contributing factor to 
that development. Consequently, an ever increasing number of proteins and their 
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interaction networks are being studied.[3][4] This calls for efficient, miniaturized 
and economic approaches to identify new bioactive molecules.[5][6][7] 
Combinatorial Chemistry and High-throughput screening (HTS) certainly 
represent two enabling technologies for identifying new bioactive molecules.[8] A 
particularly efficient embodiment of combinatorial chemistry, the one-bead one-
compound (OBOC) library concept, as invented by Lam et al.[9], allows the 
generation of large compound libraries of hundreds of thousands to millions of 
compounds on polymeric carrier beads. On-bead screening on the other hand is a 
particularly easy to use and efficient affinity based screening concept. It selects hit-
beads based on the binding of a soluble, tagged target protein or a cell to the 
immobilized compound on the bead surface[10][11]. Each bead therefore 
represents a highly miniaturized screening assay. With beads of 90 micrometer 
diameter, a loading of 100 pmol of substance and a bead volume of less than 1 nl, 
the amount of chemical substances required for a screen and the corresponding 
assay volumes are several orders of magnitude lower than even highly miniaturized 
multi-well-plate based high-throughput screening formats in homogenous 
solution.[12]  
This very efficient initial screening step can then be combined with different 
follow-up assays for further characterization and ranking of individual hit beads 
before resources are committed to the resynthesis of screening 
hits.[13][14][15][16] However, one of the major hurdles for a wider application of 
on-bead screening is the lack of simple, robust and easy screening platforms. In its 
simplest assay format, a fluorescently tagged protein can be used in on-bead 
screening for incubation of library beads. Hits, arising from the binding of the target 
protein to the bead-immobilized compounds, then need to be selected based on the 
fluorescence signal on the beads using a fluorescence microscope. Yet, the variable 
and pronounced autofluorescence intensity of library beads, which have gone 
through a combinatorial synthesis, makes a detection of hit beads based on their 
fluorescence intensity difficult. Different strategies, which were developed to 
overcome this autofluorescence problem, range from the immobilization of 3-
Nitro-Tyrosine as an internal quencher prior to library synthesis to the use of 
quantum dots as secondary detection aid.[17][18] However, any non-specific 
binding of the secondary detection reagent in sandwich assays is hard to control. 
The COPAS instrument is the only commercially available on-bead screening 
platform.[19,20] It essentially works as a fluorescence activated bead sorter and 
thereby allows a fast real-time manipulation of beads, but naturally suffers from 
the same binding signal versus bead autofluorescence problem. Pre-sorting of 
libraries to remove beads with high autofluorescence has been suggested as one 
possible, but time-consuming solution.[21] Alternatively, a multi-channel real-
time analysis was recently shown to enhance the signal-to-noise ratio on the 
COPAS instrument significantly.[22] Our own group has previously developed the 
PickoScreen instruments, a confocal nanoscanning and bead-picking platform 
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(CONA), exploiting the high-resolution fluorescence imaging capabilities of 
confocal microscopy for overcoming the bead autoflourescence.[23] The CONA 
method for the first time made a precise, quantitative detection of on-bead binding 
events possible under high-throughput screening conditions. This methodology has 
recently also been used to investigate the thermodynamics and kinetics of on-bead 
binding events.[24] However, in CONA, the need for scanning large areas with 
high resolution limits the achievable speed. Furthermore, the use of lasers, sensitive 
confocal optics and a complex bead-picking robot leads to considerable complexity 
and high instrumental costs, which render this technology inaccessible to a wider 
research community.  
We have therefore constructed an ultrafast wide field fluorescence microscopy 
based on-bead screening instrument featuring a capillary based high-speed, high-
precision z-axis picking device, which is operated by using a kinematic guided 
mechanical x-axis slider. We further demonstrate herein that this fast wide-field 
fluorescence imaging approach opens up the possibility to use an image subtraction 
approach to reliably detect hit-beads despite a significant and variable 
autoflouresence background. The image-based autofluorescence correction, 
combined with the fast wide field fluorescence imaging and the robust, yet simple 
bead picking option for the first time generates an on-bead screening platform 
which can be mounted on any standard fluorescence microscope at limited costs 
and achieves unprecedented screening speed.  
 
RESULTS 
Library bead fluorescence  
To study the fluorescence properties of typical TentaGel based one-bead one-
compound combinatorial libraries, a small library containing cyclic hexapeptides 
of the general form NH2-Pra-Glu[-Pro-X-Y-Z-Asp-], X, Y and Z being the 
combinatorial positions was constructed using Fmoc- based solid phase peptide 
chemistry. An N-terminally allyl-protected glutamate was used for side-chain 
anchoring of the cyclic peptide. The head-to-tail cyclization was affected on resin 
after palladiumacetate based allyl-group removal. This treatment resulted in a bead 
population with different levels of autofluorescence, as seen from a CONA image 
(Figure 1a). To analyze the fluorescence properties of these beads, fluorescence 
excitation- and emission spectra were collected (Figure 1b). For further 
characterization, the average fluorescence lifetimes of these library beads were 
measured using a fluorescence spectrophotometer (Figure 1c). In addition, the 
fluorescence lifetimes of individual beads were measured using a standard wide 
field fluorescence microscope equipped with a commercially available module for 
phase-domain based fluorescence lifetime determination (LIFA from- Lambert 
Instruments) (Figure 1d). These fluorescence lifetime measurements revealed that 
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the library beads exhibited surprisingly long average fluorescence lifetimes of 
about 3 ns, rendering the use of fluorescence-lifetime as a detection principle for 
hit-bead detection impractical (Table 1). We therefore decided to focus our efforts 
on obtaining an efficient spectral separation of bead autofluorescence and protein-
tag derived fluorescence signal for building an optimized fluorescence wide-field 
microscope for on-bead screening.  
 
 
 
Figure 1: Fluorescence properties of TentaGel library beads. A) CONA image of 
a well from a 96-well microtiter plate filled with typical beads from a one-bead 
one-compound library, recorded with 633 nm excitation B) Fluorescence excitation 
and emission spectra of the same bead sample as in a. C) Fluorescence life-time 
determination of average autofluorescence from the bead sample in a. D) 
Fluorescence life-time imaging of the bead sample in a. using a commercially 
available phase-domain based fluorescence lifetime unit (LIFA from- Lambert 
Instruments) mounted on the WIOBS-1 instrument. 
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Table 1: Fluorescence life-time data determined for the autofluorescence arising 
from typical one-bead one-compound library beads at different excitation/emission 
wavelengths.  
 
Instrumental design elements 
The instrumental design was driven by the principle of using commercially 
available components while avoiding complicated robotics systems (Figure 2). 
While wide field fluorescence microscopes often still rely on lamps for excitation, 
the use of cooled LEDs has become an excellent alternative. LEDs offer the 
advantage of delivering high intensities in a narrow wavelength range thereby 
overcoming the need for expensive laser equipment.  
During on-bead screening many different bead populations are encountered in a 
single field of view. There are dark beads with hardly any signal, beads with 
different levels of broad spectrum autofluorescence, originating from the various 
chromophoric elements distributed in the entire bead volume and finally, beads 
which on top show the specific fluorescence signal due to protein binding within 
the first few micrometers of the bead surface.  
This creates a need for a camera which features both, high-sensitivity as well as a 
wide dynamic range. We therefore decided to use a sCMOS technology based 
camera (Andor Technology, Belfast/UK). A standard fluorescence microscope, the 
Leica DMI6000B (Leica Microsystems, Wetzlar/Germany), equipped with a 
scanning stage, served as the platform onto which the LED lightsources and the 
camera were integrated. This setup was further complemented by a bead-picking 
device (Life Imaging Services GmbH, Basel/Switzerland) (Figure 2b). Our group’s 
previously reported bead-picker, one of the defining elements of the 
PickoScreen[23] series of prototype confocal screening instruments, used a 
complex robotic system, which moves a picking capillary in 3D. This causes the 
need for an alignment procedure between an external 3D coordinate system and the 
2D coordinates of the beads in the screening plate. Furthermore, the high-precision 
needed for the movement of the picking capillary across a distance of about 30 
centimeters limits the speed with which the robotics arm can move. We therefore 
reasoned that it would be highly desirable to have a mechanical slider, which can 
191  
be used to manually move the picking capillary and position it right in the center 
of the field of view by a magnet at the end of the slider (Figure 2a, indicated). This 
only leaves the precise up-and-down movement of the picking capillary to be 
automated. To this end, a motorized z-axis (Physik Instrumente-PI GmbH & Co. 
KG Karlsruhe/Germany) was mounted onto the slider which performs a three-step 
movement of the picking capillary holder (see bead picking). Finally, the picking 
capillary is mounted on the holder by first gluing a polyimide tubing (Accellent 
Inc. MA, USA), the picking capillary, into a short metal tubule and inserting it with 
the metal part into a silicon lined channel on the transparent capillary holder, an 
polycarbonate disc. The other end of this channel, running across the capillary 
holder is then connected via a tubing to a hydraulic pump (Kloehn Inc. USA Las 
Vegas, NV), which generates a precisely controllable negative pressure for sucking 
beads into the capillary for subsequent dispensing into a collection tube or well. 
We dubbed this new screening instrument WIOBS 1 for Widefield Fluorescence 
Imaging based On-bead Screening and bead-picking device 1.  
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Figure 2: The WIOBS-1 instrument A) 3D overview sketch, generated with 
IronCAD (version 11.0), with bead picker positioned over a 96-well microtiter 
plate. The individual parts are indicated; the close up shows the bead picker arm 
above the microtiter plate and scanning stage. B)  Zoom view of the bead-picker, 
the picker capillary, mounted into the clear polycarbonate disc is shown.  
 
Wide field fluorescence based quantitative on-bead screening 
For testing the suitability of WIOBS 1 for fast and quantitative on-bead screening 
we first generated model hit beads by decorating standard 90µm TentaGel S beads 
on their amino groups with biotin. Aliquots of 2 mg of these biotinylated beads 
were then filled into 1.5 ml Eppendorf test tubes and incubated for 6 hours with 
different concentrations of three differently labeled streptavidin conjugates, Alexa-
488-streptavidin, TMR-streptavidin and Alexa-647-streptavidin. After thorough 
washing, 1 mg beads from each tube was then transferred into a well of a 96-well 
microtiter plate and fluorescence images were recorded using constant acquisition 
parameters (Figure 3a). Streptavidin binding to the beads was clearly detectable in 
all images, as seen from a pronounced fluorescence signal in the form of a halo 
around the beads. An analysis of the average pixel intensities for each image shows 
that the fluorescence signal responds linearly to the increasing incubation 
concentrations of all tested streptavidin conjugates with linear correlation 
coefficients higher than 0.9 (the highest concentration of the TMR-streptavidin 
series was excluded from the curve-fit due to inhomogeneous fluorescence signals 
on some of the beads). Thus, WIOBS1 proved to be able to specifically and 
quantitatively detect the binding of a fluorescently labeled target protein to 
TentaGel beads under typical on-bead screening conditions.  
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Figure 3: WIOBS 1 on-bead screening images and signal dynamics A) images of 
biotinylated beads incubated with increasing concentrations of different 
streptavidin-conjugates. Left: Alexa-488-streptavidin, Middle: TMR-streptavidin, 
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Right: Alexa-647-streptavidin. Top-to-bottom: 50 nM, 150 nM, 250 nM, 500 nM 
conjugate, after 6 h incubation. B) Linear data fit of average pixel intensities 
obtained from each image in a. 
 
Image merging and screening speed  
Next, we turned our attention to verifying the underlying rational that fluorescence 
wide-field imaging can provide an ultrafast method for on-bead screening. For that 
purpose, an efficient tile-image merging procedure had to be established, which 
would allow us to screen entire wells of a 96-well microtiter plate. Due to 
inhomogeneities in excitation and detection efficiency within a single image frame, 
the individual tile images first need to be corrected for any such optical 
imperfections using a previously recorded reference image. In a first step, the 
optimal number of tile-images for complete imaging of an entire well of a 96-well 
microtiter plate for 5x, 10x and 20x magnification were determined to be 9 images, 
32 images and 84 images, respectively (Figure 4). The time needed for the system 
to record and process individual tile-images in order to obtain a merged image of a 
complete well of 96-well microtiter plate, containing 2000 standard 90µm 
TentaGel beads, under different instrumental settings was recorded (Table 2). The 
image acquisition times including autofocus determination ranged from 26 seconds 
for a well at 5x magnification to 2.5 minutes for a well at 20x magnification. The 
additionally required time for the image merging procedure can in principle be 
allocated to a second computer and done in parallel to the recording of the 
following well. Thus, at 5x magnification recording an entire 96-well microtiter 
plate, containing around 200 000 beads or bead bound compounds takes about 41 
minutes. The sensitivity even at 5x magnification proved perfectly suitable for 
detecting the binding of Alexa-647-streptavidin to the biotinylated beads after 
incubating the beads with 50 nM conjugate for 6 hours (Figure 4). At higher 
magnification the sensitivity for detecting hit-beads further improves, however at 
20x magnification, which requires 84 images per well, the recording time for a 96-
well plate increases to 4 hours with an additional 7 hours of image merging time 
on a standard PC. The 10x magnification represents a good compromise between 
speed and sensitivity and allowed us to acquire data from an entire 96-well plate in 
less than 2 hours.  
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Table 2: Typical parameters and time for imaging of entire wells of a 96-well 
microtiter plate on the WIOBS-1 instrument at different magnifications 
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Figure 4: Images of full wells from a 96-well microtiter plate containing a 
monolayer of 90 m Tentagel beads recorded on the WIOBS 1 instrument at 
different magnifications and after tile-image merging. Top: 5x, Middle 10x, 
Bottom: 20x.  
Bead picking  
The simplicity of the bead-picking device enables a fast isolation or sorting of 
beads both, in brightfield illumination mode (Figure 5A) or under fluorescence 
imaging settings (Figure 5B) in six steps:  
Step 1 - Alignment: as individually cut picking capillaries vary in length, the 
appropriate Z-axis positions have to be determined before a picking session. These 
Z-axis positions are: a) The bead selection position; which is 10 to 50µm above the 
bead monolayer and allows the picking capillary to be seen in the microscope`s 
field of view. It allows fine adjustment of the capillary`s position above the bead 
of interest by moving the x,y-stage without disturbing the beads. b) The picking 
position, which is a few micrometers above the well bottom. This ensures that the 
bead, which is captured by the capillary, will be sucked up without creating a 
turbulent flow through the capillary`s opening.  
Step 2 - Bead Selection: The x,y-coordinates of the beads are stored with each well 
image. A simple mouse click on the image allows to select the respective beads and 
causes the scanning stage to move to these positions, bringing the selected bead 
into the center of the field of view.  
Step 3 – Capillary movement to bead selection position: The capillary is lowered 
to the position immediately above the bead monolayer and consequently becomes 
visible in the field of view without disturbing the beads.  
Step 4 – Picking: Capillary is lowered further to the bead picking position and 
engulfs the selected bead. A predefined volume of liquid, ~4 µl for 90µm beads, is 
drawn into the capillary and the beads is sucked into the capillary.  
Step 5 – Capillary withdrawal: The capillary is moved out of the well to the resting 
position. The slider is manually moved to the side for dispensing the bead.  
Step 6 – Bead dispensing: A volume of 10 µl is dispensed through the capillary. 
Thereby the bead is placed along with the liquid into a well of microtiter plate, a 
glass vial or any other vessel.  
This entire picking procedure for a single bead takes approximately 20-30 seconds.  
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Figure 5: Bead picking on the WIOBS 1 instrument. A) Overview of the picking 
process, detailing the different steps and corresponding bright-field images B) 
Bead picking on the WIOBS 1 instrument under fluorescence imaging settings. 
Top row: images corresponding to different stages in the picking process; bottom-
row: images corresponding to the different stages in the bead dispensing process 
into a separate empty well. 
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Image Subtraction Approach for detection of hit-beads 
So far, the data recorded with three different fluorescently labeled streptavidine 
conjugates and biotinylated TentaGel beads demonstrate that wide-field 
fluorescence imaging with a fine-tuned instrument is perfectly suitable for 
detecting target protein binding to beads with excellent reproducibility. However, 
biotinylated Tentagel beads have only undergone one coupling step and therefore 
exhibit a uniform low autofluorescence. The discrimination of hit among a 
population of beads with various levels of autofluorescence, as seen a typical one-
bead one-compound library is more challenging. Especially so, when lower 
magnifications like 5x objectives are used for ultimately fast screening. Moreover, 
the autofluorescence of library beads is not restricted to the specific emission range 
of a label and usually much broader in its emission bandwidths (Figure 1). We 
therefore reasoned that a second fluorescence image, taken at an excitation and 
emission wavelength sufficiently below or above the specific absorption and 
emission of the label of the target protein can be used to correct for bead-
autofluorescence (Figure 6A). To demonstrate the applicability of this approach, 
beads from the prototypical cyclic peptide library used to measure the data shown 
in Figure 1 were mixed with a small number of biotinylated beads and incubated 
with 50 nM fluorescently tagged streptavidin conjugate for six hours. Entire wells 
of a 96-well microtiter plate were then imaged with two different excitation and 
emission wavelength settings using the WIOBS 1 instrument (Figure 6B). For the 
Alexa647 labeled streptavidin, the 488/520 nm channel was used for 
autofluorescence correction, whereas for the Alexa488 labeled streptavidin the 
455/485 nm channel was used to correct for autofluorescence. In addition, the 
exposure parameters were adjusted so that the average signal intensities were in the 
same intensity range. This adjustment of exposure parameters can easily be done 
before a full on-bead screen is carried out using a population of typical library 
beads. The two set of images were then simply subtracted to generate an 
autofluorescence corrected image. Under all settings used, this resulted in images, 
where only the true hit beads are visible (Figure 6C). With this method even the 5x 
magnification settings proved sensitive enough to discriminate beads with bound 
Alexa488 labeled streptavidin from beads with high autofluorescence. This 
represents a worst case scenario, as the peak of the bead autofluorescence signal is 
around 490 nm.  
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Figure 6: Image subtraction approach for on-bead screening on WIOBS 1. All 
images were recorded using 5 x magnification. Well were filled with beads from a 
one-bead one-compound library of cyclic hexapeptides, spiked with biotinylated 
beads and incubated with different streptavidin conjugates (50 nM, 6 h). A) 
schematic representation B) example from tile-images of a well incubated with 
Alex-647-streptavidin. C) full well 96-well microtiter plate images. Top row: 
Alexa-647-streptavidin conjugate. Bottom row: Alexa-488-streptavidin conjugate.  
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Cell based screening 
One conceptual advantage of using a standard wide-field microscope for on-bead 
screening is that the system can also be used for selecting cell-surface binding 
ligands when entire cells, rather than isolated soluble proteins, are used for 
screening. To test the applicability of our WIOBS 1 instrument for cell-based on-
bead screening, we used HeLa and Huh-7 cells and compared the cell-binding 
behavior of two different peptidic ligands, a cyclic disulfide bridged peptide, 
CRKRLDRNC[25], as well as the transferrin binding peptide HAIYPRH[26]. Both 
peptides were synthesized on TentaGel beads using Fmoc-chemistry. The disulfide 
bridged peptide was cyclized on-bead by iodine mediated disulfide formation.  
Beads carrying either one of the two peptides or biotin as a ligand where incubated 
with HeLa cells or Huh-7 cells at 37° C in an incubator under constant shaking 
before being imaged on the WIOBS 1 microscope using bright field illumination 
setting. As soon as five minutes after incubation, a clear difference was seen 
between the cell lines and ligands (Figure 7). HeLa cells clearly bound specifically 
to the cyclic CRKRLDRNC peptide whereas, no binding was observed to the other 
two ligands. Also, Huh-7 cells did not bind to any of the ligands. This clearly 
demonstrates, that the WIOBS instrument is also suitable for cell-based on-bead 
screening e.g. for identification of cell-type specific targeting ligands. 
 
 
Figure 7: Cell-based on-bead screening using WIOBS 1. All images were recorded 
using bright-field illumination using 5x magnification. Left: beads carrying the 
cyclic peptide CRKRLDRNC[25], Middle: beads carrying a linear peptide, 
HAIYPRH[26], Right, biotinylated beads. Top row: HELA cells, bottom row: Huh-
7 cells.  
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DISCUSSION. Three main factors contribute to autofluorescence of typical library 
beads and therefore complicate the detection of real hit beads after incubation of 
the library with fluorescently labeled target proteins: First, TentaGel, the most 
common solid support used in on-bead screening has a substantial intrinsic 
autofluorescence, arising from the polystyrene co-polymer. Secondly, during 
chemical synthesis, in-complete couplings and side reactions of reagents lead to 
by-products with pronounced fluorescence emission across the entire spectrum. 
Thirdly, individual library compounds themselves can contribute to the background 
fluorescence if they contain larger conjugated pi-electron systems. This third factor 
is the only one which can consciously be influenced and minimized during library 
design e.g. by selecting different building blocks or by the general compound 
design.  
In general, the bead autofluorescence issue in on-bead screening described above 
can either be addressed by using a high-resolution (confocal) imaging setup which 
can separate the signal on the outside of the beads from the bead interior or by 
making use of one of the many parameters of fluorescence, such as fluorescence 
lifetime or specific excitation and emission wavelength i.e. spectral separation. For 
example, if labels are used with bright fluorescence emission in the red region of 
the spectrum the ratio of specific signal intensity to autofluorescence intensity gets 
better as autofluorescence is usually much more pronounced in the blue-to-green 
region of the spectrum. Another example for a smart detection principle would be 
fluorescence lifetime. However, when investigating this possibility for on-bead 
screening unexpectedly long fluorescence lifetimes of around 3 ns were measured 
for the autofluorescence signal. This long-lifetime background signal makes any 
specific detection of fluorescence signals from standard organic dyes with lifetimes 
of 1-4 ns very difficult under screening conditions. We therefore turned towards 
spectral separation as the method for dealing with autofluorescence. In order to 
overcome the limitation of wide-field imaging for fluorescence based detection of 
hit beads during on-bead screening, we first optimized the individual components 
of the fluorescence microscope, including cooled LEDs as powerful light source 
and a detection chip based on the sCMOS technology which features favorable 
characteristics with respect to sensitivity and linearity. As a second element we 
developed a new optical image-subtraction approach. This approach uses a second 
detection channel for correcting the fluorescence signal measured in one channel 
by the autofluorescence signal measured in the second channel. Ideally, the second 
channel should be close to the specific fluorescence emission channel of the label 
but well separated in order to minimize cross-talk. Although this image subtraction 
approach effectively doubles the measurement time, it proved to be highly efficient 
in dealing with autofluorescence and allowed us to detect hit-beads even with a 5x 
objective. The very short measurement times associated with the use of 
fluorescence wide field imaging instead of confocal imaging more than compensate 
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for this extra-measurement time. This ultimately reduced the screening time for a 
96-well microtiter plate containing approximately 200 000 TentaGel S 90µm beads 
to less than 90 minutes for a 5x objective and to less than 3.5 hours for a 10x 
objective. Furthermore, there is always the possibility to take an iterative approach 
and use a higher magnification for individual wells of high interest.  
In an attempt to also simplify the isolation of hit beads and improve the so-called 
bead-picking procedure, described previously[23], we constructed a bead picking 
device which only requires a motorized movement in one axis (z) and is mounted 
on a mechanical slider for moving it over the scanning stage and positioning the 
picking capillary in the center of the field of view. With this simplified picking 
device a significantly faster picking time of 20 to 30 seconds per bead was 
achieved.  
Overall, the resulting new instrumental platform for on-bead screening is simple to 
operate, does not require sophisticated equipment and is suitable for both 
fluorescence based screening with tagged target proteins as well as bright-field 
imaging for cell based screening. Our new development represents a further step to 
make on-bead screening more easily accessible to a larger number of researchers 
who want to use this miniaturized, cost effective high-throughput screening 
platform for the identification of new bioactive molecules.  
 
Materials and Methods 
All chemicals were bought from Sigma-Aldrich. TentaGel beads (standard 90µm 
diameter) with either free amine, Rink linker or HMBA linker were bought from 
Rapp Polymers, Germany. Labeled Streptavidin conjugates were bought from Life 
Technologies Corporation, USA.  
 
Chemical syntheses: 
All syntheses were carried out using manual solid phase peptide synthesis 
equipment and standard Fmoc chemistry, following standard procedures as 
recommended by Novabiochem, Germany and described previously.[15][27] In 
brief, resin loading for HMBA resin was carried out using the MSNT/1-
methylimidazole method. For couplings the individual building blocks (5.8 equ), 
HATU (6 equ.) was used as coupling reagent with DIPEA (12 equ.) as base and 
DMF as solvent. All couplings were carried out twice with each coupling time 40 
min. Fmoc deprotection after extensive washing was carried by four repetitive 
treatments of the resin with piperidine (20% in DMF) for 5 min. For the cyclic 
peptide library a head-to-tail cyclization on resin was carried out following Pd(0) 
catalyzed removal of an ally protection group on Glutamic acid (Fmoc-Glu-OAll) 
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and on-resin cyclization with HATU. Final side-chain deprotection of peptides was 
carried out using TFA:TIS:water (95:2.5:2.5) for 2 hours. Biotinylated beads were 
generated by coupling Biotin to TentaGel S NH2 resin using the HATU coupling 
procedure. The CRKRLDRNC peptide was synthesized on TentaGel S HMBA 
resin, using C-terminal 8-amino-3,6-dioxaoctanoic acid as C-terminal spacer. The 
peptide was cyclized after on-resin side-chain deprotection by DMSO treatment for 
24 hours.  
 
Fluorescence excitation and emission spectra of TentaGel beads  
Excitation and emission spectra of Tentagel beads containing a one-bead one 
compound library of cyclic peptides were recorded on a Fluorolog tau-3 
spectrofluorometer (Horiba Jobin Yvon). All measurements were performed with 
a Hellma 1.5 ml cuvette under stirring. The beads were suspended in a methanol : 
water mixture (1:3). Instrumental parameters were: polarizers in magic angle 
settings (55°), integration time 2 seconds, excitation and emission slit widths 3 nm 
and 4 nm, respectively. All spectra shown were corrected for the blank, dark and 
reference contributions as well as for instrumental spectral characteristics. 
 
Fluorescence lifetime measurements of TentaGel beads  
Lifetime measurements were performed on the Fluorolog tau-3 in lifetime mode. 
Ludox (silica particles in water) was used as the reference. The procedure for 
obtaining lifetime data was according to the manufacturer’s guidelines. In short: 
excitation and emission slits settings optimised to obtain optimum signal from the 
bead sample. The measurement was performed with parameters set to: integration 
time 10 seconds, frequency range 20 – 200 MHz, with 10 frequencies chosen as 
measurement points, and number of averages per measurements 5 to 7 at various 
excitation and emission wavelengths, respectively which were determined from the 
excitation and emission spectra of the library beads. The data was fitted using 
Horiba’s own “lifetime modelling” software.  
 
Instrumental description of WIOBS instrument  
The WIOBS1 instrument is based on a Leica DMI6000B inverted Fluorescence 
Widefield Microscope equipped with a sCMOS NEO (Andor) camera, a high 
precision motorized stage (C7018-9012K VEXTA Stepping Motor - Oriental 
Motor CO, Ltd. Tokyo, Japan), a coolLed pE-2 LED fluorescence illuminator (4 
LED`s 400/490/550/635nm) connected by 2 liquid light-guides and a TransLED 
white light source for bright field imaging. The light path was equipped with HC 
PL APO 10x/0.40, HC Plan APO 20x/0.70 HCX PL APO 40x/1.25-0.75 oil 
Objective and 4 fluorescence filter sets (LF 405- Ex390/40 Em452/45 Di405, GFP 
3035- Ex472/30 Em520/35 Di495, TRITC- Ex542/20 Em620/52 Di570, Cy5 4040- 
Ex628/40 Em692/40 Di660) for fluorescence excitation and emission separation. 
The Bead picker system was designed by Life Imaging Services GmbH (Basel, 
Switzerland) and consisted of a stiff and light Carbon arm mounted on a high speed 
(350mm/sec) high precision (provided by a linear encoder with sensor resolution 
204  
0.1μm & a bidirectional repeatability ±1μm), motorized z-axis (travel range 50 
mm) Physik Instrumente M-683.2U4 (PI GmbH & Co. KG Karlsruhe/Germany) 
and controller PI C-867. The end of the arm carries a clear polycarbonate disc 
which slides up to medial kinematic end position defined by a magnetic stop block 
on a manual x-axis (medial-lateral mobility 32 cm) underneath the Leica S70 WD 
condenser in the light path. This disc with clear design allows a bright field 
illumination and connects an exchangeable capillary by a silicon adaptor to the 
high- precision syringe pump VersaPump3 (Kloehn Inc. USA Las Vegas, NV). The 
stable end position of the bead picker capillary can be manually fine-tuned in the 
field of view by two screws in horizontal X & Y direction.   
All components of the WIOBS where controlled by MetaMorph Microscopy 
Automation and Image Analysis Software (Molecular Devices LLC. CA/USA 
Version 7.7.5.0 64bit -Image acquisition, processing and analysis package). For the 
integration of the Kloehn pump and the additional bead picker PI z-axis in the 
MetaMorph software the common shared communication port was used and 
automated data recording for a full 96-well microtiter plate was achieved by a 
combination of standard MetaMorph macros and recording of new journals. Finally 
image analyses, quantification and image processing like stitching and image 
subtraction routines were accomplished with the MetaMorph Image Analysis 
software package.   
Fluorescence based on-bead screening assay  
For fluorescence based on-bead screening 2 mg of beads were distributed into 1.5 
ml Eppendorf tubes and the beads were allowed to swell for several minutes in 1 
ml of PBS, 0.005% Tween 20. To further dissolve any bead clusters, the test tubes 
were repetitively (3 times 10 sec) sonicated. Subsequently, the tubes were spun 
down on a table-top centrifuge, the buffer was removed and the beads were treated 
with a fresh aliquot of buffer containing varying concentrations of dye-labeled 
streptavidin. The beads were then incubated on a shaker at RT for 6 hours. Prior to 
fluorescence imaging and bead picking, the incubation buffer containing the 
fluorescently labeled target protein was removed and the beads were washed at 
least 3 times with fresh buffer.  
 
Cell-based on-bead screening assay  
For cell based on bead screening, adherent cells (HeLa & Huh7) where detached 
by 8 min incubation with Cell Dissociation Buffer (enzyme free, PBS-based - 
Invitrogen) and prepared by centrifugation 2 min, 300 x g, followed by a careful 
re-suspension in FCS free medium at high cell concentration (1x10^6 cells/ml). 1 
mg beads were briefly washed with PBS and then re-suspended in 1ml FCS free 
cell medium. The beads were mixed with 5x10^5 cells in a total volume of 750 µl 
in a 1,5ml Eppendorf tube. After incubation for 10min at 37°C on a rotator wheel, 
free floating cells where separated by taking of the supernatant from the sedimented 
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beads. 200µl fresh medium was then added and beads are transferred into wells of 
a 96-well microtiter plate and imaged immediately and after 24h incubation at 
37°C. 
 
Fluorescence imaging, bright-field imaging and image merging on WIOBS 
instrument  
Typically, 96 well glass bottom plates (Greiner) were filled with 1 mg of beads to 
obtain a bead mono layer. Typical instrumental settings for fluorescence imaging 
using streptavidin conjugates were as follows: Alexa488: excitation 490nm, Led 
intensity 50%, exposure time 200ms; TAMRA: excitation 550nm, Led intensity 
100%, exposure time 250ms; Alexa647: 635nm, Led intensity 100%, exposure 
time 350ms. Camera settings: frames to average 3; Center Quad.). For bright- field 
imaging with TransLed illumination (intensity 30-80%) exposure times were set 
between 2 to 20ms and automated illustration (colour depth, thresholds) was turned 
on. Whole 96well plate well illustration in 5x, 10x and 20x magnification was 
achieved by a three step (recording, stacking, merging) protocol.  
 
Bead picking on WIOBS instrument  
Bead picking was set up in a semi-automated way. The procedure contains a 
manually initiated sequence of standard MetaMorph software features and 
customized journals. 
Alignment: Before each picking session the standard z positions 
(home/bottom/top/Origin) were manually defined as follows: The bead picking 
arm with attached capillary was manually moved to the kinematic end position 
underneath the condenser and the capillary end was aligned in the center of the 
image by moving the polycarbonate disc of the bead picking device in x-y 
direction. In order to automate the capillary z movement of the picking procedure 
four z positions are pre-defined in the MetaMorph Z position control software. 
A) Bottom position: this position is defined by moving the capillary into a well of 
the microtiter plate and lowered until the capillary touches the well bottom. B) 
home/picking position: This position is one third of the bead diameter above the 
bottom position (e.g. 100µm bead, 33µm above the bottom position). C) Top 
position: This position is used for intra well movement about 120µm above the 
beads for capillary x-y positioning. D) Origin position: capillary position for inter 
well and manual slider movement. 
Bead picking: Whole well stitched images still contain pixel position information 
and with the MetaMorph function “move selected point to center of image” mouse 
click selected beads are positioned underneath the capillary. In the next step the 
capillary end incorporates the selected bead by moving the z axis to the picking 
position and Kloehn pump induced negative pressure sucks up (4µl volume) 
including the bead of interest. To dispense the bead the capillary is moved to the 
Origin position and a volume of 10 µl is dispensed by the Kloehn pump after 
manual trigger. 
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